Remodelling of the nuclear envelope during KSHV lytic infection by Coleman, Alexander John
  
 
 
Remodelling of the nuclear envelope during KSHV lytic 
infection 
 
Alexander John Coleman 
Submitted in accordance with the requirements for the degree of  
Doctor of Philosophy 
 
The University of Leeds 
Faculty of Biological Sciences 
School of Molecular and Cellular Biology 
 
September 2018 
 
 
 
 i 
 
 
 
 
 
 
 
 
 
 
 
The candidate confirms that the work submitted is his own and that appropriate 
credit has been given where reference has been made to the work of others. 
 
This copy has been supplied on the understanding that it is copyright material 
and that no quotation from the thesis may be published without proper 
acknowledgement. 
 
© The University of Leeds and Alexander John Coleman 
 
 ii 
 
This thesis is dedicated to the NHS staff at Leicester Royal Infirmary during my 
time there from November 1998 till my all clear in 2004. I will be forever grateful 
for their compassion and professionalism that ensured my chance to perform this 
work and live a life fulfilled. 
  
 iii 
Acknowledgements 
I would like to express my gratitude to my supervisor Professor Adrian 
Whitehouse for his invaluable support, trust and guidance over the course of my 
thesis.  
The journey of a PhD is a daunting one, so I’d also like to extend significant 
thanks to my friends and coworkers in the Whitehouse and Hewitt groups, past 
and present. It has been a great privilege to work in such a positive environment, 
surrounded by tremendous expertise and also genuinely lovely people. I’d like to 
say particular thanks to Dr. Sophie Schumann whose wit and wisdom has always 
kept me thinking straight and on the right path. 
Many thanks to Dr. Kyle Roux, for the provision of the BioID-nucleoporin 
constructs and advice on getting the best results from them. 
Thank you to Dr. Kate Heesom, Dr Sally Boxall and Dr. Brian Jackson for their 
help and technical support. 
I am grateful to the BBSRC for funding my studies and providing me with a 
diverse range of training activities to prepare me for life after a PhD. 
A big thank you to Rachel Reeves MP for Leeds West and her Leeds staff Jake 
Kelly, Jayne Hill and Stephanie Darlington, for giving me the opportunity to strike 
out and intern in the wild world of politics during one of the most tumultuous 
periods in memory. 
Whilst we’re on politics, a big thank you to Hilary Benn MP for all the support and 
encouragement. Thanks to Gina Greenley for all your support and helping ensure 
I balance my politics with my PhD. 
A small but not insignificant thank you to Dr. Geraint Parry, who in 2011 took a 
chance on an overly keen 1st year undergraduate and introduced them to the 
wonders of the Nuclear Pore Complex. 
 iv 
I am also grateful to Dr. Dada Pisconti, whose encouragement and hard work 
convinced me that a PhD was for me and that I was up to the challenge (I hope 
this proves you right!). 
A big shout out to the Brendan Rogers Fan Club (BRFC), a motley fellowship of 
PhDs led by the one and only Brendan Rogers, who ensured the journey to 
Mordor (thesis submission) contained enough boardgames, movies, Eurovisions 
and Christmases to keep us all sane. 
Finally, a huge thank you to my family, you’ve been the keystone in the arch of 
this great adventure and held me firm with your indomitable patience, love and 
unceasing belief that I could do this. 
And last but by no means least, thank you Emma, you’ve been my strength in 
weakness, my light in the dark, my song in the silence. I couldn’t have done it 
without you. 
  
 v 
Abstract 
Kaposi’s sarcoma associated herpesvirus (KSHV) is a human tumour virus and 
key aetiological agent for several malignancies including Kaposi’s sarcoma. 
KSHV exhibits a biphasic life cycle split between a persistent latent period with 
minimal gene expression and a lytic period with an expression cascade that 
culminates in the release of nascent virions. Crucially, the lytic phase has been 
shown to be important for tumorigenesis and the spread of Kaposi’s sarcoma. 
The Nuclear Pore Complex (NPC) is a protein mega-complex that regulates 
nucleocytoplasmic transport. It is formed by multiple copies of individual 
nucleoporins that combine into a sophisticated protein gateway. The regulation 
of nuclear access makes it a target for viruses that subvert the NPC in order to 
hijack the cell for viral replication. Whilst herpesvirus can induce changes at the 
NPC, little is known about KSHV NPC remodelling.  
This study presents an investigation of how KSHV targets the NPC during its lytic 
infection highlighting the targeting a specific nucleoporin, Nup98, and an attempt 
at broader interactomic analysis using proximity dependent biotin identification. 
Nup98 is specifically downregulated early during lytic infection by the E3 ubiquitin 
ligase activity of viral protein RTA. This appears to be related to the repression of 
expression at viral ORF50 promoters when Nup98 is overexpressed in the 
nucleoplasm. This study also highlights how depletion of Nup98 is detrimental to 
the virus, leading to failed virion egress.  
In summary, this project highlights how KSHV specifically targets one population 
of Nup98 but requires NPC-bound Nup98 to sequester a cellular mRNA for 
CHMP7 protein to ensure virion egress. It also provides the first attempt at using 
interactomic techniques to create a comprehensive, semi-quantitative profile of 
changes to the NPC during KSHV lytic infection that can pave the way for further 
interaction studies and the development of targeted antivirals for KSHV. 
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1 Introduction 
1.1 Herpesviriales 
1.1.1 Classification of Herpesviruses 
Viruses are a form of infectious agent that must reproduce within the living cells 
of a host organism. The origins of viruses are still disputed, but across all domains 
of life infectious agents that exhibit viral characteristics are observed, with many 
sharing key genes for viral replication and morphogenesis (Koonin et al., 2006).  
Herpesviruses are a morphologically distinct family of DNA virus that belong to 
the Herpesviriales order. The Herpesvirales order was established in 2009 by the 
International Committee on Taxonomy of Viruses (ICTV) in line with 
recommendations from the Herpesviridae study group. The Herpesvirales order 
contains three families of herpesviruses that are related to one another: 
Herpesviridae family, containing viruses that infect mammals, birds and reptiles; 
Alloherpesviridae family, incorporating viruses that infect fish and frogs; and the 
Malacoherpesviridae family, which includes viruses that can infect bivalves 
(Eberle et al., 2013). 
The largest of these families Herpesviridae is split into three further sub-families: 
alpha-, beta-, gammaherpesvirinae (Figure 1.1) (Matthews, 1979). Classification 
of viruses by the ICTV followed the basic principal that “a virus species is a 
polythetic class of viruses that constitutes a replicating lineage and occupies a 
particular ecological niche” until the advent of DNA sequencing techniques (Van 
Regenmortel et al., 1991; Davison, 2010). With the expansion of advanced 
3 
 
genomic techniques and metagenomics, the classification of viruses is moving 
further away from the polythetic rule as the size of the virome becomes one that 
cannot fully establish all the distinct ecological niches that viruses inhabit 
(Simmonds et al., 2017). 
 
Figure 1.1 The Phylogenetic tree of Herpesviridae. An outline of the evolutionary relationship of 
Herpesviridae using amino acid sequence alignment. Human herpesvirus 8 or Kaposi’s sarcoma associated 
herpesvirus is indicated with a red circle. Adapted from (McGeoch et al., 2008a). 
 
1.1.1.1 Alphaherpesvirinae 
The three main sub-families of Herpesviridae diverged between 180-210 million 
years ago (McGeoch et al., 1995). The Alphaherpesvirinae subfamily is believed 
Species Genus Sub-family 
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to have diverged first from the herpesvirus common ancestor. Within the 
Alphaberpesvirinae exist a number of different genuses originally separated by 
their infectious host. The most clinically relevant of these genuses are the 
Simplexvirus genus containing Herpes simplex 1 and 2 (human herpesviruses 
(HHV) 1 and 2) and the Varicellovirus genus containing Varicella-Zoster Virus 
(HHV-3). The predominant features of the Alphaherpesvirinae sub-family are the 
ability to infect a wide host cell range, an efficient and rapid reproductive cell cycle 
and the ability to establish latent infections in sensory ganglia. 
Alongside the above-mentioned human pathogens there are several important 
animal pathogens within the Alphaherpesvirinae sub-family. These include: 
another member of the Varicellovirus genus pseudorabies virus (Suid 
herpesvirus-1 (SuHV-1)), which primarily infects pigs but has also been shown to 
infect cattle, dogs, cats and horses; Marek’s disease virus also known as Gallid 
herpesvirus 2, an example of a member of the Mardivirus genus, which infects 
chicken and turkeys; and equine herpesvirus 1 (another member of the 
Varicellovirus genus), which causes encephalomyelitis and respiratory disease 
in horses (Woźniakowski and Samorek-Salamonowicz, 2015). 
1.1.1.2  Betaherpesvirinae 
Current approximations suggest the Betaherpesvirinae sub-familiy diverged 
slightly later than the Alphaherpesvirinae within the 180-210 million years 
divergence time frame (Davison, 2002). Betaherpesvirinae have a far more 
restrictive host range compared to Alphaherpesvirinae. Their reproductive cycle 
is also longer, with infected cells often enlarging, referred to as “cytomegaly”. 
These viruses can establish a latent infection in cells of the secretory glands, 
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reticuloendothelial system and the kidneys (Whitley, 1996). Betaherpesvirinae 
examples include human cytomegalovirus (HCMV, HHV-5) of the 
Cytomegalovirus genus and other human pathogens of the Roseolovirus genus 
(HHV-6A, HHV-6B and HHV-7). The Betaherpesvirinae sub-family also includes 
animal pathogens of the rodent family in the genus Muromegalovirus and of the 
elephant family in the genus Proboscivirus. 
1.1.1.3 Gammaherpesvirinae 
The Gammaherpesvirinae sub-family is approximated to follow a similar 
evolutionary divergence timeline as Betaherpesvirinae (Davison, 2002). 
However, Gammaherpesvirinae have the most restricted infectious range 
primarily infecting lymphocytes although some members can infect endothelial 
tissues. The most prominent members of the Gammaherpesvirinae sub-family 
are the human pathogens Kaposi’s sarcoma-associated herpesvirus (KSHV, 
HHV-8), a member of the Rhadinovirus genus, and Epstein-Barr virus (EBV, 
HHV-4), of the Lymphocrytovirus genus. Another member of the Rhadinovirus 
genus, murid herpesvirus 68 (MHV68), is an important model system for 
gammaherpesvirus study. 
1.1.2 Virion structure 
The herpesvirus virion has a distinct morphology that is shared across the order 
Herpesvirales (Figure 1.2). All herpesvirus genomes consist of a single large, 
linear double-stranded DNA molecule, that is contained within an icosahedral 
(T=16) capsid. This capsid is formed from 162 capsomers, 150 hexons and 12 
pentons, giving an approximate overall diameter of 125-130 nm. One pentameric 
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capsomere is replaced by the portal vertex, the crucial site of genome entry and 
exit (Chang et al., 2007; Deng et al., 2007). The viral capsid is surrounded by a 
tegument layer, an amorphous protein coat consisting of both cellular and viral 
proteins. Proteins within the tegument aid the virus rapidly upon viral entry in a 
variety of roles such as targeting the capsid to the nucleus, cytoskeletal 
reassembly, and intiaition of viral and host gene expression (Kelly et al., 2009; 
Penkert and Kalejta, 2011). Enclosing the tegument is the viral envelope, a lipid 
bilayer that contains a number of viral glycoproteins that facilitate host cell binding 
and membrane fusion (Mettenleiter et al., 2009). 
 
Figure 1.2 Herpesvirus virion structure. Schematic of herpesvirus virion with structural components 
highlighted. Figure taken from Swiss Institute of Bioinformatics ViralZone.ExPASy.org. 
 
1.1.3 Genomic structure 
The herpesvirus genome is a single double-stranded DNA molecule with a size 
range of 125-250 kbp. Comparative genomic analysis of herpesviruses breaks 
their genome into sections of unique and repeat regions. These repeat regions 
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(103-104 bp in size) are found in many herpesvirus genomes and different 
patterns of their placement between unique regions has led to the identification 
of six genome types (Figure 1.3). Genomes of Class A, consist of a unique 
sequence flanked by a direct repeat region an example of which is HHV-6. Class 
B genomes, such as KSHV, also exhibit a flanked unique sequence with directly 
repeated sequences at the genome termini present in multiple copy number. 
Class C, EBV being the predomiant example, is similar to Class B with its multiple 
copy number terminal direct repeats, but also contains an internal set of direct 
repeats. Class D genomes contain two unique regions each flanked by a set of 
inverted repeat sequences, an example of which is VZV. HSV-1 and 2 have class 
E genomes which exhibit two unique regions with larger repeat regions around 
the large unique sequence. Class E genomes also contain a sequence that 
contains a small section of repeats at the end of genome termini and at the 
junction between the large and small repeat region. Finally, Class F represents 
all herpesvirus genomes that do not include repeats characterised in the other 
classes. Crucially, the genome structure does not correspond to evolutionary 
relatedness and all genome types occur within Alpha-, Beta-, and 
Gammaherpesvirinae. 
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Figure 1.3 The Arrangement of Herpesvirus Genomes. Layouts of forms of herpesvirus genomes with 
unique (single lines) and repeat (boxes with relative directionality) sequences. For types B and C the 
numbers of repeats are variable. Adapted from (McGeoch et al., 2008b). 
 
1.1.4 Life cycle 
The first moment where a virus moves from an inanimate structural arrangement 
of lipids, nucleic acids, polysaccharides and proteins to an operational “living” 
entity is virion binding at the cell surface. Viral surface glycoproteins are essential 
for viral binding and entry, and in Herpesvirales are designated gL, gH and gB. 
The first contact interaction between herpesvirus and a cell is often via a host cell 
glycosaminoglycan, such as heparan sulphate (with the exception of EBV) 
(Shukla and Spear, 2001). This is a reversible reaction that is not essential to 
viral entry but has been shown to improve the efficiency of viral entry. This 
interaction with heparan sulphate anchors the virus onto the cell membrane, 
increasing its probability of interacting with additional cell surface receptors that 
will initiate viral fusion (Figure 1.4). Once a viral glycoprotein binds to the fusion 
receptor, the interaction is irreversible and the virus begins to fuse with the cell 
membrane (Spear and Longnecker, 2003). In KSHV, the viral glycoprotein K8.1A 
is responsible for the initial binding of the virus to cells via heparan sulphate (Luna 
et al., 2004). After fusion the capsid and viral tegument proteins are released into 
the cytoplasm. The capsid is trafficked to the nucleus via the microtubule network, 
which is stabilised by the action of tegument proteins (Sodeik et al., 1997; 
Naranatt et al., 2005). The capsid disassembles when it reaches the nuclear pore 
complex releasing the viral genome in linear form. This enters the nucleus and is 
circularised by covalent linkage at the head and tail of the DNA molecule 
(Poffenberger and Roizman, 1985; Garber et al., 1993; McVoy and Adler, 1994). 
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Figure 1.4 Viral entry mechanisms. a) Binding and fusion steps at the plasma membrane. Initial 
interactions between envelope glycoproteins (brown) and membrane receptors (purple) tether the virus to 
the plasma membrane, whilst other interactions trigger conformational changes that mediate membrane 
fusion (blue receptors and yellow glycoproteins). The fusion of viral and cellular membranes creates a 
hemifusion intermediate followed by full fusion. b) Alternate routes of entry, some herpesviruses are able to 
enter the cell via either fusion with the plasma membrane or fusion with the endocytic membrane after 
endocytosis. Taken from (Connolly et al., 2011). 
 
1.1.4.1  Latency 
The key characteristic of herpesviruses is their ability to establish a quiescent 
latent infection in order to maintain a long-term persistent infection. During this 
latent state the virus remains dormant and does not produce new virions. The 
sites of latency differ between the subfamilies of Herpesviridae with 
Alphaherpesvirinae such as HSV and VSV establishing a latent reservoir in 
neuronal cells, Betaherpesvirinae such as HCMV establish their latency in 
myeloid cells whilst Gammaherpesvirinae such as KSHV do so in B lymphocytes. 
How herpesviruses establish latency is poorly understood, however within the 
model herpesvirus system of HSV-1 it has been demonstrated that the 
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establishment of latency is a direct result of a failure to initiate immediate-early 
genes expression (Conn and Schang, 2013; Lee et al., 2016). This leads to 
histone deposition on the viral genome which establishes the latent 
transcriptional state (Deshmane and Fraser, 1989). During latency, 
herpesviruses transcribe a subset of genes called latency associated transcripts 
(LATs) that maintain the viral episome with minimal disruption to cell survival 
(Stevens et al., 1987). This ability to exist in a latent form is a key aspect of 
herpesvirus biology and the etymology of herpesviruses. Where the prefix 
herpes- is derived from the ancient greek verb hérpein, meaning to creep, this 
reflects the trait of establishing a dormant, creeping latent infection. 
1.1.4.2 Lytic 
The reactivation of a latent virus commits it to the second phase of the 
herpesvirus lifecycle, lytic replication (Figure 1.5). During lytic replication, an 
expression cascade is triggered leading to the full expression of the viral gene 
complement. This occurs in three different temporal stages of expression: 
immediate-early, delayed-early and late gene expression. Immediate-early genes 
are produced rapidly after the trigger of reactivation, their protein products initiate 
the transcription of delayed-early genes and begin to subvert host cell processes. 
Before DNA synthesis can begin, delayed-early genes are translated, helping 
concert efforts to drive the cell to produce nascent virions over regular cellular 
processes and begin viral DNA synthesis. The viral genome that was circularised 
when it entered the nucleus is replicated via a rolling circle style mechanism. This 
involves large-scale nuclear reorganization to form replication compartments, 
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where concatamers are produced from a single viral episome and then cleaved 
off to begin the packaging process (Reviewed in (Weller and Coen, 2012)).  
The packaging process is completed in the nucleus prior to virion maturation, 
which occurs through a series of envelopment and de-envelopment stages. This 
begins with capsids in the nucleus budding into the perinuclear space through 
the inner nuclear membrane (INM). For primary envelope-mediated nuclear 
egress to occur all herpesviruses encode two proteins that make up the nuclear 
egress complex (NEC) (Mettenleiter et al., 2013). In HSV-1, these are the 
proteins pUL34 and pUL31 which form a heterodimer which is essential for 
successful viral egress (Sam et al., 2009). The NEC recruit conserved herpesviral 
protein kinases (CHPKs) such as UL13, UL97 and BGLF4 (from HSV-1, HCMV 
and EBV respectively) to disassemble the nuclear lamina (Lee et al., 2008; 
Hamirally et al., 2009). This gives capsids access the the INM where the NEC 
hijacks cellular endosomal sorting complex required for transport-III (ESCRT-III) 
proteins (Arii et al., 2018). The ESCRT-III complex is responsible for a diverse 
number of cellular membrane-related functions including multivesicular body 
(MVB) formation, cytokinesis, and viral budding (Alonso Y Adell and Teis, 2011; 
Morita et al., 2011; Vita and Broadie, 2017). The HSV-1 NEC appears able to 
recruit ESCRT-III during nuclear egress through an interaction with ESCRT-III 
adaptor ALIX which is then able to recruit CHMP4 proteins to the INM at sites of 
HSV-1 virion envelopment (Arii et al., 2018). This envelope includes several viral 
glycoproteins such as gB and gH that promote de-envelopment of the perinuclear 
capsid by fusion with the ONM (Farnsworth et al., 2007). After de-envelopment, 
the capsid is released into the cytoplasm where tegument proteins are acquired 
by the capsid through a variety of processes including during capsid transport by 
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microtubules and within the trans-Golgi network (TGN) where the second 
envelopement step occurs (Luxton et al., 2006; Loomis et al., 2006). Viral 
glycoproteins are essential for secondary envelopement at the TGN along with 
the ESCRT-III complex which leads to a final enveloped virion within a TGN 
vesicle (Brack et al., 2000; Farnsworth et al., 2003; Pawliczek and Crump, 2009). 
Herpesviruses disrupt the TGN transport network during lytic replication which 
has been suggested to prevent recycling of TGN-derived vesicles, promoting 
forward transport to the plasma membrane (Wisner and Johnson, 2004). Capsid-
containing vesicles are then able to exocytose at the plasma membrane releasing 
newly produced virions. 
 
Figure 1.5 Herpesvirus lytic replication. a) After infection the virion releases the viral DNA which enters 
the nucleus and is rapidly circularised. b) Reactivation of the virus causes the expression of immediate-early 
(IE) genes. c) IE proteins move back into the nucleus and initiate the production of early (E) genes. d) DNA 
replication stimulates the production of late (L) genes, which encode key virion proteins. e,f) Late proteins 
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are reimported into the nucleus and assemble into nascent virions with newly replicated viral genomes. g) 
Virion egress via a multistep process, obtaining tegument proteins in the cytoplasm before final egress as 
the plasma membrane. Taken from (Knipe and Cliffe, 2008). 
 
1.2  Gammaherpesvirinae 
The Gammaherpesvirinae sub-family consists of four genera: 
Lymphocryptovirus, Macavirus, Percavirus, Rhadinovirus (Davison, 2010). The 
latent infection of Gammaherpesvirinae occurs in either B- or T-lymphocytes; 
however, their lytic infection occurs in fibroblasts or epithelial cells. These viruses 
all have a linear double-stranded DNA genome, the structure of which contains a 
large central region containing most of the viral genes. The ends of the genome 
are capped by variable numbers of direct repeat sequences required for genome 
circularisation during latency. 
The propensity to establish a latent infection in dividing lymphocytes means 
Gammaherpesvirinae have evolved a variety of mechanisms to ensure genome 
propagation without cell lysis. These include driving cell cycle progression, 
repressing antiviral signals and production of anti-apoptotic factors (Li et al., 
1997; Li et al., 1998; Sun et al., 2003). This manipulation of cell cycle and 
apoptotic signalling is linked to the ability of many gamma-herpesviruses to 
induce neoplasia and transform cells in culture. EBV and KSHV are two such 
human gamma-herpesviruses that are capable of causing multiple cancers and 
lymphoproliferative disorders. 
1.2.1 Epstein-Barr Virus 
Epstein-Barr virus (EBV) or human herpesvirus 4 is a gammaherpesvirus of the 
Lymphocryptovirus genus. The virus was first identified in 1964, after Michael 
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Epstein and Yvonne Barr visualised a section of lymphoblasts derived from 
Burkitt’s Lymphoma. This had been prompted after Epstein attended a lecture in 
1961 given by Denis Burkitt on the epidemiology surrounding the eponymous 
lymphoma in Africa. Epstein and Barr noted in their paper the “overall appearance 
of the virus resembles herpes simplex” and, after further collaboration with 
Werner and Gertrude Henle in Philadelphia, they observed viruses from “EB” (the 
name denoting the Burkitts lymphoma derived cell lines) and were confirmed as 
a new human herpesvirus (Epstein et al., 1964; Epstein et al., 1965). The virus 
was first described as Epstein-Barr Virus (after the cell lines from which it was 
first identified) and linked to the more common infection infectious mononucleosis 
by the Henle laboratory in 1968 (Henle et al., 1968).  
Structurally, EBV is a typical gammaherpesvirus with a linear double stranded 
DNA genome of 184 kbp. It encodes 85 genes that are expressed dependent on 
the lifecycle stage of the virus (Baer et al., 1984; de Jesus et al., 2003). Like other 
herpesviruses, the EBV lifecycle is split between a quiescent latent phase and a 
productive lytic phase. Whilst our understanding of EBV has improved 
significantly since its discovery in the 1960s, it remains a serious human 
pathogen due to its aetiological relationship with a number of malignancies such 
as Burkitt’s lymphoma, nasopharyngeal carcinoma, post-transplant 
lymphoproliferative disease, Hodgkin’s lymphoma and gastric carcinoma. 
Estimates in 2010 suggested that EBV-related cancers led to the deaths of 
around 143,00 people worldwide per year (a figure described as an 
underestimate), highlighting the continued relevance in understanding EBV and 
how it leads to cancer (Khan et al., 2014). 
15 
 
1.2.1.1 EBV Life cycle 
EBV forms a highly persistent infection (~95% global seroprevalence) due to its 
ability to infect the B-cell reservoir. It infects B-cells via the CD21 B-cell surface 
molecule but can also infect other cell types such as epithelial cells, 
mesenchymal cells and T-cells. Upon the initial infection of a naïve B-cell, EBV 
initiates the latency III programme with the full complement of latent viral proteins 
and RNAs expressed. This induces B-cells to transform into proliferating blast 
cells, establishing an infection-mediated lymphoblastoid cell line (Thorley-
Lawson, 2001). Within the proliferating blast cell the virus restricts its protein 
expression to latency II, which stimulates the formation of germinal centres by 
inducing infected B cell differentiation into latent B memory cells (which can be 
attributed to the viruses high persistence) (Casola et al., 2004). In B memory 
cells, EBV restricts its latent programme even further to latency I where a minimal 
number of viral proteins and RNAs are produced. Finally, these resting EBV 
positive, B cells can enter latency 0, a state with no viral protein production at all 
(Young and Rickinson, 2004).  
All EBV-induced malignancies are driven by viral latency however the alternate 
expression programmes described above are responsible for different 
pathologies (Figure 1.6). After latency 0, where no viral proteins are produced, 
latency I is the most restricted of EBV latency programmes. During latency I 
EBNA1 is the only viral protein produced, along with viral miRNAs and virally 
encoded small RNAs (EBERs) (Rowe et al., 1987; Yajima et al., 2005). Latency 
I is observed in all cases of endemic Burkitt’s lymphoma, the exact mechanism 
by which EBV induces Burkitt’s lymphoma is not well understood with some 
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studies showing EBNA1 can promote cell survival and others showing the 
contrary and it simply maintains the viral genome (Kang et al., 2001; Kennedy et 
al., 2003). Latency II, which is found in tumours in Hodgkin’s lymphoma, T cell 
and Natural Killer (NK) cell carcinomas, is characterised by the expression of 
EBNA1, latent membrane protein (LMP) 1, 2A, 2B along with EBERs and viral 
miRNAs. LMP1 is a viral oncogene capable of promoting cellular proliferation and 
survival (Pratt et al., 2012). LMP2A and 2B act together to elicit a B cell receptor 
(BCR)-like signalling cascade that promotes cell survival and proliferation 
(Fruehling and Longnecker, 1997; Lynch et al., 2002). Latency III, has the largest 
expression complement with all viral nuclear antigens produced (EBNA- 1, 2, 3, 
3A, 3B, 3C, leader protein), along with the LMPs, EBERs and viral miRNAs. 
These additional EBNAs have roles in promoting cell growth and survival 
(Tomkinson et al., 1993; Hsieh and Hayward, 1995). Latency III is observed in 
lymphomas in immunodeficient individuals whether post-transplant or in AIDS 
patients (Kutok and Wang, 2006). 
 
Figure 1.6 EBV latency programmes and associated disorders. Key viral proteins and non-coding RNAs 
for each latency programme along with associated disorders are highlighted. 
 
1.2.2 Kaposi’s sarcoma-associated herpesvirus 
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Human herpesvirus 8 (HHV-8) was initially discovered as Kaposi’s sarcoma-
associated herpesvirus (KSHV). Kaposi’s sarcoma (KS) was first described by 
Hungarian physician and dermatologist Moritz Kaposi in 1872 as “idiopathic 
multiple pigmented sarcoma of the skin” (Kaposi, 1872). Until the 1980s, the 
incidence of KS was very rare (at between 0.02 and 0.06 per 100,000 people), 
with greater prevalence in middle-aged to elderly men of Mediterranean 
European or Jewish origin (Safai and Good, 1981). However, with the onset of 
the AIDS epidemic in the early 1980s, when unprecedented numbers of AIDS 
patients began to present with KS, careful epidemiological research at this time 
identified that KS may be caused by a sexually transmitted infectious agent (Beral 
et al., 1990). It was not until 1994 that DNA fragments of a herpesvirus were 
isolated from a KS tumour using representational difference analysis of a 
patient’s genomic DNA in both unaffected tissue and tumour tissue (Chang et al., 
1994). Subsequently, KSHV was linked to multicentric Castleman’s disease 
(MCD), an atypical lymphoproliferative disorder, and primary effusion lymphoma 
(PEL), a B-cell lymphoma (Soulier et al., 1995; Cesarman et al., 1995). The viral 
genome was fully sequenced in 1996, yielding a ~165 kb viral genome, with 81 
open reading frames (ORF), many of which were functional homologues of 
herpesvirus saimiri (HVS), an old world monkey gammaherpesvirus (Russo et 
al., 1996) (Figure 1.7). Furthermore, KSHV also encodes 25 mature miRNAs, 
long non-coding RNAs (lncRNAs) and, recently, a number of upstream and small 
ORFs have been identified (Sun et al., 1996; Cai et al., 2005; Arias et al., 2014). 
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Figure 1.7 KSHV genome map. With ORF locations highlighted for each temporal phase of KSHV lifecycle. 
KSHV miRNA cluster also included. Adapted from (Coscoy, 2007) after data in (Arias et al., 2014) and 
(Paulose-Murphy et al., 2001).  
 
With the formalisation of KSHV as the key aetiological agent responsible for KS, 
PEL and MCD efforts began to understand the epidemiology of the virus. KSHV 
does not ubiquitously infect the world’s population as seen with EBV. A 
compilation of seroprevalence data in 2010 showed highest seroprevalence in 
sub-saharan Africa (>50%) (Figure 1.8). However, in Northern Europe and the 
USA seroprevalence is much lower at <10% and in the Mediterranean and South 
America seroprevalence is at 10-30% (Mesri et al., 2010). Interestingly, recent 
studies of the KSHV and KS incidence in Asia has found a marked variation in 
the seroprevalence of the virus across the continent with high levels of 
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seroprevalence in the Chinese autonomous region of Xinjiang, once a staging 
post on the ancient Silk Road between Europe and China, as well as high levels 
in Taiwan and Cambodia of between 10-30%. This is compared with very low 
levels of seroprevalence in Japan and Thailand of <10% (Zhang and Wang, 
2017).  
 
Figure 1.8 KSHV global seroprevalence data. % KSHV seroprevalence mapped per country with countries 
lacking data coloured grey. Adapted from (Mesri et al., 2010) with additional data from (Zhang and Wang, 
2017). 
 
1.2.2.1 KSHV associated diseases 
KSHV has been identified as the aetiological agent in three malignancies: 
Kaposi’s sarcoma (KS), multicentric Castleman’s disease (MCD) and primary 
effusion lymphoma (PEL) (Chang et al., 1994; Soulier et al., 1995; Cesarman et 
al., 1995). 
1.2.2.1.1 Kaposi’s Sarcoma 
Kaposi’s sarcoma presents as red-brown macules on the skin that range in size 
from several millimetres to centimetres. KS is categorised into 4 forms: classic 
% KSHV 
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KS, AIDS-associated KS, Endemic KS and Iatrogenic KS (Dezube, 1996). 
Classic KS is a rare presentation of the disease in elderly Mediterranean men, 
with lesions predominantly forming on the lower extremities. Patients often live 
with the disease for 10 years or more and typically do not die of KS (Hengge et 
al., 2002). AIDS-associated KS is an extremely aggressive form of the disease 
with lesions developing multifocally on the upper body, head and neck (Hengge 
et al., 2002). It quickly develops from lesions to tumours with tumour 
dissemination to organs rapidly leading to high mortality. KS is now the most 
common neoplasm in homosexual and bisexual men with AIDS. The frequency 
of this form of KSHV exploded during the AIDS epidemic in the early 1980s with 
incidence rates in homosexual men in San Francisco USA at 40% (Martin et al., 
1998; Goedert, 2000). HIV-1 infection appears to exacerbate KSHV 
pathogenesis through the HIV-1 tat protein that drives IL-8 expression promoting 
angiogenesis that contribute to KS tumour formation (Vogel et al., 1988; Lane et 
al., 2002). Endemic KS or African KS is predominantly observed in young men 
and young children, with a high prevalence across equatorial Africa. This was 
proposed to relate to the barefoot exposure to volcanic soils and subsequent 
uptake of aluminosilicates inducing a level of immunosuppression (Ziegler et al., 
1984; Wabinga et al., 1993). However, with the outbreak of the AIDS epidemic, 
KS also reached epidemic proportions in Africa rendering it difficult to study 
African KS as an independent disease. Iatrogenic KS is an unusual clinical 
presentation of KS that occurs on the induction of immunosuppressive therapy. 
It can occur chronically or rapidly onset and is an emerging clinical concern for 
those who have received organ transplants (Hengge et al., 2002). Intriguingly, 
studies have shown that iatrogenic KS is reversible on the removal of 
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immunosuppression (Hengge et al., 2002). Whilst high active anti-retroviral 
therapy (HAART) has proven to be highly effective at reversing the effects of 
AIDS and thus KS, seroprevalence rates are still high among certain 
demographics, especially in Africa. Furthermore, the emergence of iatrogenic KS 
in combination with an ageing population in many Western countries highlights 
the critical importance of continuing research into KS and KSHV to reduce 
mortality (Figure 1.9). 
 
Figure 1.9 Kaposi’s sarcoma incidience rates worldwide. Follows the levels of KSHV seroprevalence 
shown above with highest KS rates in central Africa. No data available for countries in white. Taken from 
(Mesri et al., 2010). 
 
1.2.2.1.2 Kaposi’s sarcoma-associated immune reconstitution inflammatory 
syndrome (KS-IRIS) 
Kaposi’s sarcoma-associated immune reconstitution inflammatory syndrome 
(KS-IRIS) is a form of immune restoration disease (IRD) that occurs in patients 
treated with HAART. IRDs are rare disorders that develop when the HAART 
22 
 
restored immune system stimulates an immunopathological reaction leading to 
disease. Whilst IRDs are more commonly seen with bacteria such as Cryptococci 
and mycobacteria, they have also been observed in patients with latent HSV-1 
infection and hepatitis B (French et al., 2004). The establishment of KS as an 
IRIS-associated disease comes from observations in Africa where a proportion 
of patients who successfully responded to HAART treatment for HIV went on to 
develop KS (Bower et al., 2005). Whilst KS-IRIS is not always fatal, it can 
complicate a patient’s recovery. Furthermore, the increasing use of HAART to 
treat HIV-1 in Africa makes KS-IRIS an emerging clinical problem (Martin et al., 
2009). 
1.2.2.1.3 Multicentric Castleman’s Disease 
Multicentric Castleman’s Disease (MCD) is a subtype of Castleman’s Disease, a 
group of lymphoproliferative disorders characterised by lymph node enlargement. 
Whilst there are 3 main subtypes of Castleman’s disease, KSHV has only been 
shown to cause MCD (Soulier et al., 1995). KSHV-MCD saw a resurgence during 
the AIDS epidemic with a strong correlation of MCD cases in a HIV context being 
KSHV-associated. The pathophysiology of KSHV inducing MCD is proposed to 
involve inflammatory dysregulation stimulated by lytic gene product viral homolog 
of interleukin-6 (vIL-6) (Polizzotto et al., 2012). Whilst the exact mechanism by 
which vIL-6 drives MCD development is unknown overexpression of IL-6 leads to 
MCD-like symptoms in mice (Brandt et al., 1990).  
1.2.2.1.4 Primary Effusion Lymphoma 
Primary effusion lymphoma (PEL) is a B-cell lymphoma that leads to the 
overproduction of malignant B-cells that invade body cavities such as the pleural 
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space. KSHV is required for PEL to develop and is often found as a complication 
of HIV-1 induced immune dysfunction (Cesarman and Knowles, 1999; Chen et 
al., 2007). PEL is highly aggressive and often found at a late stage of lymphoma 
progression, leading to very poor clinical outcomes for those diagnosed, with only 
a 52% 1-year survival rate in those diagnosed at an early stage (El-Fattah, 2017).  
1.2.2.2 Life cycle 
The KSHV life cycle follows the typical herpesvirus pattern as described above. 
KSHV encodes five conserved glycoproteins gB, gL, gH, gM, and gN. 
Furthermore, KSHV encodes several unique lytic cycle associated glycoproteins 
K8.1A, K8.1B, K1, K14, K15 KSHV glycoprotein gB binds heparan sulphate, but 
also contains the RDG motif which binds specifically to integrin α3β1, unlike other 
herpesvirus gBs (Akula et al., 2002). This targeting of integrin α3β1	broadly 
correlates with KSHV target cells, although it is not known whether virus binding 
to integrin facilitates fusion as gH, gL and gB have been shown to be required for 
KSHV fusion (Pertel, 2002). The attachment of the virus at the cell surface is then 
followed by entry and internalisation into the cell which is shown to be rapid 
reaching a peak within 60 minutes post infection (Krishnan et al., 2004). The 
interaction of viral glycoprotein gB with host receptors induces focal adhesion 
kinase (FAK) stimulating cellular signalling pathways to aid with actin 
rearrangements for virus internalization (Sharma-Walia et al., 2004; Veetti et al., 
2010) (Reviewed in (Chakraborty et al., 2012)). Once the viral envelope has fused 
with the cell membrane the internalized capsids are then trafficked via the host 
microtubule network to the nuclear periphery. The activation of FAK signalling by 
gB leads to downstream activation of  Rho and Rac, via intermediate signalling 
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steps by Src and phosphoinositide 3-kinase (PI3K), which lead to the stabilization 
of microtubules for the passage of capsids to the nucleus (Naranatt et al., 2005). 
Upon reaching the nuclear periphery, the capsid will release its genome cargo 
into the nucleus. The exact mechanism of KSHV genome delivery at the nuclear 
pore is not yet fully understood; however, the HSV-1 capsid (which is of a 
comparable size and diameter to KSHV) has been shown to dock to the nuclear 
pore via nucleoporins Nup214 and Nup358 (Copeland et al., 2009; Pasdeloup et 
al., 2009). A currently unidentified triggering event induces the uncoating of the 
capsid and the viral genome translocates through the nuclear pore complex. It is 
theorized that the efficiency and speed of the translocation process is driven by 
either pressurization of the viral genome during packaging, with electrostatic 
forces between the DNA and capsid proteins maintaining pressurization, or by 
immediate transcription of the genome providing a mechanical force to pull the 
viral genome into the nucleus (Reviewed in (Liashkovich et al., 2011)). Upon entry 
into the nucleus, the KSHV genome is in a linear double-stranded conformation. 
A crucial step before the establishment of latency is genome circularisation, the 
exact mechanism by which KSHV circularises its genome is poorly understood 
but may relate to the initiation of a DNA damage response (DDR) (Lieberman, 
2013). This occurs quickly after nuclear entry by the viral genome through the 
activation of ataxia-telangiectasia mutated kinase (ATM) and an increase in 
phosphorylation and protein level of histone 2AX (H2AX). This culminates in the 
formation of phosphorylated H2AX (γH2AX) foci which colocalise with the viral 
genome and has been hypothesised to assist in the recruitment of chromatin 
modifier proteins that are required for the establishment of viral latency (Singh et 
al., 2014).  
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1.2.2.2.1 Latency  
Following de novo infection it has been shown that the viral transactivator RTA is 
expressed immediately activating the Latency-associated-nuclear antigen 
(LANA). LANA expression downregulates RTA and represses its expression, a 
critical step in the establishment of latency (Lan et al., 2005). During a latent 
infection, KSHV is maintained as high copy number, circular episomes (~50 per 
cell) within the nucleus with minimal protein expression. Latently expressed 
genes predominantly feature around the latency locus which encodes 
ORF73/LANA, ORF72/v-Cyclin, ORF71/v-Fas-associated death domain-like 
interleukin-1β-converting enzyme-inhibitory protein (vFLIP) and K12 along with 
12 virally encoded microRNAs (Rainbow et al., 1997; Kedes et al., 1997; Dittmer 
et al., 1998; Sadler et al., 1999; Burýsek and Pitha, 2001). As well as repressing 
RTA, LANA acts to tether the viral episome to host chromosomes during mitosis, 
ensuring proper segregation and partition into daughter cells (Ballestas et al., 
1999). LANA has also been shown to maintain latency by inhibiting expression of 
the viral transactivator protein RTA (ORF50) (Lu et al., 2006). v-Cyclin is a viral 
cyclin homologue that forms a complex with cyclin-dependent kinase 6 and 
phosphorylates retinoblastoma protein (pRB) in order to dysregulate the cell cycle 
and promote the expansion of KSHV-infected cells (Godden-Kent et al., 1997; 
Verschuren et al., 2004). vFLIP is a viral homolog of cFLIP that inhibits Fas ligand 
induced apoptosis by preventing procaspase-8 activation (Thome et al., 1997). 
vFLIP also activates NF-kB pathways promoting cell survival (Matta and 
Chaudhary, 2004). As such these genes contribute to the primary aims of latency: 
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to maintain the viral genome and ensure transmission to host daughter cells 
during cell division in order to maintain viral copy number. 
1.2.2.2.2 Lytic Replication 
Latently infected cells transition to lytic replication can be triggered by a range of 
stimuli, including hypoxia, co-infection with HIV-1, oxidative stress and 
inflammatory cytokines (Mercader et al., 2000; Davis et al., 2001; Merat et al., 
2002; Ye et al., 2011). All latent-lytic switch events promote the expression of the 
viral transactivator protein RTA that initiates a temporally regulated sequence of 
gene expression which culminates in the assembly and egress of nascent virions 
and cell death. The induction of lytic replication leads to a cascade of changes 
within the cell, initiated by the virus, to subvert cellular machinery to achieve its 
key evolutionary goal: replication. In KSHV, lytic replication is marked by three 
distinct temporal stages of gene expression: immediate-early, delayed-early and 
late. At the apex of this transcriptional cascade is RTA (ORF50), an immediate-
early transcript that is sufficient and necessary for successful viral lytic replication 
(Lukac et al., 1998; Sun et al., 1998). In vitro phorbol esters are commonly used 
to induce lytic replication of KSHV-infected cell lines via a proposed activation of 
ERK activation leading to the production of the transcription factor c-Fos and c-
Jun which come together to form the AP-1 complex that promotes RTA 
expression (Cohen et al., 2006).  
Reactivation of KSHV from latency is a critical pathogenic step during the 
progression of KS (Moore et al., 1996). Furthermore, the transition to lytic 
replication in vivo appears inversely related to immunocompetency with tumour 
development observed in KSHV-positive transplant recipients using 
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immunosuppressants. Tumour development has been shown to successfully 
regress after the cessation of immunosuppressant treatment in some cases 
(Farge et al., 1999; Hengge et al., 2002). 
Expression of the viral gene ORF50 leads to the production of the RTA protein, 
which contains an N-terminal basic domain and a C-terminal acidic domain 
similar to the transactivating domains in the EBV Zta transactivator protein (Lukac 
et al., 1998). RTA is expressed as a 110 kDa protein with a 90 kDa minor protein 
also observed. These two forms differ in their phosphorylation patterns with 
experiments demonstrating that RTA is phosphorylated by cyclin-dependent 
kinase 9 (CDK9) in order to maximise its transactivational function (Lukac et al., 
2001a; Tsai et al., 2012). Initial studies of how RTA induces the transcription of 
KSHV genes were focused on two immediate-early transcripts: (MTA) mRNA 
transcript accumulation protein and polyadenylated nuclear (PAN) RNA. This 
highlighted two alternate methods of transcriptional activation by RTA. PAN RNA 
is an abundant non-coding poly-adenylated RNA that is expressed during KSHV 
lytic replication and appears to be critical for the expression of late viral transcripts 
(Sun et al., 1996; Borah et al., 2011). RTA was shown to directly bind to the PAN 
promoter which, in conjugation with the C-terminal activator domain, is sufficient 
for PAN RNA production. A consensus sequence within the PAN promoter is also 
found in other immediate-early genes such as Kaposin and is described as an 
RTA-responsive element (RRE) (Song et al., 2004; Chang et al., 2005). At RREs, 
RTA directly regulates the expression of certain immediate-early transcripts 
inducing their expression (Figure 1.10a).  
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However, RTA also activates transcription via an alternative pathway highlighted 
through studies on the regulation of expression of MTA protein at the ORF57 
promoter. MTA, also referred to as the ORF57 protein, is a viral immediate-early 
protein that subverts normal nucleocytoplasmic transport to preferentially export 
intronless viral mRNAs via the cellular TREx complex (Reviewed in (Schumann 
et al., 2013)). Through experiments characterising the role of RTA at the ORF57 
promoter, RTA was shown to bind to Recombination Signal Binding Protein 
(RBP)-Jk (Lukac et al., 2001b). This interaction between RBP-Jk and RTA 
appears crucial for the transcription of certain viral genes via the activation of the 
Notch signalling pathway (Liang et al., 2002; Swaminathan, 2005) (Figure 1.10b).  
RTA also appears to regulate expression through inducing degradation of 
transcriptional repressors (Yang et al., 2008). This is attributed to an intrinsic 
ubiquitin E3-ligase activity within RTA that targets cellular repressor proteins for 
degradation during lytic infection. Specifically, RTA has been shown to induce 
the degradation of the transcriptional repressor Hey1, allowing for RTA 
upregulation during lytic replication (Gould et al., 2009) (Figure 1.10c). 
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Figure 1.10 Outline of RTA mechanisms for gene transactivation. a) RTA binds directly to the RTA-
response element (RRE) initiating transcription. b) RTA recruits cellular transcription factors such as RBP-
jk to initiate transcription. c) RTA degrades a transcriptional repressor allowing for transcription. 
 
Through this variety of mechanisms, RTA is able to orchestrate the expression of 
a variety of immediate-early viral factors that begin to bring the cell under the 
control of the viral replication programme. K8, modulates cellular transcription via 
the recruitment of CREB-binding protein (CBP) (Zhu et al., 1999; Hwang et al., 
2001). Whilst, viral G-protein coupled receptor (vGCPR) acts as a constitutively 
active CXC chemokine receptor activating mitogen-activated protein kinase 
(MAPK), Akt, and phospholipase C (PLC)-mediated pathways in order to promote 
proliferation (Sun et al., 1999; Chiou et al., 2002; Smit et al., 2002; Cannon, 
2007). These immediate-early genes rapidly subvert normal host cell processes 
and allow for efficient expression of the delayed-early genes prior to viral genome 
replication.  
a) 
b) 
c) 
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The delayed early genes continue subverting host cell processes via the action 
of viral proteins like ORF37, which reduces cellular gene expression via 
increasing global mRNA turnover (Glaunsinger and Ganem, 2004; Glaunsinger 
et al., 2005), and prepares for the replication of viral genomes via genes such as 
ORF59, which translocates the viral polymerase ORF9 to the nucleus to initiate 
viral DNA replication (McDowell et al., 2013). After viral DNA replication the last 
temporal cohort of genes are expressed, which include components of the virion 
such as ORF65 and viral glycoproteins like gB (Lin et al., 1997; Pertel et al., 
1998).  
Nascent virions assemble in the nucleus and undergo a multi-step egress 
process. This begins at the nuclear membrane where KSHV virions bud into the 
perinuclear space through the action of the KSHV nuclear egress complex (NEC). 
This is composed of two proteins ORF67 and ORF69, which share strong 
similarity with HSV-1 NEC proteins UL34 and UL31(Santarelli et al., 2008). Whilst 
the HSV-1 NEC proteins have been shown to interact with ESCRT complex 
proteins to aid with nuclear egress how KSHV subverts ESCRT-III during its own 
egress is less well characterised. However, experiments in EBV have shown that 
EBV NEC components also recruit ESCRT-III to aid with nuclear egress 
suggesting this process may be shared between herpesvirus sub-families. 
Overexpression of EBV NEC proteins is able to form nuclear membrane-derived 
vesicles suggesting they are involved in the initial envelopment step at the 
nuclear membrane during viral egress (Klupp et al., 2007). The enveloped virion 
then fuses via interactions with ONM proteins and viral glycoproteins with the 
ONM losing its envelope and releasing the virion into the cytoplasm. Within the 
cytoplasm the KSHV virion acquires tegument proteins such as ORF45 which 
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interacts with kinesin-2 and is responsible for capsid-tegument transport along 
microtubules and has been shown to help direct viral particles to the Golgi for 
final maturation (Sathish et al., 2009; Wang et al., 2015). Within the Golgi viral 
particles acquire their final envelope containing viral glycoproteins and are 
transported within a Golgi-derived vesicle to the cell membrane where the vesicle 
fuses with the cell membrane and releases the virion (Mettenleiter et al., 2009). 
1.3 The Nuclear Envelope 
The defining separation between prokaryotes and eukaryotes is the presence of 
a membrane separating the DNA genome from other cytoplasmic compartments. 
The nuclear envelope (NE) is the specific subcellular compartment that gives rise 
to this separation and is typically split into three components: the nuclear lamina, 
the nuclear membrane and the nuclear pore complex (NPC) (Figure 1.11). The 
nuclear membrane is split into the outer nuclear membrane (ONM) which is 
continuous with the endoplasmic reticulum and is orientated towards the 
cytoplasm, while the inner nuclear membrane (INM) is orientated towards the 
nucleoplasm. The nuclear lamina is a proteinaceous meshwork of class V 
intermediate filament proteins that act as a scaffold for the nuclear membrane 
interacting at the INM (Prokocimer et al., 2009). NPCs exist within pores of the 
nuclear membrane and regulate nuclear cytoplasmic transport. Traditionally, the 
nuclear envelope was viewed as a static structure that only underwent significant 
change during mitosis; however, a large body of emerging evidence shows the 
nuclear envelope compartment is a highly dynamic and responsive part of the 
cell. 
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Figure 1.11 Overview of the Nuclear Envelope compartment. Heterochromatin loops close to the nuclear 
lamina which is attached to the nuclear membrane made up of two lipid bilayers. Nuclear pore complexes 
reside within natural pores in this double membrane which also houses trans-nuclear membrane proteins 
that interact with the cytoskeleton through the LINC complex. 
 
 
1.3.1 The Nuclear Lamina 
The lamina is composed of type A or B lamin proteins, lamin B1 and B2 are the 
most common B lamins and are encoded by distinct genes LNMB1 or LNMB2. B-
type lamins have an acidic isoelectric point, at least one form is expressed in all 
cells, and are permanently found to be isoprenylated (which helps tether the 
protein to the INM) (Nigg et al., 1992; Gruenbaum et al., 2003). A-type lamins are 
formed from two splice variants of the LNMA gene that give rise to lamin A and 
lamin C. These proteins have a neutral isoelectric point, are expressed in a 
tissue-specific manner and may not always be isoprenylated (Gruenbaum et al., 
2003). Both types consist of a N-terminal head domain, a coiled-coil central rod 
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domain and a C-terminal tail domain, and include a nuclear localisation 
sequence, an immunoglobulin (Ig) fold and a CaaX motif (Gruenbaum and Aebi, 
2014). Experiments using 3D-structured illumination microscopy (3D-SIM) 
showed that lamin filaments form separate continuous meshworks in mammalian 
nuclei with A-type lamins playing a crucial role in regulating the distribution of 
NPCs (Shimi et al., 2015; Xie et al., 2016).  
The lamin meshwork not only acts as a simple scaffold but also has a multitude 
of binding partners. These include nuclear envelope transmembrane proteins 
(NETs) which allow the nuclear lamina to transmit mechanical signals to cellular 
actin filaments via the linker of nucleo- and cytoskeleton (LINC) complex 
(Padmakumar et al., 2005; Crisp et al., 2006). Lamins also play a role in binding 
heterochromatin to the nuclear periphery through interaction of LEM domain 
proteins and barrier to autointegration factor (BAF). Experimental studies have 
demonstrated how relocating actively transcribed genes to the nuclear lamina 
leads to gene silencing, demonstrating the regulatory role of the lamina (Reddy 
et al., 2008). This highlights how the nuclear lamina contributes to the physical 
organisation of nuclear contents (especially the genome) in order to regulate 
gene expression. Localisation to the nuclear periphery and the lamina is 
associated with an increased level of repression, whilst localisation of genes to 
the nuclear interior leads to their expression. In developmental contexts this has 
been shown to be especially important in defining stages of differentiation (Peric-
Hupkes et al., 2010). 
1.3.2 The Nuclear Membrane 
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The nuclear membrane is composed of two lipid bilayer membranes that are 
connected via membrane-bound proteins and at NPCs (Figure 1.12). The outer 
nuclear membrane (ONM) is contiguous with the endoplasmic reticulum and 
features a number of membrane-bound proteins, such as the Nuclear envelope 
spectrin repeat proteins (Nesprin) family. These proteins act to help transmit 
mechanosensory signals between nuclear filaments and the cytoskeleton 
through the functioning of the LINC complex (Burke and Roux, 2009; Uzer et al., 
2015). 
The inner nuclear membrane (INM) interacts with the nuclear lamina, giving the 
nucleus its overall shape, and is also the surface for many membrane-bound 
proteins. These include proteins that act within the LINC complex to transmit 
mechanosensory information, such as Sun2. Sun2 binds lamins and other 
nucleoplasmic factors but also has a lumenal domain targeted to the perinuclear 
space (the lumenal space between the ONM and INM). There Sun2 interacts with 
Nesprin proteins, forming a crucial bridge between the nucleus and the cytoplasm 
for the LINC complex (Hodzic et al., 2004; Crisp et al., 2006; Burke and Roux, 
2009). 
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Figure 1.12 Overview of the nuclear membrane. The lamina represented by alternating filaments of lamin 
A and B attached to the inner nuclear membrane (INM) via Sun1/2 proteins. These proteins bind to Nesprin 
proteins in the perinuclear space (PNS) which exists as a transmembrane protein between the PNS and the 
outer nuclear membrane (ONM) attaching to either plectin and then intermediate filaments (Nesprin 3) or 
actin via Nesprin 1/2. 
 
1.3.3 The Nuclear Pore Complex 
The Nuclear Pore Complex (NPC) is a highly conserved protein mega-complex 
that sits within pores formed within the nuclear membrane. Present in all forms of 
eukaryotic life, the NPC is the most significant conduit of information in the cell, 
giving rise to a selective bidirectional transport system. In humans, the complex 
is approximately 125 MDa in mass and is composed of ~500-1000 copies of 30 
different nucleoporins (Nups) (Cronshaw et al., 2002; DeGrasse et al., 2009). 
These give rise to a protein mega-structure that exhibits eightfold radial symmetry 
with a series of subcomplexes that perform critical roles in regulating 
nucleocytoplasmic transport. 
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1.3.3.1 Structure of the NPC 
Over the past 50 years significant work has elucidated a highly ordered structure 
comprising of multiple copies of nucleoporins arranged in eightfold radial 
symmetry around a pore within the nuclear membrane. Nucleoporins are 
complexed into different sub-complexes which come together to form 
substructures that form the overall NPC superstructure. These substructures can 
be classified into 6 main groups: integral membrane proteins of the pore 
membrane domain of the nuclear envelope (POMs); membrane apposed coat 
nucleoporins; adaptor nucleoporins; channel nucleoporins; nuclear basket 
filaments; and cytoplasmic filament nucleoporins (Hoelz et al., 2011) (Figure 
1.13). 
The first work on the nuclear pore began in 1950, when H. G. Callan used nuclei 
from amphibian Xenopus laevis to visualise the nuclear membrane using electron 
microscopy. Through his preparation he observed pores within the nuclear 
membrane which he described as “evenly space out over its area [outer nuclear 
membrane]” (Callan and Tomlin, 1950). In 1959, Michael Watson identified 
discrete densities at these pores with the appearance of a channel and 
cytoplasmic extrusions. He described these as “sufficiently well differentiated to 
be classed as an anatomical unit for which we propose the name pore complex” 
(Watson, 1959). Further work showed the pore complex was not circular but 
exhibited eight-fold radial symmetry and also extended significantly out into the 
nucleus and the cytoplasm (Abelson and Smith, 1970; Wischnitzer, 1973). As 
electron microscopy technology improved, the NPC quite literally came into focus 
with a 90 Å structure in 1982, beginning to highlight the discrete substructures 
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that make up the NPC (Unwin and Milligan, 1982). In 1986, Günter Blobel’s 
laboratory isolated the first nucleoporin and yielded an antibody for visualising 
the nuclear pore complex using immunofluorescence (Davis and Blobel, 1986). 
Increasing improvements have established that the structure of the NPC has two 
coaxial rings, at both the nuclear and cytoplasmic periphery, which are connected 
by eight elongated spokes and a central spherical plug region (Jarnik and Aebi, 
1991; Stoffler et al., 2003; Beck et al., 2004a). Whilst the core appears like a 
symmetric doughnut structure, the major structural projections out of the core are 
not symmetric and form a nuclear basket region and multiple cytoplasmic 
filaments.  
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Figure 1.13 The Structure of the Nuclear Pore Complex. a) Cryo-electron tomographic reconstruction of 
the Dictyostelium discoideum NPC [Electron Microscopy Data Bank (EMDB) code 1097, Beck et al. 2004]. 
The cytoplasmic filaments, the symmetric core, and the nuclear basket are coloured in cyan, orange, and 
purple, respectively. b) A schematic model of the NPC. The four concentric cylinders are composed of 
integral pore membrane proteins (POMs), coat nucleoporins, adaptor nucleoporins, and channel 
nucleoporins. Natively unfolded phenylalanine-glycine (FG) repeats of a number of nucleoporins make up 
the transport barrier in the central channel and are indicated by a transparent plug. Taken from (Hoelz et al., 
2011). 
 
The nucleoporin composition of these distinct structures has demonstrated how 
nucleoporins combine into small substructures that exist in multiple copies to give 
rise to the larger structures. Starting with the non-symmetric structures at the 
NPC, the cytoplasmic filaments are made up of three nucleoporins 
Nup358/RanBP2, CAN/Nup214 and Nup88/84 (Kraemer et al., 1994; Wu et al., 
1995; Bastos et al., 1997). Nup358 is a nucleoporin specific to vertebrates and is 
the largest nucleoporin, with purified Nup358 forming ~36 nm long, 5 nm thick 
filaments (Yokoyama et al., 1995; Delphin et al., 1997). It acts as a key junction 
during the RanGTP cycle and contains several phenylalanine-glycine (FG) 
repeats which function as binding sites for transport receptors (Yaseen and 
Blobel, 1999). Nup88/Nup84 forms a cytoplasmic orientated subcomplex with 
CAN/Nup214, an apparent component of the cytoplasmic filaments (Kraemer et 
al., 1994; Panté et al., 1994; Fornerod, van Deursen, et al., 1997; Bastos et al., 
1997). Both proteins appear to play a key role in nuclear localisation sequence 
(NLS)-mediated protein import and bulk mRNA export (van Deursen et al., 1996; 
Uv et al., 2000). 
The other major non-symmetric NPC structure is the nuclear basket. In 1991 the 
development of high resolution scanning electron microscopy enabled the first 
visualisation of a basket structure on the nucleoplasmic face of the NPC 
(Goldberg and Allen, 1992). Starting with the nucleoplasmic coaxial ring at the 
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nuclear pore, eight fibres extend out ~40 nm into the nucleoplasm and attach to 
a small ‘basket’ ring of 60 nm in diameter (Goldberg and Allen, 1992). In 
vertebrates the nuclear basket is composed of three nucleoporins: Nup50, 
Nup153 and TPR. TPR is the most significant component of the nuclear basket 
with a molecular mass of 265 kDa forming a coiled-coil structure, although its 
exact localisation at the nuclear basket is disputed (Cordes et al., 1997; Frosst et 
al., 2002; Krull et al., 2004). TPR also appears to play a role relating to CRM1-
dependent export and mediating a level of RNA export quality control prior to 
export (Frosst et al., 2002; Coyle et al., 2011). Nup153 is a more peripheral 
component of the nuclear basket with immunogold staining showing it localises 
to the nucleoplasmic coaxial ring (Krull et al., 2004). It appears to play a crucial 
role in nuclear export, and during nuclear pore assembly after cell division 
(Sukegawa and Blobel, 1993; Ullman et al., 1999; Vollmer et al., 2015). Nup153 
also appears to be a mobile nucleoporin, able to diffuse off the NPC, and perform 
functions within the nucleus (Nakielny et al., 1999; Griffis et al., 2004; Vaquerizas 
et al., 2010). The final vertebrate nuclear basket nucleoporin is Nup50, a small 
mobile nucleoporin with a very short residence time at the NPC (Guan et al., 
2000; Rabut et al., 2004). Nup50 binding at the nuclear pore is dependent on 
Nup153 and suggests Nup50 has a role in nuclear import. Furthermore, studies 
have shown Nup50 binds to importins (Lindsay et al., 2002; Makise et al., 2012). 
Interestingly, Nup50-depletion is not lethal but does prevent differentiation events 
in C2C12 myoblasts, suggesting a non-transport based role of this nucleoporin 
(Buchwalter et al., 2014).  
The symmetric core of the NPC is composed of three stacked rings: an inner ring 
that spans the fused nuclear membranes, and cytoplasmic and nucleoplasmic 
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rings which stack upon the inner ring from each respective side (Unwin and 
Milligan, 1982). The key scaffold subcomplexes of these rings are the Y-complex 
and the inner ring complex. The Y-complex is the most well-known and best 
structurally defined of these subcomplexes with its distinct Y-shape made up of 
a small arm, a large arm and a stem (Lutzmann et al., 2002; Beck et al., 2004b; 
Kampmann and Blobel, 2009). The small arm is composed of Nup85, Seh1 and 
Nup43, whilst the large arm comprises Elys, Nup37, Nup160. These two arms 
connect to one another via Nup160-Nup85 complex and the stem through Nup96 
and Sec13. Nup96-Sec13 connect to a highly flexible stem tip containing Nup133 
and Nup107 (Bui et al., 2013; Kelley et al., 2015). Multiple copies of the Y-
complex oligomerise into two head-to-stem rings at both the cytoplasmic and 
nucleoplasmic side. These two rings form an inter-complex crosslink between the 
inner and the outer ring (Figure 1.14). These rings act as the crucial scaffold on 
which the asymmetric structures already described connect to the NPC itself.  
The inner ring complex is composed of five nucleoporins: Nup205, Nup88, 
Nup93, Nup155 and Nup53. Nup53 has been shown to bind to the integral 
membrane protein component of the nuclear pore NDC1 that spans the nuclear 
membrane, anchoring the NPC (Eisenhardt et al., 2014). Nup155 has also been 
shown to make contact points with the nuclear membrane and surrounds the 
membrane in multiple copies as a first layer between the membrane and the 
remaining inner ring complex proteins (Bui et al., 2013). The second layer of the 
inner ring complex is comprised of Nup205 and Nup188; however, due to the 
small size of Nup93 current methods struggle to identify its exact position in the 
inner ring complex (Andersen et al., 2013) (Figure 1.14). Other subcomplexes 
have also been shown to interact with the inner ring complex, with both Nup188 
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and Nup93 binding to Nup214-Nup84-Nup62-Nup98-Rae1 complex (Von Appen 
et al., 2015). Importantly, this highlights that the understanding of the NPC 
architecture is still developing, with areas of the NPC such as the inner ring 
complex still poorly understood. 
 
Figure 1.14 The architecture of the NPC scaffold. a) One symmetric unit of the NPC with four copies of 
the Y-complex that form the scaffold of the cytoplasmic ring (CR) and the nucleoplasmic ring (NR). The outer 
copy is shown in orange; the inner copy is shown in gray. Multiple membrane contacts of the inner ring 
complex: region of outer bilipid layer where contacts made are shown in green and purple; apparent 
transmembrane domains are shown in blue. b) Nup155 (green) appears to interact with the membrane at 
the points indicated in a). c) Nup205 and Nup188 densities (red) per asymmetric unit localise to the CR, IR 
and NR. Another copy might reside only on the cytoplasmic site and is shown in orange. d) Proteins of 
neighbouring asymmetric units are shown as well. Taken from (von Appen and Beck, 2015). 
 
The final symmetric subcomplex is composed of channel nucleoporins Nup62, 
Nup58 and Nup54. These nucleoporins give rise to the selective barrier of the 
NPC and many aspects of their protein structure are highly conserved across all 
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eukaryotic life. The Nup62-Nup58-Nup54 complex attaches to the inner ring 
complex protein Nup93 and extends into the central channel. In the central 
channel, these subcomplexes oligomerise into a ring structure, able to constrict 
and dilate dependent on the binding of transport factors (Sharma et al., 2015). 
These nucleoporins are also rich in FG-repeat regions that extend into the central 
channel and create the selective barrier. The exact mechanism of nuclear 
transport that arises from the FG-repeat density in the central channel but is 
poorly understood although a range of theories have been proposed. 
1.3.3.2 Nuclear Transport  
The key function of the NPC is to facilitate selective bidirectional transport 
between the nucleus and cytoplasm. This includes the export of RNAs into the 
cytoplasm, the import of mature proteins into the nucleus, and the export of 
enormous ~2.5 MDa pre-ribosomal subunits, to name a select few transport 
operations. These processes must all occur near simultaneously and in a highly 
selective manner to prevent damage to the nuclear compartment. Statistical 
modelling has predicted the scale of nuclear transport to be approximately 1000 
translocation events per second of approximately 100 MDa/s (Ribbeck and 
Görlich, 2001). The NPC achieves this via a highly regulated transport system 
that combines a permeability barrier and a receptor-based transport system.  
1.3.3.2.1 Receptor Transport system 
The machinery behind receptor-based transport systems is highly conserved 
within eukaryotes. This suggests that the development of this system was a 
critical juncture in the evolution of eukaryotic life, when one of the key constraints 
of evolving a contained compartment for the genome was overcome. Behind this 
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evolutionary significance is the small GTPase Ras-related nuclear protein (Ran), 
which is highly conserved and a member of the Ras family of GTPases (Moore 
and Blobel, 1993).  
The Ran cycle describes the process of nucleotide exchange that Ran performs 
between the cytoplasm and the nucleus. The classical cycle of nuclear transport 
begins with the formation of a heterotrimer of importin beta, importin alpha and a 
cargo containing a nuclear localisation sequence (NLS). This complex docks to 
and is transported through the NPC where the importins facilitate transport 
through the FG-repeat layer. Once in the nucleus, a high RanGTP environment, 
importin beta is bound by RanGTP, promoting the disassembly of the 
heterotrimer. The cargo can now fulfil its role in the nucleus and importin beta 
and alpha are separately exported after being bound by RanGTP, in the case of 
importin alpha also binding cellular apoptosis susceptibility gene (CAS) (Kutay et 
al., 1997). After these factors are transported through the NPC into the cytoplasm, 
a high RanGDP environment, RanGTP is hydrolysed by RanGAP1 and RanBP1 
which causes the dissociation of RanGDP and the importin complex. This 
releases the importins for any subsequent import events. Meanwhile RanGDP is 
reimported into the nucleus where the nucleotide exchange factor RCC1 
promotes the exchange of GDP for GTP (Figure 1.15). 
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Figure 1.15 The Ran cycle. 1. A heterotrimer of importin alpha, beta and a cargo containing a nuclear 
localisation sequence (NLS) forms. 2. This complex moves to the NPC. 3. The complex is transported 
through the NPC with importins interacting with nucleoporins. 4. RanGTP binds causing the dissociation of 
the heterotrimer binding to importin beta. 5. Importin beta and RanGTP are re-exported out of the nucleus. 
6. RanBP1 and RanGAP1 induce the hydrolysis of RanGTP to RanGDP leading to the release of importin 
beta. 7. Importin alpha interactions with CAS and RanGTP in the nucleus forming a complex. 8. This complex 
then exits the nucleus. 9. RanBP1 and RanGAP1 induce the hydrolysis of RanGTP to RanGDP inducing the 
dissociation of importin alpha and CAS in the cytoplasm. 10. RanGDP travels down the concentration 
gradient into the high RanGTP environment in the nucleus. 11. RanGDP is converted back into RanGTP by 
RCC1. Taken from (Dasso and Pu, 1998). 
 
Whilst the energetic system powering nuclear transport is well-defined, the exact 
mechanism of how transport receptors such as importins bind nucleoporins and 
facilitate transport is less well understood. The hydrophobic environment of the 
central channel of the NPC has been demonstrated to be critically important for 
successful transport (Ribbeck and Görlich, 2002). Crystal structure analysis of 
importin beta bound to the FG-motif complex shows that importin beta has 
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several hydrophobic pockets that interact with hydrophobic residues in the FG-
nucleoporins (Bayliss et al., 2000; Liu and Stewart, 2005; Otsuka et al., 2008). 
Studies investigating the structure of members of the karyopherin beta 
superfamily (of both importins and exportins) show a high level of structural 
similarity between family members even though sequence similarity is very low 
(Xu et al., 2010; O’Reilly et al., 2011). Structurally, they are composed of a 
number of HEAT motifs (19-21 repeats), containing two amphiphilic alpha helices 
connected by a short linker region (Chook and Blobel, 1999; Cingolani et al., 
1999). These structures are highly flexible, which is thought to relate to their role 
binding different cargoes and RanGTP (Conti et al., 2006; Forwood et al., 2010). 
Many investigators have noted the apparent paradox of strong interactions 
between karyopherins and FG-nucleoporins and the speed of nuclear transport, 
questioning how transport complexes do not get trapped within the NPC through 
these strong hydrophobic interactions. Recently, it has been demonstrated that 
importin beta undergoes a conformational change during passage through the 
NPC, mediated by a series of weak hydrophobic interactions with nucleoporins. 
It is hypothesised that these induced changes lead to highly stochastic transport 
with a number of outcomes, including a proportion of transport events failing to 
cross the nuclear pore on a single attempt (Yoshimura et al., 2014). 
1.3.3.2.1.1 mRNA Transport 
mRNA transport is a crucial example of receptor based transport facilitated by 
the NPC. mRNA export occurs via a distinct mechanism from nuclear export of 
proteins, tRNA and miRNAs. The two predominant export adaptor proteins that 
are loaded onto messenger ribonucleoprotein (mRNP) complexes are Nxf1-Nxt1 
and Crm1.  
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Bulk mRNA export occurs through the action of heterodimer of Nxf1/TAP and 
Nxt1 (Segref et al., 1997; Herold et al., 2000). Nxf1-Nxt1 heterodimer is recruited 
to mRNP complexes via interactions with ALY a component of the TREX 
complex. Nxf1-Nxt1 act as a nuclear export receptor that then facilitates passage 
through the NPC. 
A subset of cellular mRNAs are exported via an alternate pathway facilitated by 
karyopherin Crm1 (Fornerod, et al., 1997). Crm1 is also responsible for mediating 
export of unspliced and partially spliced HIV mRNA through the action of the HIV 
Rev protein (Cullen, 2003). The Crm1 pathway requires additional adaptor 
proteins due to Crm1 lack of an RNA binding function. These appear to vary 
depending on the transcript being exported, with eukaryotic initiation factor 4E 
(eIF4e) for cyclin D1 mRNA and HuR reported as an adaptor for Cd83 and Fos 
mRNA export (Brennan et al., 2000; Culjkovic et al., 2006). 
Once these export receptors are recruited to the mRNP it is considered export 
competent. This targets the mRNP to the NPC where the export receptor is able 
to directly interact with FG-nups. It has been suggested that the 5’ end of the 
mRNP leads the mRNP into the pore at the nuclear face of the NPC (Visa et al., 
1996). How the binding of export receptors to FG-nups facilitates movement of 
the mRNP in the NPC is unclear and different theories surrounding this are 
addressed in the next section. However, work has shown that not all FG-nups 
are required for mRNA export, only specific subcomplexes in the central channel 
and at the nuclear face hinting that export occurs through a series of thresholds 
in the pore before final commitment to exit into the cytoplasm (Terry and Wente, 
2007). 
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1.3.3.2.2 Permeability barrier 
The permeability barrier acts to prevent the passive diffusion of large molecules 
into the nucleus; the limits of which are either a mass greater than 40 kDa or a 
diameter greater than 390 Å (Panté and Kann, 2002). FG-nucleoporins that line 
the inner channel of the NPC are responsible for the formation of the barrier. 
Typically, these proteins are composed of a folded domain and an intrinsically 
disordered domain (IDD) (Wagner et al., 2015). IDD are domains that lack a 
stable secondary or tertiary protein structure. This often leads to difficulties 
visualising these proteins through crystallographic techniques and is the 
predominant research hurdle towards understanding FG-nucleoporin formation 
at the NPC. FG-nucleoporins also have a low net charge and high mean 
hydrophobicity, along with repeats of the eponymous FG-motif (Schmidt and 
Görlich, 2016). The most common of these motifs are: FG, FxFG, GLFG, PxFG, 
SxFG (Cushman et al., 2006; Denning and Rexach, 2007).  
The structure formed by the convergence of FG-nucleoporins in the central 
channel is a current area of debate and further investigation. A number of models 
have been proposed, but there is currently no consensus on what structure may 
exist in the central channel. Some of these models include: the selective 
phase/hydrogel model, reduction of dimensionality model, the kap-centric model, 
and the polymer brush model. The selective phase model, also known as the 
hydrogel model, hypothesises that intra- and intermolecular interactions between 
FG-nucleoporins create a cohesive, gel-like network (Ribbeck and Görlich, 2002; 
Frey and Görlich, 2007) (Figure 1.16b). This creates a 3D molecular sieve that 
occludes large molecules but allows for the diffusion of small molecules, whilst 
nuclear transport receptors (NTR) are able to pass through the gel via their 
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hydrophobic domains (similar to how lipids pass through a lipid bilayer). To 
support this theory FG-nucleoporins form a hydrogel in vitro and permit the 
selective transport of importins (Frey and Görlich, 2009; Hülsmann et al., 2012).  
The reduction of dimensionality (ROD) model arose from observations that the 
NPC appeared to be saturated with NTRs at all times and suggested that FG-
domains coat the walls of the central channel and are occupied continuously with 
NTRs (Peters, 2005) (Figure 1.16c). This binding was speculated to cause a 
collapse of the FG-filaments, creating a small inner lumen at the centre of the 
pore to allow for small molecule diffusion. FG-bound NTR were then confined to 
move in only two dimensions, where they would random walk over the FG surface 
on the sides of the central channel and reach their transport destination (Peters, 
2009; Schleicher et al., 2014).  
The kap-centric model posits that due to the proportionally greater numbers of 
karyopherins present in cells compared to nuclear pores, it is karyopherins (kaps) 
that regulate the speed and selectivity of the NPC (Reviewed in (Lim and 
Kapinos, 2015)). Proponents of this hypothesis point to evidence that in 
permeabilised cells where high karyopherin concentrations are added nuclear 
transport increases, whilst in low karyopherin environments nuclear transport is 
slower (Timney et al., 2006; Yang and Musser, 2006). They argue that if FG-
nucleoporins were predominantly responsible for managing nuclear transport 
speeds, a high kap environment means more FG-NTR saturation at the NPC 
leading to slower transport (Figure 1.16d). Given the experimental evidence, they 
suggest that the key regulators of nuclear transport efficiency and speed are the 
kaps themselves. They also point to experiments performed which advocate the 
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hydrogel model and claim these observations support the idea that karyopherins 
are able to regulate the permeability of FG-nucleoporins with in vitro FG-
nucleoporin hydrogels able to ‘heal’ after the diffusion of NTRs through the 
hydrogel (Frey and Görlich, 2009). 
The virtual gate or polymer brush model contrasts with many of the other 
hypothesises by proposing a mechanism based on thermodynamic 
considerations rather than elucidating the role of FG-FG interactions (Rout et al., 
2003) (Figure 1.16a). This suggests that the movement of a molecule from the 
cytoplasm to the nucleus involves a loss of entropy, due to few movement 
possibilities in the smaller nucleus. The energy price of this loss of entropy would 
be increased by non-cohesive FG-domains that were posited to act as repulsive 
or entropic bristles which moved randomly (Lim et al., 2006). This would create 
an entropic gate, preventing the random diffusion of molecules into the nucleus. 
For transport to occur it was hypothesised that interactions with FG-domains 
would release enthalpy and, if the binding energy generated was high enough to 
overcome the loss of entropy, transport would occur.  
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Figure 1.16 Models of the central NPC channel. a) Virtual gating/polymer brush model, characterised by 
non-cohesive FG-domains acting as entropic barriers. b) Selective phase/hydrogel model, characterised by 
cohesive FG-domain interactions (blue) between other FG-domains and the NTR (green) this allows for the 
movement of cargo (red) through the NPC. c) The reduction of dimensionality, FG-nups bind to the NTR 
allowing for transport along a 2D axis at the sides of the channel, binding of the NTR facilitates collapse of 
the FG-filaments. d) Kap-centric, the binding of karyopherins occurs continuously and regulates the speed 
and permeability of the NPC barrier.  
a) 
b) 
c) 
d) 
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1.3.4 The Dynamic NPC 
With the expansion in understanding of the structure and function of the NPC 
evidence has begun to emerge suggesting the NPC is a much more dynamic 
structure than initially thought. The residency time of almost a third of NPC 
components, typically central channel and nuclear/cytoplasmic facing 
nucleoporins, has been shown to be short (ranging from a few seconds to a few 
hours) (Rabut et al., 2004). Scaffold nucleoporins exhibit a far longer residency 
time often greater than a cell cycle. How these dynamic movements on and off 
the pore are implicated in the function of the NPC is a developing knowledge 
domain that has also begun to highlight the many non-transport related roles of 
nucleoporins. 
1.3.4.1 The NPC during development 
A number of nucleoporins have been shown to be necessary for the 
differentiation of different cell types. Nup210 or GP210 is required for both 
myogenesis and neuronal differentiation in mice. Its expression is induced during 
differentiation; however its incorporation into the NPC does not appear to alter 
nuclear transport but rather the expression of myogenesis genes (Capelson et 
al., 2010; Kalverda et al., 2010; D’Angelo et al., 2012). 
Similar to GP210, Nup358 has also been attributed to myoblast differentiation. 
Increased Nup358 expression is required for correct myoblast differentiation, 
although, as above, this does not alter nuclear transport pathways. It has been 
observed that myoblasts and myotubes exhibit different Nup358 copy number at 
their NPC, suggesting these differentiation changes are structurally-related; 
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however, how this change is important for differentiation is not yet understood 
(Asally et al., 2011). 
Nup133 and ELYS, both components of the Y-complex, are required for 
successful differentiation of certain cell types. In Zebrafish, the absence of the 
ELYS homologue results in abnormal neuronal differentiation affecting 
development of the retina (Cerveny et al., 2010). In mice, a mutation that 
generates a null allele of Nup133 also leads to neuronal development defects 
and is lethal (Lupu et al., 2008). The mechanism behind this role is not well 
understood, but the structural nature of these nucleoporins suggests they 
function away from the pore during differentiation. 
1.3.4.2 Cell type specific NPCs 
A number of nucleoporins have been identified that exhibit tissue specific 
expression patterns. These include Nup210, Nup45, Nup50, Nup133, Nup155 
and ALADIN (Hu and Gerace, 1998; Zhang et al., 1999; Guan et al., 2000; Olsson 
et al., 2004; Cho et al., 2009). Furthermore, mutations in several nucleoporins 
lead to tissue-specific pathologies. A mutation in Nup155 (found highly expressed 
in heart, placenta, liver and skeletal muscle) preventing it binding at the NPC 
leads to heart malfunction and cardiac disease (Zhang et al., 1999; Zhang et al., 
2008). Missense mutations in Nup62, a key FG-nucleoporin in the central 
channel, lead to autosomal recessive infantile bilateral striatal necrosis, a severe 
brain disorder with degeneration of the basal ganglia (Basel-Vanagaite et al., 
2006). Mutations in the nucleoporin ALADIN cause triple A syndrome (AAAS) 
which causes adrenocorticotropic hormone (ACTH)-resistant adrenal failure (Cho 
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et al., 2009). These findings developed into a hypothesis that NPCs exists as 
much more specialised structures across different cell types (Figure 1.17). 
 
Figure 1.17 Overview of specialised nuclear pore complexes. a) Specialised NPCs with alternate 
transport pathways. b) Specialised NPCs able to interact with different chromatin sections. c) A model of 
specialised NPCs within a single cell. Taken from (Raices and D’Angelo, 2012). 
 
1.3.4.3 Nup98 
Nup98 is a well-characterised example of a dynamic nucleoporin. Nup98 is 
expressed predominantly as a bicistronic peptide comprising of Nup96-Nup98. 
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This polypeptide undergoes autoproteolytic cleavage that allows both 
nucleoporins to localise at the NPC. At the NPC, Nup96 and Nup98 have 
unrelated roles, with Nup96 acting a component of the structural Y-complex with 
a residency time of several months, whilst Nup98 cycles on and off the pore and 
is turned over rapidly (Toyama et al., 2013). This cycling leads to the existence 
of two pools of Nup98 within the cell, one at the NPC and one within the 
nucleoplasm (Griffis et al., 2002; Oka et al., 2010). At the NPC, Nup98 is involved 
in mRNA export through its interaction with mRNA export factors Rae1 and Nxf1 
(TAP) (Powers et al., 1997; Bachi et al., 2000; Blevins et al., 2003). Nup98 also 
interacts with members of the importin beta family and the exportin CRM1 (Allen 
et al., 2001; Oka et al., 2010).  
The nucleoplasmic fraction of Nup98 is a remarkable case study of the dynamic 
nature of the NPC (Figure 1.18). Extensive work in Drosophila has shown that 
nucleoplasmic Nup98 binds at the promoters of genes responsible for 
development, and that depletion of Nup98 leads to robust suppression of these 
promoters (Kalverda et al., 2010; Capelson et al., 2010). Furthermore, Nup98 
directly interacts with histone modifying enzymes such as CBP/p300 and histone 
deacetylases (HDACs) through its unique form of FG repeat, GLFG (Lawryn H. 
Kasper et al., 1999; Bai et al., 2006). Nup98 translocation mutants are also key 
promoters of the onset of acute myeloid leukaemia (AML) through the ability of 
Nup98 to recruit histone deacetylases to promote oncogenic expression (Bai et 
al., 2006). The GLFG domain is also responsible for the formation of discrete 
Nup98 foci within the nucleus called GLFG-bodies (Griffis et al., 2002; Griffis et 
al., 2004). The exact function of these discrete bodies is unclear, and they are 
not observed across all cell types. RNA polymerase II does not localise at GLFG 
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foci, leading to the suggestion that GLFG-bodies act as dynamic storage centres 
of nucleoplasmic Nup98 that can rapidly cycle to transcriptional start sites when 
needed (Griffis et al., 2002; Franks et al., 2017). Nup98 also regulates the 
expression of antiviral response genes and has been attributed to a phenomenon 
called ‘epigenetic transcriptional memory’. This is predominantly linked to the 
interferon gamma (IFN-γ) response with IFN-γ-inducible genes able to be 
induced faster after an initial IFN-γ treatment due to the presence of a histone 
modification and Nup98 (Light et al., 2013; Panda et al., 2014). 
 
Figure 1.18 Model of the alternate cellular pools of Nup98. The NPC-bound Nup98 is shown in grey. 
Nup96-bound Nup98 promotes the localisation of Nup98 at the nuclear pore. Free Nup98 (shown in red) is 
able to diffuse off the NPC and form GLFG bodies or bind at promoters and recruit histone remodelling 
complexes. Adapted from (Franks et al., 2017). 
 
1.3.5 Viral remodelling of the Nuclear Pore Complex 
The position of the NPC as the primary conduit between the nucleus and the 
cytoplasm makes it a key target for certain viruses. For viruses that replicate 
relatively quickly access to the nucleus provides an effective way of utilising host 
DNA replication machinery. If a virus has a relatively longer replication cycle, 
access to the nucleus provides a safer environment to protect the viral genome 
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and coordinate slow subversion of other cellular processes. Due to the complexity 
of the NPC, viruses have developed an incredible variety of strategies for 
subverting its selective barrier function. These include brute force demolition of 
the central channel, or viral factors binding to nucleoporins or manipulating 
nuclear transport. 
1.3.5.1 Capsid remodelling Events 
A common form of NPC remodelling occurs during de novo infections where the 
viral capsid is transported to the nuclear pore. At this stage the goal of the virus 
is to deliver its genome into the nucleus through capsid interactions with 
nucleoporins. 
Adenovirus is one such virus that utilises capsid-based remodelling to deliver its 
genome. After internalisation at the plasma membrane, the adenovirus virion is 
transported along cellular microtubules to the nucleus. The capsid is then able to 
bind to Nup214 targeting it to the NPC and kinesin-1 light-chain Klc1/2 (Trotman 
et al., 2001). Nup358, which is a component of the cytoplasmic filaments that 
includes Nup214, is then bound by kinesin-1 heavy-chain Kif5C (Strunze et al., 
2011). This seems to exert a force upon the capsid that causes disassembly and 
the release of the viral genome along with relocalising Nup358, Nup214 and 
Nup62 from the NPC. This increases the permeability of the NPC and appears to 
aid with the import of the viral genome into the nucleus (Strunze et al., 2011). 
HSV-1 also exhibits capsid-NPC interactions during initial viral genome delivery. 
Viral tegument proteins pUL36 and pUL25 mediate docking of the virion to the 
NPC through interactions with Nup358 and Nup214 at the cytoplasmic filaments 
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(Copeland et al., 2009; Pasdeloup et al., 2009). These tegument proteins are also 
involved in the uncoating of the virion once docked to the NPC, triggering the 
release of the viral DNA.  
Hepatitis B virus (HBV), a hepadnavirus that has a double-stranded DNA genome 
but replicates through an RNA intermediate step, transports its DNA genome into 
the nucleus on initial infection. Within the nucleus HBV produces pre-genomic 
RNAs which it uses as a template to produce genomic DNA for new virions. The 
process of the nuclear entry by HBV is poorly understood, leading to two main 
theories of HBV genome delivery: the capsid disassembles in the cytoplasm and 
the DNA-viral polymerase complex is imported into the nucleus via karyopherins; 
or the virion is imported into the nucleus and disassembles on binding to Nup153, 
releasing the DNA-viral polymerase complex (Reviewed in (Gallucci and Kann, 
2017)). 
1.3.5.2 Non-capsid remodelling Events 
The alternate form of viral remodelling events is coordinated by non-capsid viral 
proteins. The overwhelming aim of these remodelling events is to aid viral 
replication by breaking down normal nucleocytoplasmic transport and inducing 
preferential transport of viral factors. These strategies range from more subtle 
hijacking of nucleoporins to the destruction of the NPC central channel. 
The Picornaviridae family have a single stranded, positive sense RNA genome 
and replicate exclusively in the cytoplasm. They achieve this by inducing the 
relocalisation of numerous nuclear factors through a dramatic remodelling of the 
NPC. Poliovirus, or Enterovirus C, is a form of Enterovirus from the larger 
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Picornaviridae family. Poliovirus encodes 2Apro, a viral protease that causes the 
proteolysis of a number of key nucleoporins responsible for nucleocytoplasmic 
trafficking (Gustin and Sarnow, 2001; Gustin and Sarnow, 2002; Park et al., 
2008). Nup98 is cleaved first early post infection, followed by Nup62 and then 
Nup153 at later periods (Gustin and Sarnow, 2002; Park et al., 2008). Electron 
microscopy appears to show the actions of the cleavage remove a large density 
at the centre of the NPC attributed to the relocalisation of nuclear factors (Belov 
et al., 2004). Intriguingly, Cardiovirus, another genus of Picornaviridae, increases 
permeability of the NPC via a different mechanism. The Cardiovirus L protein 
induces hyperphosphorylation of nucleoporins dependent on the presence of its 
zinc-finger domain (Bardina et al., 2009; Porter et al., 2010). Nup62, Nup98, 
Nup153 and Nup214 are all hyperphosphorylated through the action of the L 
protein, mediated by mitogen activated kinases (Porter and Palmenberg, 2009). 
These changes inhibit nuclear import and cause nuclear efflux, allowing the virus 
to utilise nuclear factors for its replication (Porter and Palmenberg, 2009). 
Herpesviruses have also been shown to act on the NPC after the capsid 
remodelling events described above. HSV-1 decreases the expression of 
Nup153 by greater than 3-fold and Nup153 is relocalised to the cytoplasm during 
early stages of infection (Ray and Enquist, 2004; Leuzinger et al., 2005). The 
HSV-1 protein ICP27 interacts directly at the NPC via Nup62 and inhibits several 
forms of nucleocytoplasmic transport (Malik et al., 2012). This is similar to another 
herpesvirus, EBV, which encodes a protein kinase BGLF4 that binds Nup62 and 
Nup153 and induces a reorganisation of the NPC (Chang et al., 2012). The action 
of BGLF4 on these nucleoporins attenuates importin beta trafficking and 
promotes the nuclear import of large molecules. BGLF4 appears to enhance the 
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import of several non-NLS containing EBV proteins that are crucial to viral DNA 
replication (Chang et al., 2015). 
HIV-1, a retrovirus, initially utilises the NPC to target the delivery of its genome to 
the nucleus. HIV-1 appears to undergo uncoating upon entry into the cytoplasm; 
however, observations suggest this process is not a key delineating step before 
transport to the nucleus. A number of studies have also shown that HIV-1 capsid 
proteins are an important determinant of nuclear import and that by interacting 
with Nup358 HIV-1 are able to attach to pores for genome delivery (Yamashita 
and Emerman, 2004; Ocwieja et al., 2011). After docking at the NPC via Nup358, 
the capsid delivers the pre-integration complex (PIC), a complex of the HIV-1 
genome and viral and cellular factors that reverse transcribes the HIV-1 ssRNA 
genome into cDNA (Reviewed in (Jayappa et al., 2012)). The PIC translocates 
through the NPC and interacts with Nup153, which mediates its exit from the 
NPC. Nup153 and Nup98 appear to aid in the process of PIC targeting to host 
chromatin for successful genome integration (König et al., 2008; Woodward et 
al., 2009; Di Nunzio et al., 2012). However, these interactions don’t constitute a 
formal remodelling of the NPC, rather a hijacking of their normal cellular roles. 
Nevertheless, over the course of HIV-1 infection, the NPC does appear to be 
remodelled with significant decreases in the abundance of 18 nucleoporins 
(Monette et al., 2011a). Furthermore, microarray data of HIV-1 infected T 
lymphocytes have shown that Nup62 is upregulated 24 h post infection, whilst 
Nup50 is downregulated (Imbeault et al., 2009). The exact purpose of these 
changes is poorly understood, although high-throughput screens show many of 
these nucleoporins are necessary host cofactors for HIV-1 infection (König et al., 
2008; Zhou et al., 2008). One proposed downstream effect of these remodelling 
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events is the induced cytoplasmic retention of hnRNP A1, allowing the virus to 
positively regulate HIV-1 transcripts with an internal ribosome entry site (IRES) 
(Monette et al., 2009). 
1.4 Proteomic approaches 
With the advent of mass DNA sequencing technologies in the 1990s, 
investigators began to look at methods for analysing the global complement of 
proteins that corresponded to the genome. In 1995, the word ‘proteome’ was first 
used to describe the protein complement to the genome and hence the field of 
proteomics (the study of the global protein network) was born (Wasinger et al., 
1995). The idea of the proteome was later described as “the idea of a finite 
totality, comprising of the functional (protein) molecular specifications of a 
genome” (Anderson and Anderson, 1998). The large scale study of proteins 
actually began much earlier in the 1970s with the development of two-
dimensional electrophoresis (O’Farrell, 1975). The development of these 
technologies briefly focused scientific attention on a project to construct the 
Human Protein Index (HPI); however, major political changes in the early 1980s, 
and the failure to attract large-scale support, stifled the expansion of this project 
(Anderson and Anderson, 1982). With the advent of restriction enzyme 
technology, the genomic revolution quickly overtook much of the previous focus 
on the HPI, given the feasibility and ease of genomic techniques (Reviewed in 
(Anderson and Anderson, 1998)). The identification of many of the proteins 
visualised by 2D gel electrophoresis proved a serious bottleneck until the advent 
of highly sensitive mass spectrometry (MS)-based techniques combined with 
protein sequence databases.  
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Mass spectrometry allowed for the identification and quantification of protein 
samples with greater speed and in a high-throughput work flow. When combined 
with polyacrylamide gel electrophoresis (PAGE) or liquid chromatography (LC) 
highly complex protein mixtures could be resolved into more manageable 
samples, allowing for the potential to resolve proteins from whole-cell lysates 
(Reviewed in (Owen et al., 2014)). The work flow of MS-based analysis of protein 
samples begins with a separation step through either LC or PAGE. Samples are 
then digested into peptides, typically using trypsin, before further separation by 
LC. Peptides are then ionised through approaches such as matrix-assisted laser-
desorption-ionisation-time-of-flight (MALDI-TOF) and electrospray ionisation 
(ES) and analysed through tandem mass spectrometry (MS/MS) (El-Aneed et al., 
2009). In the first round of MS (MS1) the mass to charge ratio (m/z) of peptides 
is determined, generating a spectrum of m/z. These initial peptide spectra are 
then taken forward for an additional fragmentation step using an approach such 
as collision induced dissociation (CID), where ions are crashed into inert gas 
molecules, and fragments are again separated in another round of mass 
spectrometry. The m/z of these new fragments are then compared to a theoretical 
database of fragment m/z in silico using peak intensities to determine quantities 
of these peptides (Figure 1.19) (Yates et al., 1995; Washburn et al., 2001; Han 
et al., 2008). 
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Figure 1.19 Work flow of protein identification and quantification by LC tandem mass spectrometry. 
The protein sample is separated through electrophoresis (1DE, 2DE) or liquid chromatography (LC), it is 
then digested into peptides with trypsin and separated again by LC. The first round of mass spectrometry is 
then performed (MS1) followed by peak identification and further mass spectrometry (MS2) to identify 
peptides. Taken from (Owen et al., 2014). 
 
1.4.1 Quantitative techniques 
Since the advent of 2D gel electrophoresis technologies investigators have also 
asked how changes in the quantities of these proteins relate to cellular conditions. 
Initially, computer algorithms were developed to create standard maps of healthy 
versus pathological cell proteomes. These worked by comparing the intensity of 
a stain for a given protein on the 2D gel based on the assumption that the staining 
density corresponded to the protein concentration (Arora et al., 2005). With the 
application of mass spectrometry technologies, it was possible for the first time 
to dramatically increase the throughput of quantitative studies. Whilst the 
intensities of ions observed in MS are theoretically proportional to peptide 
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abundance in a sample, absolute signal intensities can vary from run to run. 
Differences in sample complexity, chromatographic separation and peptide 
ionisation efficiency can all contribute to variability when comparing ion ratios 
(Dijkstra et al., 2007). The application of stable isotopes to proteomic studies 
provided a crucial answer to these variability problems. Isotopes such as 13C, 15N, 
18O and 2H could be incorporated into proteomic samples that allowed for MS 
traces to highlight ‘light’ and ‘heavy’ peptide ions. These signals can be directly 
compared to give a relative ratio of protein levels between labelled conditions. 
1.4.1.1 Isotope-coded affinity tag (ICAT) 
An early approach that incorporated stable isotopes was isotope-coded affinity 
tagging (ICAT). This approach utilises a biotin affinity tag coupled to a stable 
isotope labelled linker (initial deuterium) and a thiol-reactive group (Gygi et al., 
1999). Differences between two cell states were compared by treating cells with 
isotopically light and heavy ICAT reagents. These are then combined and treated 
with a protease before affinity isolation of ICAT-labelled peptides, which are then 
analysed by LC-MS/MS. The ratio of the peptide pairs then provide a relative 
quantification of the labelled protein (Gygi et al., 1999). This approach suffers 
from the drawback of relying on cysteine-containing peptides to ensure 
attachment of the label via the thiol linker, leading to the under-representation of 
peptides lacking a cysteine, resulting in the development of alternative 
techniques (Hsu et al., 2003).  
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1.4.1.2 SILAC 
Another commonly raised drawback of ICAT approaches was whether the 
differences observed only related to differences in sample preparation during the 
labelling step. Stable isotope labelling with amino acids in cell culture (SILAC) 
was a metabolic approach that attempted to resolve this problem (Oda et al., 
1999; Ong et al., 2002). SILAC involves the addition of isotopically labelled amino 
acids to cell culture media, ensuring that as cells grow and express protein they 
incorporate these ‘heavy’ or ‘light’ amino acids(Ong et al., 2002). These samples 
can then be harvested, treated with a protease and analysed by LC-MS/MS. The 
differences observed between the samples are again calculated into a ratio of the 
peptide pair and expressed as a relative quantitation (Figure 1.20). This approach 
alleviated some of the drawbacks of ICAT; however, SILAC is an expensive and 
time-consuming approach for quantitation that suffers from limitations when 
attempting to multiplex multiple conditions.  
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Figure 1.20 Overview of SILAC. Cells are cultured in media containing synthetic arginine with either heavy 
or light nitrogen isotope. Treatment is then added and incubated onto the cells. These are then collected 
and analysed via LC-MS/MS. This yields a trace with measurable abundance differences between light and 
heavy versions of the same peptide. Adapted from (Watanabe and Kanai, 2011). 
 
1.4.1.3 Isobaric labelling approaches: iTRAQ and TMT 
The development of iTRAQ (isobaric tag for relative and absolute quantification) 
arose from the limitations of both ICAT and SILAC approaches (Ross et al., 
2004). During iTRAQ, samples from each treatment are harvested and digested 
with trypsin. The fragments are then treated with the iTRAQ tag to label fragments 
from each treatment with a specific mass tag. These are then mixed and 
separated via LC where, due to the isobaric nature of the tags, peptides from 
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differing treatments with alternate tags migrate at the same rate. Peptides 
analysed by MS/MS and iTRAQ tags are identified after MS2, when the 
fragmentation stage induces the dissociation of the specific mass tag. This allows 
for the generation of peptide ratios and relative quantitation data for a given 
peptide across several treatments (Figure 1.21). Initially, iTRAQ was 
demonstrated for multiplexing across four different conditions, but has since been 
developed for eight condition experiments (Ross et al., 2004; Choe et al., 2007). 
The nature of iTRAQ has alleviated previous drawbacks of quantitative 
techniques like poor label uptake, multiplexing and detection of post-translation 
modifications (Zieske, 2006). 
Tandem mass tagging (TMT) is another isobaric reporter approach that utilises 
different structured tags to iTRAQ, but operates on the same experimental basis 
(Thompson et al., 2003). TMT tags utilise a m/z range from 126 to 131 allowing 
for a six-plex experiment, although recent advances have enabled TMT to label 
up to ten different samples through high-resolution instrumentation (McAlister et 
al., 2012; Werner et al., 2012). TMT has also been used in conjunction with 
SILAC to create ‘hyperplexing’, with up to eighteen different experimental 
conditions analysed through six tag TMT combined with three different SILAC 
media conditions (Dephoure and Gygi, 2012). This approach could be further 
combined with the previously described ten-plex TMT approach with the 
possibility of analysing relative protein changes across up to thirty different 
conditions. 
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Figure 1.21 Schema of isobaric mass tagging techniques. Protein is extracted from sample conditions 
and protein digested. Mass tag labels (MT) are added and samples and mixed. These are then separated 
by liquid chromatography (LC) and analysed by tandem mass spectrometry (MS/MS). In MS1 precursor ions 
are produced by ionisation, these are then selected and fragmented further before separation into product 
ions in MS2. MS2 peaks can then be selected and further fragmented before separation in MS3 where mass 
tags form distinct peaks highlighting relative levels of that peptide between each sample. 
 
1.4.2 Interactome techniques 
Whilst advances in proteomics helped identify and quantify changes in proteins 
across different environmental conditions, these approaches do not, in isolation, 
elucidate the specific interaction networks of proteins. However, through the 
combination of modern proteomic techniques and in situ labelling techniques 
major advances have been made in understanding a variety of protein-protein 
interactions (PPI). This has expanded into the field of interactomics, or the study 
of both indirect and direct protein interactions (Sanchez et al., 1999). These 
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approaches allow for the development of a more coherent understanding of how 
proteins accomplish the myriad of cellular processes. With the advent of tools for 
quantitative proteomics the potential now exists to investigate PPI in a 
quantitative high-resolution manner, providing new insights into how many of the 
multiprotein complexes that exist within the cell change over the course of drug 
treatment, cancer progression or development. 
1.4.2.1 Selective proteomic proximity labelling using tyramide 
Through investigations into the interaction of the B cell receptor (BCR), a IgM 
class immunoglobulin, the interactomic technique of selective proteomic 
proximity labelling using tyramide (SPPLAT) was developed (Figure 1.22) (Li et 
al., 2014). SPPLAT utilises an unreactive tyramide-biotin molecule and a 
horseradish peroxidase conjugated antibody that is complementary for a target 
protein. This anti-target antibody is added to live cells along with tyramide-biotin 
and hydrogen peroxide. The anti-target antibody binds to the target cell surface 
molecule and catalyses hydrogen peroxide to water, and in the process adds a 
free radical to tyramide-biotin allowing it to react rapidly with adjacent molecules. 
This process labels proximal proteins to the target protein with biotin, allowing 
them to be specifically purified using streptavidin and analysed using LC-MS/MS 
(Johanna Susan Rees et al., 2015). Investigators have also combined this 
approach with quantitative proteomic techniques such as SILAC in order to 
identify the relative transience of interactions (Li et al., 2014). However, this 
approach is limited to cell surface proteins and the labelling efficiency of tyramide-
biotin is strongly determined by the efficacy of the antibody used. 
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Figure 1.22 Overview of SPPLAT. Anti-target peroxidase conjugated antibody is added along with 
tyramide-biotin. Anti-target antibody binds and hydrogen peroxide is added leading to activation of tyramide-
biotin which reacts with nearby proteins. Cells are then lysed and streptavidin beads are used to pull down 
biotinylated proteins which are analysed by LC-MS/MS.  Taken from (Johanna Susan Rees et al., 2015). 
 
1.4.2.2 APEX tagging 
Another independently developed labelling method utilises engineered ascorbate 
peroxidase (APEX). This technique was developed for in vivo labelling that 
occurs rapidly, within a small radius, and is performed via a genetically targetable 
enzyme (Rhee et al., 2013). The first demonstrated use of APEX was targeting 
the enzyme to the mitochondrial matrix. The targeted protein, Mito-APEX, was 
expressed and, on the addition of biotin-phenol, catalysed the reaction of phenol 
to phenoxyl-radicals which exist for a short half-life and react with adjacent 
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proteins labelling them with biotin (Rhee et al., 2013). Cells can be lysed, and 
protein extracted before biotinylated proteins are purified with streptavidin beads 
and analysed by mass spectrometry (Figure 1.23). Whilst SPPLAT allows for 
biotin labelling at the cell surface, APEX can be expressed within the cell allowing 
for specific and temporally regulated labelling. This control of the time of labelling 
is often contrasted to the final interactomic approach described, namely BioID, 
where the labelling process can take several hours (Hwang and Espenshade, 
2016). APEX can again be adapted to combine quantitative proteomic 
approaches to include relative quantitation of the specific interactome under 
investigation (Hung et al., 2016). An important consideration of this approach is 
whether the diffusion of the enzyme-labelling complex will introduce false-
positively labelled proteins. It has been argued that even with a biotinylation 
speed of 1 min this would give sufficient time for the complex to diffuse around 
half the size of a typical cell (10 µm) (Johanna S. Rees et al., 2015).  
 
Figure 1.23 Outline of APEX in mitochrondria. Mito-APEX is transfected into cells with targeting to the 
mitochrondrial matrix. Biotin-phenol is then added with hydrogen peroxide, mito-APEX catalyses the 
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conversion of phenol to phenoxyl which rapidly reacts with local proteins labelling them with biotin. Cells are 
then lysed and biotinylated protein captured with streptavidin beads and identified via mass spectrometry. 
Taken from (Rhee et al., 2013). 
 
1.4.2.3 Proximity dependent biotin identification  
Proximity dependent biotin identification (BioID) was developed in 2012 as a 
method for understanding protein interactions in vivo. BioID utilises a mutant form 
of Escherichia coli biotin ligase (BirA*) to promiscuously biotinylate proximal 
proteins on the addition of biotin (Roux et al., 2012). In E.coli this biotin ligase is 
responsible for post-translationally modifying a subunit of acetyl-Coenzyme A 
(acetyl-CoA) carboxylase. The process of biotinylation is ATP dependent, with 
the ligase using biotin and ATP to produce a biotinyl-5’-AMP (adenosine 
monophosphate) intermediate, which is able to react with the target protein 
forming an amide bond between biotin and a lysine functional group, releasing 
AMP (Lane et al., 1964; Chapman-Smith and Cronan, 1999). The wild type form 
of BirA has a high affinity for biotinyl-5’-AMP, which is retained in its active site 
until binding to the acetyl-CoA carboxylase subunit. A mutant form of BirA* was 
also discovered that carries the R118G mutation at the active site leading to 
reduced affinity for biotinyl-5’-AMP leading to premature release (Kwon and 
Beckett, 2000; Choi-Rhee et al., 2004). The development of BirA* allowed for the 
cloning of a fusion gene of a target protein of interest and BirA* at either the C or 
N terminus. These fusion proteins can then be expressed in cells and biotinylation 
induced by the addition of biotin to cell culture media. Cells are then harvested, 
proteins extracted and biotinylated proteins purified using streptavidin. Mass 
spectrometry can then be used to identify the biotinylated proteins (Figure 1.24). 
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Figure 1.24 Outline of proximity dependent biotin identification. A fusion protein of BirA* and the target 
protein is expressed, biotin is added to the media leading to biotinylation of adjacent proteins within a ~10 
nm radius. Cells are then lysed, proteins extracted and streptavidin is used to purify biotinylated protein 
before analysis by mass spectrometry. Taken from (Varnaitė and MacNeill, 2016). 
 
The labelling process is proximity dependent on the area reachable by biotinyl-
5’-AMP and was initially described as within a radius of 20 to 30 nm from the 
ligase (Roux et al., 2012). Further experiments demonstrated a small range of 10 
nm when using the construct to label components of the nuclear pore complex, 
based on the known structural dimensions of the NPC (Kim et al., 2014). Through 
this radius of biotinylation, BioID is able to label not only proximal protein-protein 
interactions at the target molecule, but also indirect and dynamic interactions. 
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This makes BioID a key tool in understanding the adaptive landscape of protein 
interactomes over time with successful implementation of BioID investigating the 
nuclear lamina, centrosome components, c-Myc interacting partners in tumour 
cells and chromatin-associated proteins (Roux et al., 2012; Firat-Karalar et al., 
2014; Dingar et al., 2015; Lambert et al., 2015). Nevertheless, the accuracy of 
the BioID approach is also constrained by the radius of labelling and the duration 
of biotinylation. Even with a labelling radius of 10 nm it has been suggested that, 
due to the crowded nature of the cell, there is still a large risk of biotinylating 
unrelated proteins (Phillips et al., 2009). This potential for false-positives is 
exacerbated by the long duration of labelling (18-24 h) which increases the 
potential of labelling false-positives. Overall, these constraints are common 
across all forms of in vivo proximity-based labelling systems and require crucial 
consideration when interpreting data. Often it has been shown that combining 
these techniques with quantitative proteomics aids in determining degrees of 
association (Rhee et al., 2013). 
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1.5 Thesis Aims 
The aim of this thesis is to build upon previous work from the Whitehouse 
Laboratory, which highlighted through quantitative proteomic analysis changes in 
the protein levels of nucleoporins after the induction of KSHV lytic infection. Little 
is known about how KSHV alters the NPC during the lytic infection and this work 
aimed to address this lack of knowledge through two approaches. First, using 
traditional biochemical techniques identify and characterise specific changes at 
the NPC during KSHV lytic infection. Second, utilise new interactomic techniques 
to capture a more holistic understanding of changes at the NPC during KSHV 
lytic infection. 
Chapter 3 aimed to validate and characterise observations from quantitiative 
proteomic work previously performed by the Whitehouse laboratory. This 
identified Nup98 as a nucleoporin specifically downregulated early after the 
induction of KSHV lytic infection (8 h post induction). Interestingly, this 
nucleoporin appears to have a restrictive effect on the expression at the viral 
ORF50 promoter, which appears related to the role of Nup98 within the nucleus 
rather than at the NPC. The targeting of Nup98 by KSHV is linked to the E3 
ubiquitin ligase activity of viral immediate-early protein RTA and appears 
important for the transcription of viral genes containing an RTA-response 
element. 
Chapter 4 expands on a series of investigations that also aimed to characterise 
KSHV targeting of Nup98 using siRNAs to depleted Nup98 before lytic replication 
was induced. Contrary to expectations, results show Nup98-depletion 
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detrimental to the virus, leading to failed virion egress at the late stage of KSHV 
lytic replication. Results suggested this was related to the role of Nup98 at the 
nuclear pore as a component of the Nup98-Rae1 complex, which is targeted by 
KSHV to induce nuclear retention of a subset of host RNAs. One such RNA 
encodes the ESCRT-III component CHMP7, which has a crucial role recruiting 
the ESCRT-III complex to membranes, to induce repair and abscission. Results 
suggested that overexpression of CHMP7 induced a phenotype in lytic replicating 
cells similar to that of Nup98-depletion, corroborating the hypothesis that nuclear 
pore-bound Nup98 is crucial for successful viral replication due to its anchor role 
at the NPC for Rae1. 
Finally, chapter 5 aimed to implement proximity dependent biotinylation (BioID) 
and tandem mass tagging at the NPC during KSHV lytic infection to identify 
stochiometric changes at the pore. This involved attempts to develop cell lines 
that stably expressed BioID nucleoporin fusion proteins ensuring proper targeting 
at the nuclear pore complex. However, difficulties establishing stable cell lines 
led to the use of transient transfection procedures to incorporate correctly 
localised fusion nucleoporins. A pilot experiment was then performed to confirm 
successful streptavidin immunoprecipitation of biotinylated proteins, before a 
large scale ten-plex experiment was performed to attempt to characterise 
changes at the NPC during lytic infection. The results of these experiments were 
then analysed using automated data analysis scripts written in R and interactome 
maps generated using STRING-db. 
Overall, this work highlights the specific targeting of a nucleoporin and the NPC 
during KSHV lytic infection. It highlights the alternate roles of Nup98 with KSHV 
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appearing to target a specific subcellular population of the protein, whilst requiring 
the presence of Nup98 at the NPC. In the longer term, the characterisation of this 
interaction and further elucidating of mechanisms by which the virus targets 
cellular proteins early during lytic infection may highlight potential targets for 
future antiviral therapies. Furthermore, the datasets acquired from the BioID 
analysis may offer a unique insight into KSHV-interactomic approaches. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Antibodies 
All antibodies, their species, working dilutions and suppliers are outlined in Table 
2.1 Horseradish peroxidase (HRP)-conjugated anti-mouse, anti-rabbit and anti-
rat secondary IgG, used for Western Blotting at a 1:5000 dilution, were obtained 
from Dako (a brand subsidiary of Agilent). For confocal immunofluorescence (IF) 
Alexa Fluor® 594-, 488-, 546-, and 633- conjugated anti-rabbit, anti-mouse and 
anti-rat were used at a dilution of 1:500 and obtained from Life Technologies 
(Thermo Fisher Scientific). 
Table 2.1 List of antibodies, their species, working dilution for western blotting (WB) and 
immunofluoresence (IF) and suppliers. 
Antibody Species 
Working dilution 
Supplier 
WB IF 
Anti-GAPDH Mouse 1:5000 - Abcam® 
Anti-Mab414 Mouse 1:1000 1:200 Abcam® 
Anti-Lamin B1 Rabbit 1:1000 1:500 Abcam® 
Anti-Nup98 Rat 1:1000 1:100 Abcam® 
Anti-Nup98 Rabbit For ChIP Abcam® 
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(ab45584) 
Anti-ORF57 Mouse 1:1000 1:200 Santa Cruz 
Biotech® 
Anti-ORF65 Mouse 1:500 1:200 S J Gao, 
University of 
Southern 
California 
Anti-RTA Rabbit 1:500 1:500 David Blackburn, 
University of 
Birmingham 
 
2.1.2 Cell culture reagents 
All cell culture reagents, media and selection antibiotics used were supplied as 
shown in Table 2.2. 
Table 2.2 List of cell culture reagents and their suppliers. 
Reagent Supplier 
Doxycycline hyclate Sigma-Aldrich® 
Lipofectamine 2000 Thermo Fisher 
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Hygromycin B 
Puromycin dihydrochloride 
Nucleofector Reagent V 
Lonza 
Phosphate buffered saline (PBS) 
Dulbecco’s Modified Eagle Medium 
(DMEM) 
Roswell Park Memorial Institute 
medium (RPMI1640) 
Gibco™ 
Opti-MEM® 
Foetal Bovine Serum (FBS) 
Penicillin/Streptomycin (P/S) 
Trypsin-EDTA 
 
2.1.3 Chemicals 
Unless otherwise stated, chemicals were obtained from Sigma-Aldrich®, Thermo 
Fisher Scientific brands (including Invitrogen™ and Gibco™), Melford, VWR 
International, Merck Millipore. Sterilisation was achieved by sterile filtering (0.22 
μm filters, Millipore) or by autoclaving (121 oC, 30 min, 15 psi). 
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2.1.4 Enzymes 
All enzymes and their suppliers are listed in Table 2.3. 
Table 2.3 List of enzymes and their suppliers. 
 
Enzyme Supplier 
DNA-free DNA removal kit (DNase I 
treatment) 
Ambion 
DNase I 
Invitrogen™ 
ProtoScript II Reverse transcriptase 
RNase inhibitor, Murine New England Biolabs 
 
2.1.5 Oligonucleotides 
Oligonucleotide primers used in quantitative PCR (qPCR), as well as oligo(dT)15 
were obtained from Sigma-Aldrich®. 
Table 2.4 List of oligonucleotides used and their sequences (forward and reverse, 5'-3'). 
Gene name Sequence (5'-3') 
ORF57 F – GCCATAATCTAAGCGTACTGG 
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 R - GCAGACAAATATTGCGGTGT 
ORF47 
 
F  - CGCGGTCGTTCGAAGATTGGG 
R - CGAGTCTGACTTCCGCTAACA 
GAPDH 
 
F - TGTGGTCATGAGTCCTTCCACGAT 
R – AGGGTCATCATCTCTGCCCCCTC 
CHMP7 
 
F – TCCCAGACAGATCAGATGGTT 
R - TTCATCCTGGGTGTCACAGA 
Nup98 
 
F - TGGGTGAAGGGCTAAATAG 
R - GGCGATCTGGGCTCTTTATT 
Myc (ChIP) 
-475 to -396 
F - TTTGTCAAACAGTACTGCTACGG 
R - CTCCCTCTCAAACCCTCTCC 
ORF50 
 
F - ATGACAAGGGTAAGAAGCTTCGG 
R - ACTGGTAGAGTTGGGCCTTCAGTT 
 
2.1.6 DNA constructs 
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All DNA plasmid constructs were either present in the Whitehouse Laboratory, 
purchased from commercial sources or kindly donated by collaborators, as 
shown in Table 2.5. 
Table 2.5 List of all DNA constructs used, their donors and references. 
Plasmid Kindly provided by Reference 
pLX_TRC317 
CHMP7 
Mission TRC3 Sigma 
TRCN0000478910  
Purchased from the MISSION® 
TRC3 Human LentiORF 
collection 
pLX_TRC317 IST1 Mission TRC3 Sigma 
TRCN0000471238 
pLX_TRC317  Mission TRC3 Sigma 
TRCN0000472187 
pLX_TC317 VPS4A Mission TRC3 Sigma 
TRCN0000480591 
pVSV.G 
Dr. Edwin Chen - 
psPAX2  
pLKO.1 DHX9 shRNA  Purchased from Dharmacon  
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TRCN0000001208 TRC Lentiviral Human shRNA 
RHS4533-EG1660 pLKO.1 DHX9 shRNA TRCN0000001209 
pLKO.1 DHX9 shRNA TRCN0000001210 
pLKO.1 DHX9 shRNA TRCN0000001211 
pLKO.1 DHX9 shRNA TRCN0000001212 
Nup85-GFP 
Dr. Kyle Roux (Roux et al., 2012) 
Nup133-GFP 
Nup160-GFP 
Nup53-GFP 
pcDNA3.1 mycBioID-
Nup53 
pcDNA3.1 mycBioID-
Nup160 
pcDNA3.1 mycBioID-
Nup133 
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pcDNA3.1 mycBioID-
Nup85 
pcDNA3.1 mycBioID 
pcDNA3.1 mycBioID-
R118G 
GFP-Nup98 Professor Richard Wozniak (Capitanio et al., 2017) 
pGL3-RTA-luc Professor Adrian 
Whitehouse 
(Gould et al., 2009) 
pRTA Gary Hayward (Yu et al., 2005) 
pEGFP-N1 Clontech Catalogue No. 6085-1 
pRTLK Renilla Promega Catalogue No. E2261 
 
2.2 Methods 
2.2.1 Cell culture 
2.2.1.1 Cell lines 
BCBL-1 are a cell line derived from B lymphocytes latently infected with KSHV 
originally from a patient with body cavity-based lymphoma. These cells were 
obtained from the American Type Culture Collection (ATCC). TREx BCBL1-Rta, 
a cell line derived from BCBL-1 cells containing an inducible myc-tagged RTA 
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plasmid, were a kind gift of Jae Jung, University of Southern California 
(Nakamura et al., 2003). Both BCBL-1 and TREX BCBL-1-Rta cells (referred to 
as TREx cells) were used for KSHV lytic replication experiments, unless 
otherwise stated. Human embryonic kidney (HEK) 293T cells (referred to as 293T 
cells) were obtained from the European Collection of Authenticated Cell Cultures 
(ECACC). These cells were used for all plasmid transfection experiments. 
2.2.1.2 Cell maintenance 
BCBL-1 and TREx cells were grown in RPMI medium 1640 (Gibco) with 
glutamine, supplemented with 10 % (v/v) foetal bovine serum (FBS, Invitrogen) 
and 1 % (v/v) penicillin-streptomycin (Invitrogen) (referred to hereafter as 
complete RPMI). This cell line was maintained under hygromycin B (Life 
technologies) selection (100 μg/ml). 293T cells (ATCC) were grown in DMEM 
(Life technologies) and supplemented with 10 % (v/v) foetal bovine serum (FBS, 
Invitrogen) and 1 % (v/v) penicillin-streptomycin (Invitrogen) (referred to hereafter 
as complete DMEM). TREx cells were maintained under hygromycin B selection 
(100 μg/ml). All cells were grown at 37 oC in a humidified incubator with 5 % CO2. 
2.2.1.3 Cell viability assay 
Cell viability was determined using the MTS-based CellTiter 96® AQueous One 
Solution Cell Proliferation Assay (Promega). For this 1 ml of 1 x 106 TREx cells 
were seeded into a 12-well plate with fresh complete RPMI containing drug or 
selection agent (G418). After 24 h, 100 μL of treated cells were transferred into 
a 96-well plate and 20 μL of CellTiter 96® AQueous One Solution Reagent was 
added. The 12-well plate was then incubated at 37 oC for 1 h before the 
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absorbance was measured at 490 nm using the Infinite® F50 Robotic microplate 
reader (Tecan). 
2.2.1.4 siRNA knockdown 
8 x 106 TREx cells were transfected once with 100 μL of Nucleofector solution V 
(Lonza) to which 100 nM Allstars negative control siRNA (Qiagen) or Nup98 
Silencer Select siRNA (ID s9782, Life Technologies) was added. Cells were 
transfected using the T-01 programme of an Amaxa nucleofector I (Lonza). 
Immediately after nucleofection, 300 μL fresh RPMI 1640 media was added and 
cells incubated for 10 min at room temperature. Cells were then added to 8 mL 
of fresh complete RPMI 1640 media and maintained in 6-well plates. Cells were 
then reactivated 48h post transfection and incubated for the desired time. 
2.2.1.5 Transient transfection 
3 x 106 293T cells were seeded out per well into 6-well plates and grown to 
approximately 60 % confluence before transfection. Cells were transfected using 
Lipofectamine® 2000 following the manufacturer’s instructions. Briefly, per well, 
100 μL of Opti-MEM was mixed with 3 μL Lipofectamine® 2000 and in a different 
mix 100 μL of Opti-MEM was combined with 1 μg of plasmid DNA for 10 min at 
room temperature with gentle agitation. Mixtures were then combined and 
incubated at room temperature for a further 10 min. Fresh media was added to 
cells during this time and finally the combined 200 μL Opti-MEM 
lipofectamine:plasmid mix was added dropwise to the cells. Experiments were 
conducted 24 h post transfection unless otherwise stated. 
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2.2.1.6 Lentiviral transduction 
3 x 106 293T cells were seeded into a volume of 1 mL complete DMEM per well 
of a 6-well plates and grown until reaching >80 % confluence. Cells were then 
transfected with 0.65 μg of psPAX and pVSV and 1.2 μg of lentiviral plasmid of 
interest (Table 2.5) using Lipofectamine® 2000. Cells were then incubated for 48 
h after which the lentivirus-containing supernatant was collected and filtered with 
0.45 μm filter. 1 mL of lentivirus-containing supernatant was added to 0.5 mL 
fresh RPMI 1640 media containing 0.5 x 106 TREx cells supplemented with 8 
μg/mL polybrene and spin-inoculated by centrifuging for 1 h at 800 x g at room 
temperature. Media-lentiviral supernatant was then left on the cells till the end of 
the day before being removed and replaced with fresh RPMI 1640 medium. 2 
μg/mL of puromycin was added 48 h after viral spin-inoculation to select for 
successfully transduced TREx cells (Figure 2.1) (Balistreri et al., 2016). Cells 
were selected alongside a non-transduced control in 6-well plates for 12 days 
before being transferred into T75 flasks for expansion for experiments. Complete 
RPMI medium supplemented with 2 μg/mL of puromycin was used for all 
subsequent passaging. 
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Figure 2.1 Puromycin kill curve for TREx cells. Different dilutions of puromycin were mixed with fresh 
media and incubated with TREx cells for 24 h before an MTS assay was performed to determine cell viability. 
n=4, standard deviation shown. Experiment from (Baquero et al. unpublished data). 
 
2.2.2 Virus based assays 
2.2.2.1 Induction of KSHV lytic replication 
To induce KSHV lytic replication, 0.8 x 106 TREx cells were treated with 2 μg/ml 
doxycycline (Sigma). Unless stated otherwise, viral mRNA export assays, protein 
expression studies, immunoprecipitation and immunofluorescence experiments 
were performed at 24 h post-induction of KSHV lytic replication. BCBL-1 cells 
were induced by the addition of 3 mM sodium butyrate and 20 ng/mL 12-O-
tetradecanoylphorbol-13-acetate (TPA). 
2.2.2.2 Viral re-infection assay 
Lytic replication was induced for 72 h in 2.0 x 106 TREx cells. Cells were then 
spun down at 500 x g for 5 min at room temperature and 2 mL of cell supernatant 
was mixed 1:1 with 2 mL of DMEM and added to confluent 293T cells seeded in 
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6-well plates. After 24 h, the 293T cells were washed with PBS and total RNA 
was extracted using 1 mL TRIzol (Invitrogen™) as described below and were 
subsequently used for quantitative reverse transcriptase PCR (qRT-PCR) as 
described below. 
2.2.2.3 Viral replication assay 
To assess changes to the level of KSHV DNA production within cells after siRNA 
treatment, 1 x 106 TREx cells per well were seeded onto 6-well plates and 
nucleofected with either scrambled or Nup98 siRNAs, as described in section 
2.2.1.4, and then induced 48 h post-nucleofection. 72 h post-doxycycline 
induction cells were spun down at 500 x g for 5 min at 4 oC. Viral and cellular 
DNA was purified using the QIAamp DNA Mini kit (QIAGEN) following the 
manufacturer’s instructions. Initially the cell pellet was resuspended in 200 μL 
PBS and cells were lysed by addition of proteinase K (QIAGEN) and buffer AL 
followed by 15 s pulse vortexing and 10 min incubation at 56 oC. 100 % ethanol 
was then added, and the solution was applied to a QIAquick spin column. 
Columns were centrifuged at 6,000 x g for 1 min at room temperature and flow-
through was discarded. Wash buffer AW1 was then added to the column and the 
above centrifugation step was repeated. Wash buffer AW2 was then added and 
the column was centrifuged at 8,000 x g for 3 min at room temperature. Flow-
through was discarded and DNA was eluted by the addition of 50 μL dH2O. The 
column was then incubated at room temperature for 1 min and centrifuged at 
6,000 x g for 1 min. Eluted DNA was stored at -20 oC. Viral and cellular DNA 
levels were quantified by qPCR as described below (Section 2.2.5.4). 
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2.2.2.4 Cytoplasmic fractionation 
1 x 106 TREx cells were induced as described in section 2.2.2.1 and 24 h later 
cells were collected by 500 x g 5 min spin followed by a wash in 1 mL of PBS. 
Cells were then lysed in 600 μL of 1 % (v/v) Triton X-100 in PBS for 10 min on 
ice. 350 μL of the lysate were then transferred to fresh microcentrifuge tubes and 
spun for 5 min at 2000 x g at 4 oC and the supernatant was transferred to fresh 
microcentrifuge tubes as the cytoplasmic fraction. The remaining 250 μL was 
divided into 200 μL for extraction of RNA with the use of TRIzol as described in 
section 2.2.5.1 and the remaining 50 μL were kept for protein analysis via western 
blotting. The supernatant of the cytoplasmic fraction was also divided for total 
RNA extraction and protein analysis into volumes of 300 μL and 50 μL. 
2.2.3 Analysis of proteins 
2.2.3.1 Quantification of protein samples 
Protein sample concentrations were determined using the Bio-Rad DCÔ protein 
assay following the manufacturer’s instructions. In a 96-well plate, 5 μL of protein 
lysate or pre-diluted bovine serum albumin (BSA) standards, obtained by serial 
dilution of a 5 mg/ml BSA stock, were incubated with 25 μL Reagent A’ (25 μL of 
reagent S in 1 mL of reagent A) and 200 μL reagent B. After 15 min of incubation 
at room temperature with constant agitation absorbance was measured at 620 
nm using the Infinite® F50 Robotic microplate reader (Tecan). Protein 
concentration was determined through calculation of a standard curve of known 
protein concentrations using BSA in the specific lysis buffer used for the 
experiment. The absorbance of the known concentrations was determined as 
described above and Microsoft Excel was used to determine the function of the 
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standard curve. The function was then applied to all experimental samples to 
determine protein concentration. 
2.2.3.2 SDS-PAGE Electrophoresis 
Protein samples were mixed 1:1 with 2 x SDS loading buffer [100 mM Tris/HCl, 
pH 6.8, 4 % (w/v) SDS, 20 % (w/v) glycerol, 10 mM DTT, 0.25 % (w/v) 
bromophenol blue], and subsequently boiled for 5 min at 95 oC. Samples were 
then separated via molecular weight using sodium dodecyl sulphate (SDS)-
polyacrylamide gel electrophoresis (PAGE). After boiling samples, these were 
loaded alongside Precision Plus ProteinÔ Dual Colour Standards (Bio-Rad®) 
onto a 10 % polyacrylamide gel (unless otherwise stated) composed of a stacking 
gel [5 % (v/v) acrylamide/bis-acrylamide 37.5.1 (Severn Biotech Ltd.), 375 mM 
Tris/HCl, pH 8.8, 0.1 % (w/v) SDS, 0.12 % (v/v) APS, 0.012% TEMED (v/v)] and 
a resolving gel [10% (v/v) acrylamide/bis-acrylamide 37.5.1 (Severn Biotech 
Ltd.), 125 mM Tris/HCl, pH 6.8, 0.1 % (w/v) SDS, 0.08 % (v/v) APS, 0.008 % 
TEMED (v/v)]. Gels were run at 180 V for 60 min or until the dye front reached 
the bottom of the resolving gel. The running buffer used was 25 mM Tris, 192 mM 
Glycine, and 0.1 % (w/v) SDS. 
2.2.3.3 Western Blotting 
Protein samples separated by SDS-PAGE (Section 2.2.3.2) were transferred to 
an AmershamÔ ProtranÔ NC Nitrocellulose Membrane (Thermo Fisher 
Scientific). Proteins were electrophoretically transferred onto the nitrocellulose 
membrane via a wet transfer system. The nitrocellulose membrane was 
assembled into a “blotting sandwich” composed of a blotting pad, two pieces of 
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Whatman filter paper, gel, nitrocellulose membrane, two pieces of Whatman filter 
paper and a blotting pad. Prior to use the membrane was pre-soaked alongside 
all other blotting components in transfer buffer [20 % (v/v) methanol, 25 mM Tris, 
192 mM glycine]. The “blotting sandwich” was then transferred into a blotting rig 
and run at 100 V for 1 h. The transfer of the ladder onto the nitrocellulose 
membrane was used to evaluate the efficiency of the transfer. Non-specific 
protein binding was then blocked for 1 h incubating the membrane in 5 % (w/v) 
non-fat milk (Marvel) in Tris buffered saline and Tween-20 (TBS-T) [150 mM 
NaCl, 50 mM Tris/HCl, pH 7.5, 1 % (v/v) Tween-20] on a rocking platform. The 
membrane was then incubated with primary antibody in 2.5 % (w/v) non-fat milk 
in TBS-T for 60 min at room temperature, followed by three 5 min washes in TBS-
T. Secondary antibody (HRP-conjugated IgG) was applied in 2.5 % (w/v) non-fat 
milk in TBS-T for 60 min at room temperature, followed by five 5 min washes in 
TBS-T. Chemiluminescence was developed by adding enhanced 
chemiluminescence (ECL) system (Geneflow) to the membrane for 1 min. A 
photographic HyperfilmÔ ECL (Thermo Fisher Scientific) was then exposed to 
the membrane for the desired amount of time. The film was developed with a 
Konica SRX-101A developer. 
2.2.4 Analysis of protein interactions 
2.2.4.1 Immunofluorescence 
293T cells or TREx cells were grown on 24-well plates containing sterile glass 
coverslips, which had been coated in poly-l-lysine (Sigma-Aldrich®) for 5 min and 
washed three times in PBS. Once 293T cells had reached at least 50 % 
confluence they were transfected as described in section 2.2.1.5. TREx cells 
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were nucleofected as described in section 2.2.1.4 and seeded onto coverslips 
immediately. TREx cells were then induced either 48 h post-transfection as 
described in section 2.2.2.1. At the required experimental time point coverslips 
were washed in PBS and fixed with 4 % (v/v) formaldehyde for 15 min at room 
temperature. Formaldehyde was then removed, and coverslips washed three 
times with PBS. Cells were then permeabilised using 1 % (v/v) Triton X-100 in 
PBS for 15 min at room temperature. To prevent non-specific binding cells were 
incubated with 1 % (w/v) BSA in PBS for 1 h at 37 oC in a humidity chamber. After 
blocking, cells were incubated with primary antibodies in 1 % (w/v) BSA in PBS 
for 1 h at 37 oC in a humidity chamber. After three washes with PBS, Alexa 
Fluor®-conjugated secondary antibodies were incubated under the same primary 
antibody conditions. For the analysis of biotinylation, Alexa Fluor®-conjugated to 
streptavidin was used. Following secondary antibody treatment, coverslips were 
washed a further five times with PBS and mounted onto microscope slides with 
DAPI containing mounting medium (VECTASHIELD®, Vector Laboratories) for 
nuclei labelling. Slides were stored at 4 oC until visualisation on an inverted LSM 
880 confocal microscope (Ziess) using Zen 2011 software (Ziess).  
2.2.4.2 Co-immunoprecipitation of proteins 
For co-immunoprecipitation assays, TREx cells were prepared and induced as 
described in section 2.2.2.1. At different time points post induction of lytic 
replication (0, 8, 16, 24 h), cells were harvested at 500 x g for 5 min at 4 oC, 
washed once with PBS and lysed for 10 min using 1 mL of modified RIPA buffer 
[150 mM NaCl, 50 mM Tris/HCl; pH 7.6, 1 % (v/v) Nonidet™ P-40 (NP-40)]. The 
insoluble fraction was pelleted at 10,000 x g for 10 min and the supernatant was 
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kept on ice. The supernatant was then incubated by rotation with 5 μg of Nup98 
antibody (Abcam®) overnight at 4 oC. The following day, protein A agarose beads 
(Roche) were pelleted at 500 x g for 5 min and washed 3 times with modified 
RIPA buffer to remove residual storage buffer. 30 μL of beads were then 
incubated by rotation with the antibody-supernatant mix for 1 h at 4 oC. The beads 
were then pelleted by centrifugation at 500 x g for 5 min at 4 oC and washed in 
ice cold modified RIPA buffer 3 times further before the agarose-antibody-antigen 
complex was mixed with 60 μL 2 x SDS loading buffer (Section 2.2.3.2) and 
proteins eluted by heating at 95 oC for 5 min before analysis by SDS-gel and 
Western blotting. 
2.2.4.3 Chromatin immunoprecipitation (ChIP)  
1 x 107 TREx cells were prepared per ChIP in a six-well plate and induced as 
described in section 2.2.2.1. Cells were fixed for 10 min with 1 % (v/v) 
formaldehyde at room temperature. Fixation was then quenched by the addition 
of 10X Glycine solution to a final concentration of 1X and incubated for 5 min at 
room temperature. Formaldehyde crosslinked chromatin was then obtained using 
the Pierce Chromatin Prep Module (Thermo Scientific) according to the 
manufacturer’s protocol to obtain formaldehyde crosslinked chromatin. 
Chromatin was digested incubating six units of micrococcal nuclease (MNase) 
per 100 μL of MNase digestion buffer in a 37 oC water bath for 15 min. These 
conditions resulted in optimal digestion of chromatin with most fragments ranging 
between 150-300 nucleotides in length which was confirmed via running for 40 
min at 100 V on a 1 % (w/v) TAE-agarose gel and staining with 0.2 μg/mL 
ethidium bromide. Immunoprecipitations were carried out using EZ-ChIP kit 
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(Millipore) according to the manufacturer’s instructions. Immunoprecipitations 
were performed overnight at 4 oC and contained 50 μL of digested chromatin (1 
x 107 cells), 450 μL ChIP dilution buffer and 1.5 μg Nup98 antibody (ab45584) or 
1.5 μg of normal mouse IgG (Millipore) which was used as negative control 
antibody. Prior to qPCR analysis, DNA was subjected to a DNA clean up step 
using DNA spin columns provided in the EZ-ChIP kit (Millipore). qPCR reactions 
were performed as described in section 2.2.5.4. using either 4 μL ChIP DNA or 4 
μL of 1 % input DNA as template. 
2.2.5 Quantification of mRNA levels 
2.2.5.1 Total RNA isolation 
Total RNA was extracted from cells using the TRIzol reagent (Life Technologies) 
according to the manufacturer’s protocol. 1 mL of TRIzol was added to 2 x 106 
TREx, BCBL-1 or confluent 293T cells from one well of a 6-well plate. Cells were 
resuspended in TRIzol for 5 min at room temperature after which 200 μL of 
chloroform was added and samples were vigorously shaken for 15 s. Samples 
were then incubated for a further 3 min at room temperature and then centrifuged 
at 12,000 x g for 15 min at 4oC. 500 μL of the upper phase layer, containing RNA, 
was transferred to a fresh microcentrifuge tube containing 500 μL of isopropanol. 
Samples were mixed and incubated for 10 minutes at room temperature before 
a further centrifugation step to precipitate the RNA at 10,000 x g for 10 minutes 
at 4oC. The supernatant was then discarded, and the RNA pellet was washed in 
70% ethanol and centrifuged at 7,500 x g for 5 minutes at 4oC. After this 
centrifugation the supernatant was discarded, and the RNA pellet was air-
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at room temperature for approximately 5 minutes. The pellet was then 
resuspended in 16 μL of DNase and RNase free H2O. 
2.2.5.2 DNase I treatment 
To remove any contaminating DNA from the total RNA isolate, samples were 
treated with DNA-freeÔ DNA removal kit (Ambion®) following the manufacturer’s 
instructions. Briefly, 0.1 volumes of 10x DNase I buffer and 1 µL of DNase I were 
added per sample and incubated for 30 min at 37 oC. Next, samples were treated 
with 0.1 volumes of DNase inactivating reagent and gently mixed for 2 min at 
room temperature. The DNase inactivating agent was pelleted from the RNA 
solution by centrifugation at 10,000 x g for 2 min at 4 oC. The supernatant was 
transferred to a new microcentrifuge tube and stored at -80 oC. 
2.2.5.3 Reverse transcription (RT) 
Total RNA concentrations were measured using a NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies, a Thermo Fisher Scientific 
Company). 1 µg of total RNA was added to the following reaction to synthesise 
complementary DNA (cDNA). Initially, 1 µL Oligo(dT)15 (500µg/mL) and 1 µL 
dNTP mix (2.5 mM/dNTP) were added per sample and incubated at 65 oC for 5 
min and then immediately cooled on ice. The following master mix was then 
added per sample: 4 μL 5x ProtoScript® II Reverse Transcriptase Reaction Buffer 
(NEB), 2 μL 0.1 M DTT (NEB), 1 μL RNase Inhibitor, Murine (NEB), 1 μL 
ProtoScript® Reverse Transcriptase (NEB). Samples were also prepared with 
the same master mix but omitting the reverse transcriptase, as a negative RT 
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control. Samples were then incubated at 42 oC for 50 min, followed by inactivation 
of the reverse transcriptase at 65 oC for 20 min. The cDNA was stored at -20 oC. 
2.2.5.4 Quantitative PCR (qPCR) 
Quantification of cDNA or genomic DNA was carried out using a Rotor-Gene 
6000 Real-Time PCR machine (QIAGEN) and sequence-specific primers. The 
amplification efficiency of primers was determined prior to primer use for qPCR 
by the following procedure: serial dilutions of cell lysate cDNA were prepared 
from neat to 1:128 and qPCR was performed using the primer set. Cycle 
threshold (Ct) values were then determined using the method outlined below. 
These were plotted on a logarithmic scale and a linear function was determined. 
The slope coefficient of the function was then used to calculate the % 
amplification efficiency using the formula E=-1+10$- 1slope%. Primers with efficiencies 
between 90 % and 110 % were selected for subsequent use. For each sample 4 
μL of cDNA, as well as RT negative samples and no-template control samples 
were added to a master mix [10 μL 2x SensiMixÔPlus SYBR (Bioline), 5 μL dH2O, 
1 μL primer mix (10 μM forward and reverse primers)]. These were prepared in 
0.1 mL strip tubes (QIAGEN). The qPCR programme used was: initial 
denaturation step 95 oC for 10 min, 35 cycles of denaturation 95 oC for 15 s, 
annealing at 60 oC for 30 s, and elongation at 72 oC for 20 s. Ct values were 
acquired at the elongation step of each cycle and analysed using the Rotor-Gene 
6000 Series Software Version 1.7. After the completion of 35 cycles, a melt curve 
analysis was performed to confirm single-product amplification. Samples were 
normalised against the housekeeping gene GAPDH (unless otherwise stated) 
and quantified using the comparative CT method. This involves calculating the 
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difference in Ct values (∆Ct) between the gene of interest and reference 
housekeeping gene. The difference between the ∆Ct values between the 
experimental condition versus control condition are then calculated giving a ∆∆Ct 
value. The fold change between these conditions was then calculated using the 
formula 2(-∆∆Ct). 
2.2.6 Molecular cloning 
2.2.6.1 Transformation of E.coli DH5a 
All constructs contained a kanamycin or ampicillin resistance gene. Initially 
competent E. coli DH5a cells were thawed on ice. 1 ng of plasmid DNA was 
mixed with 50 μL of competent cells and incubated on ice for 30 min. Cells then 
underwent heat shock at 42 oC for 30 s before immediately cooling on ice for 5 
min. SOC medium [0.5 (w/v) yeast extract, 2 % (w/v) tryptone, 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM Glucose] was then added and 
the mixture was incubated at 37 oC for 1 h while shaking at 140 rpm. After 1 h 
cells were then spread onto Luria-Bertaini (LB) broth-agar plates [1.5 % (w/v) 
microagar in LB medium] containing 100 μg/mL ampicillin or kanamycin. Plates 
were then incubated at 37 oC overnight.  
Transformed DH5a cells were saved as glycerol stocks for long term storage. 
This was obtained by picking a single bacterial colony from an agar plate and 
grown in 3 mL LB medium containing 100 μg/mL ampicillin or kanamycin 
overnight at 37 oC with shaking at 140 rpm. This starter culture was then mixed 
with LB-medium containing 40 % glycerol at 1:1 ratio and stored at -80 oC. 
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2.2.6.2 Plasmid purification 
For isolation of large amounts of plasmid DNA the Plasmid Maxi Kit (QIAGEN) 
was used following the manufacturer’s guidelines. For each plasmid, a single 
bacterial colony of DH5a cells were picked from agar plates and grown in 3 mL 
LB medium containing 100 μg/mL ampicillin or kanamycin overnight at 37 oC with 
shaking. Of these starter cultures, 200 μL were then used to inoculate 100 mL LB 
media containing 50 μg/mL of the relevant antibiotic and was grown overnight at 
37 oC with shaking. The bacterial cultures were harvested at 5,000 x g for 15 min 
at 4 oC and then resuspended in 10 mL buffer P1. 10 mL of lysis buffer P2 was 
then added and the solution incubated for 5 minutes at room temperature. 10 mL 
of neutralisation buffer P3 was then added and incubated on ice for 10 min. 
Insoluble debris was then spun down at 5,000 x g for 1 h at 4 oC and the clear 
supernatant was added to a pre-equilibrated QIAGEN-tip 500. After the 
supernatant had passed through the column by gravity flow, two rounds of resin 
washing were performed with 30 mL of wash buffer QC. The plasmid DNA was 
then eluted into 10.5 mL of 100 % isopropanol by addition of 15 mL elution buffer 
QF. The eluted DNA:isopropanol solution was then spun at 5,000 x g for 1 h at 4 
oC to produce a precipitated DNA pellet. This was then washed in 1 mL of 70 % 
ethanol and spun down at 16,000 x g for 10 min. The supernatant was removed, 
and the DNA pellet was then air-dried at room temperature for 5 min and 
resuspended in 200 μL dH2O. DNA content and purity were determined using a 
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, a Thermo 
Fisher Scientific Company). 
2.2.7 Biotin affinity identification (BioID) 
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2.2.7.1 Transfection of BioID constructs 
8 x 106 TREx cells were nucleofected once with 100 μL of Nucleofector solution 
V (Lonza) to which 2 μg of plasmid DNA was added. Cells were nucleofected 
using the protocol described in section 2.2.1.4. 
1 x 106 293T cells were transfected with the same amount of BioID plasmid DNA 
using the previously described technique in section 2.2.1.5. 
2.2.7.2 Biotin affinity purification 
Two independent nucleofections for each BioID plasmid in TREx cells were 
performed as described in section 2.2.1.4 and then pooled to give a final cell 
number of 1.6 x 107. Cells were either induced to KSHV lytic replication as 
described in section 2.2.2.1 or maintained as unreactivated. 24 h prior to 
harvesting, cells were incubated with 100 μM biotin (Sigma)-containing media. 
Cells were lysed following the protocol described in (Roux et al., 2012) which is 
briefly outlined below. Cells were harvested by a 5 min spin at 500 x g in PBS 
and then lysed in Roux lysis buffer [50 mM Tris, pH 7.4, 500 mM NaCl, 0.4 % 
(w/v) SDS, 5 mM EDTA, 1 mM DTT and 1x Complete Protease Inhibitor (Roche)] 
for 10 min at room temperature and then sonicated. Triton X-100 was then added 
to 2 % (v/v) final concentration. An equal volume of chilled 50 mM Tris, pH 7.4 
was added before another round of sonication and centrifugation at 4 oC 16,000 
x g. Supernatants were then incubated by rotation with 200 μL of Dynabeads 
(MyOne Streptavidin C1, Invitrogen) overnight. Beads were collected by spinning 
at 500 x g for 5 min and washed twice for 8 min at room temperature in wash 
buffer 1 [2 % (v/v) SDS in dH2O], then washed at room temperature in wash buffer 
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2 (0.1 % deoxycholate (w/v), 1 % triton-X100 (v/v), 500 mM NaCl, 1 mM EDTA 
and 50 mM HEPES, pH 7.5), once with wash buffer 3, (250 mM LiCl, 0.5 % NP-
40 (v/v), 0.5 % deoxycholate (w/v), 1 mM EDTA, and 10 mM Tris, pH 8.1) and 
twice with wash buffer 4 (50 mM Tris, pH 7.4, and 50 mM NaCl). Bound proteins 
were eluted from the beads with 50 μL 2 x SDS loading buffer (Section 2.2.3.2) 
saturated with 100 mM biotin by incubating beads at 95 oC for 5 min. Protein 
samples were then stored at -80 oC before being shipped to the University of 
Bristol Proteomic Facility in dry ice. 
2.2.8 Data analysis 
2.2.8.1 Experimental design and null-hypothesis significance testing 
Experiments were performed as experimental replicates by the n number 
specified in the figure legends (unless otherwise stated) and data analysis for bar 
plots was performed exclusively in Microsoft® Excel. Data was averaged using 
the built in AVERAGE function and standard deviations calculated using the 
STDEV.S function. Standard error of the mean was then calculated using the 
standard deviation and number of samples and 95 % confidence intervals were 
calculated for error bar parameters. All error bars shown are the 95 % confidence 
intervals around the mean of the data and all p-values shown were calculated 
using the T.TEST function set for a two-tailed, two-sample with equal variance 
test. 
All box and whisker plots were plotted using R package ggplot2 utilising the 
geom_boxplot setting. In ggplot2 a box and whisker plot shows the median, the 
25th and 75th percentiles (interquartile range, IQR) as the upper and lower hinges, 
and whiskers extending 1.5*IQR. The box plots are notched to highlight the 95 % 
103 
 
confidence intervals around the median calculated as 1.58*IQR/√(. More 
documentation can be found at 
https://ggplot2.tidyverse.org/reference/geom_boxplot.html.  
2.2.8.2 Densitometry analysis 
Densitometry analysis was performed using ImageStudioLite® from Li-COR 
Biosciences. Scanned .tiff images were imported into ImageStudioLite® and 
converted to grayscale. Using the draw rectangle function a box was drawn 
around a band and then using the copy and paste function the identical shape 
was produced for each band to be analysed. This was performed for both GAPDH 
and the protein band of interest producing a data table that was copied into Excel. 
The signal column was then used to calculate the relative intensity of the band 
versus the control band, this relative intensity was then normalised by  protein of 
interest relative intensity divided by loading control (GAPDH) relative intensity. 
These were plotted as a standard Excel bar plot. 
2.2.8.3 ImageJ analysis 
For the counting of BioID-expressing cells to calculate biotinylation rates: 
Nucleofected TREx cells were prepared as described in section 2.2.4.1. Tile 
scans were performed using the LSM 880 confocal microscope (Ziess) creating 
an RGB 3000 x 3000 pixel image of approximately 1.5 cm2 of a tile. This was 
exported as a .tiff from Zen 2011 using the Save As function and then opened in 
Fiji (Schindelin et al., 2012). The image was then split into three separate images 
for each channel. The following was performed on both the blue channel for DAPI, 
and the red channel for Biotin: Remove background, threshold was adjusted with 
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a maxima of approximately 40. Images were then converted to mask, the fill holes 
command was used and watershed was performed. Particles were then analysed 
using a size threshold of 25 pixels-infinity, no circularity threshold was set, and 
outlines were selected as the preferred output. The data from this count was then 
exported as a .csv file and analysed using Excel. 
For cell membrane analysis using phalloidin: 
Transduced TREx cells were prepared as described in section 2.2.4.1. Tile scans 
were performed using the LSM 880 confocal microscope (Ziess) creating an RGB 
3000x3000 pixel image of approximately 1.5 cm2 of a tile. This was exported as 
a .tiff from Zen 2011 using the Save As function and then opened in Fiji 
(Schindelin et al., 2012). The image was then split into three separate images for 
each channel. The red channel (phalloidin) was kept, background was removed, 
and threshold set to 25-255. Images were converted to mask, holes filled and 
watershed set. Global measurement settings had been set to mm and particles 
were analysed for perimeter and area using a size threshold of 10 mm-infinity, no 
circularity threshold was set, and outlines were selected as the output. Data was 
then exported as a .csv and analysed in Rstudio (R version 3.4.0 (2017-04-21) -
- "You Stupid Darkness") using the script in section 2.2.8.4.2.1. 
2.2.8.4 Bioinformatics analysis: 
Tandem mass tagging (TMT) mass spectrometry data was provided as an excel 
spreadsheet that was converted to a .csv file using the Excel Save As function. 
Rstudio (R version 3.4.0 (2017-04-21) -- "You Stupid Darkness") was then used 
to filter data to provide a new enriched hits datasheet using the ratio of protein 
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between IP and R118G, the non-biotinylating control, (induced or uninduced 
depending on the IP sample) was greater than 1.5, code available in section 
2.2.8.4.1. This list of proteins was further refined using an additional R script 
(Section 2.2.8.4.1.3) which also included proteins that were significantly 
downregulated or upregulated using the protein ratio between reactivated and 
unreactivated conditions (BioID-nup+/BioID-nup-). This produced a new list 
including enriched proteins compared to beads-only, and proteins upregulated 
during lytic replication by >2.0 or downregulated during lytic replication <0.33. 
This list was then outputted as a .csv and protein accession codes were 
converted to gene names using Uniprot mapper 
(https://www.uniprot.org/mapping/, Options: UniProtKB AC/ID to Gene name). All 
successfully mapped identifiers were copied and used in a multiple protein search 
on STRING (https://string-db.org/). The STRING network map was rendered and 
filtered to exclude edges derived from text mining data. Using the Analysis tab 
nodes were coloured by selecting the Gene Ontology cellular component 
categories cytoplasm and nuclear part. 
 R language scripts for BioID data analysis 
2.2.8.4.1.1 BioID script workflow 
Import and initial filter script 
V 
Combinatorial refinement script 
V 
Protein names then converted from accession to gene names 
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V 
STRING-db analysis 
 
2.2.8.4.1.2 Import script and initial filter versus background 
Below example for unreactivated samples: 
library(dplyr) 
library(ggplot2) 
# Set working directory for import of mass spec csv files 
setwd("C:/Users/bsac/OneDrive for Business/PhD/PhD s- drive/Omic 
data/BioID/TMT/Total with Human and KSHV prot/CSV Human and KSHV 
prot") 
# create a dataframe containing .csv data from reactivated BioID 
sample 
BioIDun <- data.frame(read.csv("211116 Total Human Plus KSHV v BioID -
.csv", header = TRUE)) 
# create a dataframe containing .csv data from unreactivated 
R118G (beads only) sample 
R118Gun <- data.frame(read.csv("211116 Total Human Plus KSHV v R116G-
.csv", header = TRUE)) 
# filter a refined table with only columns of accession, description, 
R118G/nup- and nup+/nup- 
# produce a table of nup+/nup- 
nup_ratio <- BioIDun[,c("Accession","Description","X128C.131")] 
# filter for induced nup hits 
BioIDun_hits <- filter(R118Gun, R118Gun[,"X128_C.129_N"] > 1.5) 
# BioIDind_hits has a list of enriched hits compared to beads only 
# for validation purposes we will save this data to confirm these hits 
# are nuclear versus bioid 
setwd("/Users/alexcoleman/OneDrive - University of Leeds/Code/R 
scripts/Bioid analysis/Enriched hits scripts/Enriched lists") 
write.csv(BioIDun_hits, file = "BioIDind_hits.csv") 
Below example for reactivated samples: 
library(dplyr) 
library(ggplot2) 
# Set working directory for import of mass spec csv files 
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setwd("C:/Users/bsac/OneDrive for Business/PhD/PhD s- drive/Omic 
data/BioID/TMT/Total with Human and KSHV prot/CSV Human and KSHV 
prot") 
# create a dataframe containing .csv data from reactivated BioID 
sample 
BioIDun <- data.frame(read.csv("211116 Total Human Plus KSHV v BioID -
.csv", header = TRUE)) 
# create a dataframe containing .csv data from reactivated 
R118G (beads only) sample 
R118Gind <- data.frame(read.csv("211116 Total Human Plus KSHV v 
R116G+.csv", header = TRUE)) 
# filter a refined table with only columns of accession, description, 
R118G/nup- and nup+/nup- 
# produce a table of nup+/nup- 
nup_ratio <- BioIDun[,c("Accession","Description","X128C.131")] 
# filter for induced nup hits 
BioIDind_hits <- filter(R118Gind, R118Gind[,"X128_C.129_N"] > 1.5) 
# BioIDind_hits has a list of enriched hits compared to beads only 
# for validation purposes we will save this data to confirm these hits 
# are nuclear versus bioid 
setwd("/Users/alexcoleman/OneDrive - University of Leeds/Code/R 
scripts/Bioid analysis/Enriched hits scripts/Enriched lists") 
write.csv(BioIDind_hits, file = "BioIDind_hits.csv") 
 
2.2.8.4.1.3 Combinatorial refinement script 
# this is the working library for allocating final key hits 
# it takes from previous enriched hits versus beads only 
# then creates final list of hits that are present in both OR 
# present in uninduced list but ratio is less than <0.33 OR 
# present in induced list but ratio is greater than 2 
library(dplyr) 
# set working dir 
setwd("/Users/alexcoleman/OneDrive - University of Leeds/Code/R 
scripts/Bioid analysis/Enriched hits scripts/Enriched lists") 
# imports Nup85 hits datasets (enriched over R118G) 
Nup85in <- data.frame(read.csv("Nup85ind_hits.csv", header = TRUE)) 
Nup85un <- data.frame(read.csv("Nup85un_hits.csv", header = TRUE)) 
# Imports original Nup85 unreactivated dataset containing the 
Nup85+/Nup85- ratios 
Nup85un_origin <- data.frame(read.csv("/Users/alexcoleman/OneDrive - 
University of Leeds/PhD/PhD s- drive/Omic data/BioID/TMT/Total with 
Human and KSHV prot/CSV Human and KSHV prot/211116 Total Human Plus 
KSHV v Nup85-.csv", header = TRUE)) 
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# create a list of shared proteins in both Nup85+ hit list and Nup85- 
hit list 
shared_85 <- Nup85in[Nup85in$Accession %in% Nup85un$Accession,] 
# Create a long list of all hits identified but not all necessarily 
shared between +/- 
prot_names <- bind_rows(Nup85un, Nup85in) 
# removes duplicates 
prot_names <- unique(prot_names) 
# creates new dataframe to calculate relative abundance differences 
from  
# original dataframe versus Nup85- by selecting out proteins by 
Accession from long list of all hits 
prot_names1 <- Nup85un_origin[Nup85un_origin$Accession %in% 
prot_names$Accession,] 
# reduce columns to relevant columns 
prot_names1 <- 
prot_names1[,c("Accession","Description","X..Unique.Peptides","X129_C.
127_N")] 
# filter the list for proteins in the shared list defined above, or 
proteins with a Nup85+/Nup85- ratio greater than 2 or proteins with a 
Nup85+/Nup85- ratio less than 0.33. 
prot_names1 <- prot_names1[prot_names1$Accession %in% 
shared_85$Accession | prot_names1$X129_C.127_N > 2.0 | 
prot_names1$X129_C.127_N <= 0.33,] 
# create a new column to highlight if this protein was present in the 
Nup85+ hit list 
prot_names1$In <- prot_names1$Accession %in% Nup85in$Accession 
# create a new column to highlight if this protein was present in the 
Nup85- hit list 
prot_names1$Un <- prot_names1$Accession %in% Nup85un$Accession 
# set working directory for saving  
setwd("/Users/alexcoleman/OneDrive - University of Leeds/Code/R 
scripts/Bioid analysis/Enriched hits scripts/Enriched lists") 
write.csv(prot_names1, file = "Nup85_hits_combo2.csv") 
 
 R language scripts for perimeter data analysis 
2.2.8.4.2.1 Boxplot analysis of perimeter data 
library(ggplot2) 
# quick analysis of ImageJ features 
rx1_scr <-data.frame(cbind(read.csv('dir/to/csv 
/reactivated_tile1.csv'),treatment='Mock'))[,c(2,3,4)] 
rx2_scr <- data.frame(cbind(read.csv('/Users/alexcoleman/OneDrive - 
University of Leeds/Images for 
classification/Phalloidin/Scr/Analysis/Rx 
only/reactivated_tile2.csv'),treatment='Mock'))[,c(2,3,4)] 
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rx1_ist1 <- data.frame(cbind(read.csv('/Users/alexcoleman/OneDrive - 
University of Leeds/Images for 
classification/Phalloidin/ist1/Analysis/Rx_only/reactivated_tile1.csv'
),treatment='IST1'))[,c(2,3,4)] 
rx2_ist1 <- data.frame(cbind(read.csv('/Users/alexcoleman/OneDrive - 
University of Leeds/Images for 
classification/Phalloidin/ist1/Analysis/Rx_only/reactivated_tile2_outl
i.csv'),treatment='IST1'))[,c(2,3,4)] 
rx1_7 <- data.frame(cbind(read.csv('/Users/alexcoleman/OneDrive - 
University of Leeds/Images for 
classification/Phalloidin/chmp7/Analysis/Rx_only/reactivated_tile1.csv
'),treatment='CHMP7'))[,c(2,3,4)] 
rx2_7 <- data.frame(cbind(read.csv('/Users/alexcoleman/OneDrive - 
University of Leeds/Images for 
classification/Phalloidin/chmp7/Analysis/Rx_only/reactivated_tile1_2.c
sv'),treatment='CHMP7'))[,c(2,3,4)] 
main_df <- rbind(rx1_scr,rx2_7,rx2_ist1,rx2_scr, 
row.names=c('Perim.','Area','Label')) 
main_df$Area <- sapply(sapply(main_df$Area, as.character), as.numeric) 
main_df$Perim. <- sapply(sapply(main_df$Perim., as.character), 
as.numeric) 
main_df$Perim.Area <- main_df$Perim./main_df$Area 
# set up saving at 300dpi 
tiff('test.tiff',units = 'px', width = 1500, height = 1200,res= 300) 
ggplot(main_df, aes(x=treatment, y=Perim.Area))+ 
  stat_boxplot(geom=’errorbars’)+ 
  geom_boxplot(notch=TRUE, 
               lwd = 0.7) + 
  scale_x_discrete(limits=c('Mock','IST1','CHMP7'), 
                   name = 'LentiORF')+ 
  scale_y_continuous(expand=c(0,0), 
                     limits=c(0,2.6), 
                     breaks=seq(0,2.6,0.2), 
                     name = 'Perimeter/Area')+ 
  theme_classic() 
# confirm saving of tiff file 
dev.off() 
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3 Nup98 is remodelled by KSHV during lytic 
infection 
3.1 Introduction 
KSHV is a member of the Gammaherpesvirinae sub-family. Its lifecycle is divided 
into two distinct replication stages: latency with minimal gene expression and a 
focus on episome maintenance; and lytic replication, where the full complement 
of viral open reading frames (ORFs) are expressed and nascent virions are 
produced and released. Lytic replication itself is split into three temporal stages 
based on the kinetics of ORF expression: immediate-early, delayed-early and 
late. At each of these stages different viral proteins are expressed that remodel 
endogenous cellular processes from mRNA export through immediate-early 
ORF57 protein to global mRNA turnover via delayed-early ORF37 protein 
(Glaunsinger and Ganem, 2004; Majerciak and Zheng, 2009). 
The nuclear pore complex (NPC) is a protein mega-complex that sits at the 
nuclear envelope and regulates nucleocytoplasmic transport. It is formed from 
multiple copies of 30 different proteins called nucleoporins, giving rise to a mega-
complex of approximately 125 MDa (Hoelz et al., 2011). It acts as both a barrier 
and a sophisticated conduit permitting regulated transport of protein and RNA 
(Moore, 1998; Cautain et al., 2014). Nup98 is a nucleoporin crucial for various 
RNA export pathways, as well as playing a variety of off-pore regulatory roles 
within the nucleus (Powers et al., 1997; Light et al., 2013). Viral remodelling of 
nucleoporins is an established strategy of cellular subversion during viral infection 
and alterations in nucleoporin levels had been identified from whole cell lysate 
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proteomic data from lytically induced KSHV-infected B cells (Sophie Schumann, 
Unpublished data). Therefore, it was speculated that KSHV may specifically 
remodel components of the NPC during lytic infection to aid its replication. 
In this chapter, Nup98 is identified as a nucleoporin that is remodelled during 
early KSHV lytic infection via a large quantitative proteomic screen. A range of 
techniques are then employed to confirm and characterise the importance of 
Nup98 targeting during KSHV lytic replication. 
3.2 Nup98 is specifically downregulated early during KSHV lytic 
infection 
SILAC-based quantitative proteomics is a mass spectrometry technique that 
detects changes in protein abundance between samples using non-radioactive 
isotope labelling (Oda et al., 1999; Ong et al., 2002). Previously, members of the 
Whitehouse laboratory had prepared BCBL-1-Rta cells (subsequently referred to 
as TREx cells) grown in either heavy, light or medium isotopic conditions. Cells 
in the heavy and medium conditions were treated with doxycycline to induce 
KSHV lytic replication through an inducible mycRTA construct and lysed at 24 h 
and 8 h post doxycycline treatment, respectively. Lysed samples were then sent 
to Dr Kate Heesom at the University of Bristol Proteomic Facility for analysis and 
the SEQUEST data was obtained with relative protein levels expressed as ratios 
between the three conditions. Whole cell lysate quantitative proteomic data with 
a 1% false discovery rate (FDR) showed Nup98 levels were reduced by 
approximately half when comparing the SILAC ratio of protein levels between 0 
h and 8 h post induction of lytic replication (Figure 3.1a). Nup98 is a 
nucleoplasmic-orientated nucleoporin containing GLFG repeats that has a key 
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role in nuclear export but has also been shown to diffuse off the pore into the 
nucleus (Powers et al., 1997; Griffis et al., 2002). Nup98 therefore, exists as two 
populations within the cell, a pore-bound population facilitating export with the 
adaptor protein Rae1 (Blevins et al., 2003), and a nucleoplasmic population 
playing roles in transcription (Capelson et al., 2010; Kalverda et al., 2010). Similar 
decreases in other nucleoporin levels were not observed for other nucleoporins 
including Nup160, Nup133, Nup107, key structural nucleoporins that form the 
Nup160-Nup107 complex (Walther et al., 2003), and Nup153, another 
nucleoplasmic-oriented nucleoporin involved in nuclear import (Sukegawa and 
Blobel, 1993; Ullman et al., 1999). From the quantitative proteomic data 
corresponding to Nup160-Nup107 complex nucleoporins it could be inferred that 
the overall number of nuclear pores did not decreased within 8 h of lytic infection.  
To validate the observed downregulation of Nup98, western blot analysis was 
performed on TREx cells at different time points post induction of KSHV lytic 
replication via doxycycline-inducible mycRTA (Figure 3.1b). The decrease in 
Nup98 protein levels was confirmed at 8 h and shown to be specific when 
compared to Nup153, similar to the quantitative proteomic data. Densitometry 
analysis confirmed this decrease in Nup98 protein levels was significant 
compared to Nup98 levels at 0 h and was comparable in magnitude to the 
observation in the quantitative proteomic data (Figure 3.1c). Intriguingly, qPCR 
analysis of Nup98 mRNA levels over the course of KSHV lytic infection did not 
show a decrease in Nup98 mRNA, in fact at 8 h post induction of lytic replication 
Nup98 mRNA levels rose significantly to 2.5 fold when compared to 0 h post 
doxycycline treated TREx cells (Figure 3.1d). These results suggest that Nup98 
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was specifically targeted by the virus rather than the NPC as a whole and that 
Nup98 protein was specifically targeted rather than Nup98 mRNA. 
 
Figure 3.1 Nup98 is specifically downregulated at 8 h post induction of KSHV lytic replication in TREx 
cells. a) 1% FDR quantitative proteomic ratio of nucleoporin protein levels at 8 h post induction of lytic 
replication compared with protein levels at 0 h post induction of lytic replication (Sophie Schumann, 
unpublished data). n=1. b) A representative Western blot of nucleoporin levels at 0 h, 8 h and 24 h post 
induction of lytic replication in TREx cells. mycRTA represents a control for induction of lytic replication via 
the doxycycline-inducible mycRTA construct, ORF57 shows mycRTA is able to activate the viral lytic 
cascade and GAPDH represents a loading control. c) Quantified densitometry of Nup98 band intensity 
normalised to GAPDH for reactivation time course experiments shown in b). n=3, 95% confidence intervals 
shown, T-test p-value shown between indicated conditions. d) qPCR analysis of Nup98 mRNA levels relative 
to GAPDH mRNA from TREx cells at times shown post induction of lytic replication. n=3, confidence intervals 
shown, T-test p-value shown between indicated conditions.  
 
3.3 The localisation of Nup98 is not altered during KSHV lytic 
infection 
a) b) 
c) 
d) 
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In order to understand the above changes, it was important to first determine the 
proportion of TREx cells that undergo KSHV lytic replication after treatment with 
doxycycline to promote mycRTA expression. Using confocal microscopy, it was 
possible to determine the percentage of lytically replicating TREx cells at each 
time point (Figure 3.2). This shows that in TREx at 0 h there were <5 % of cells 
that expressed RTA in line with expectations surrounding rates of spontaneous 
reactivation (Lukac et al., 1998). At 8 h, the time point where we observe a 
decrease in Nup98 protein levels, 23.8 % of cells were expressing RTA. This 
suggests that the level of Nup98 protein decrease may be greater than that 
observed through western blot analysis given the low proportion of cells that were 
expressing RTA at 8 h post induction of lytic replication. These data help inform 
subsequent analyses given that the virus is reactivated only within a proportion 
of TREx cells at each time point with a majority of cells expressing RTA by 24 h 
(57.2 %). 
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Figure 3.2. Confocal microscopy-based quantification of the proportion of TREx cells that undergo 
KSHV lytic replication. Representative tilescan confocal images of TREx cells at either 0, 8 or 24 h after 
the induction of lytic infection. DAPI in blue, RTA in red. ImageJ quantification of the % of RTA positive cells 
shown. n=3, 95% confidence intervals shown. 
 
Following on from these observations, confocal immunofluorescence was 
performed to determine whether a decrease in Nup98 protein levels could be 
visualised in RTA expressing TREx cells. Confocal immunofluorescence analysis 
of the localisation of Nup98 in TREx at different time points after the induction of 
KSHV lytic replication showed that there was no obvious decrease of Nup98 
signal at the nuclear pore or relocalisation of Nup98 as KSHV lytic replication 
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progressed (Figure 3.3). Nup98 can be observed through confocal 
immunofluorescence predominantly at the nuclear pore as strong, discrete 
signals indicating NPCs, there is also a faint diffuse signal in the nucleoplasm 
although no discrete GLFG-bodies are visible as has been observed in some cell 
types (Griffis et al., 2002). At 0 h, differences in Nup98 levels can be observed in 
cells lacking RTA expression suggesting a level of baseline variability. At 8 h, 
there are some cells that have begun to express RTA however there is no 
consistent Nup98 phenotype when these cells are compared to cells lacking RTA 
expression. At 24 h, replication compartments have begun to form in RTA 
expressing cells but again there is no observable decrease in Nup98 signal or 
localisation. These results suggest that decreases in Nup98 protein levels during 
KSHV lytic replication may not occur at the NPC. The approach taken for confocal 
microscopy here aimed to minimise background signal and therefore involved 
focusing upon the NPC Nup98 signal at the expense of the more diffuse signal 
within the nucleoplasm. Technically this made visualising nucleoplasmic Nup98 
difficult in TREx cells however the observation of no consistent NPC Nup98 
phenotype suggested that the nucleoplasmic fraction of Nup98 may be being 
targeted. 
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Figure 3.3 Nup98 localisation in TREx cells is not altered on the reactivated of KSHV. Confocal 
immunofluorescence analysis of Nup98 in TREx cells at 0 h, 8 h and 24 h post induction of KSHV lytic 
replication with doxycycline, endogenous RTA staining present to confirm induction to lytic replication, DAPI 
to identify cell nucleus. 
 
3.4 Increased Nup98 degradation in the presence of KSHV RTA is 
dependent on the ubiquitin-proteasome pathway 
The decrease of Nup98 protein during KSHV lytic infection appeared to occur 
within 8 h of reactivation of TREx cells without a concurrent downregulation of 
Nup98 mRNA levels. Therefore, it was hypothesised that Nup98 could be being 
targeted for degradation through the ubiquitin-proteasome pathway. 
Furthermore, KSHV immediate-early protein RTA, the viral transactivator 
responsible for initiating the transition from latency to lytic replication (Lukac et 
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al., 1998), has previously been shown to specifically target other cellular proteins 
via a ubiquitin E3 ligase-like domain (Yu et al., 2005; Gould et al., 2009). 
Therefore, the targeted degradation of Nup98 during KSHV lytic infection could 
be linked to RTA-induced proteasomal degradation. 
In order to test this hypothesis a series of experiments were performed in RTA-
transfected 293T cells. Initially, these experiments simply involved transfecting a 
construct that constitutively expressed RTA into 239T cells, incubating the cells 
for 24 h before western blot analysis of Nup98 protein levels. This showed that 
24 h after transfection with an RTA expression plasmid Nup98 protein levels 
decreased significantly compared to an untransfected control (Figure 3.4a). This 
was further quantified using densitometry confirming a significant decrease when 
compared to Nup98 protein levels in untransfected control 293T cells (Figure 
3.4b). To confirm that the transfection of RTA did not lead to a decrease in Nup98 
mRNA levels, RNA was also extracted from transfected cells and analysed by 
qPCR. A modest decrease in Nup98 mRNA levels after RTA transfection was 
observed however the scale of the decrease did not account for the decrease in 
protein levels observed (Figure 3.4c). This suggested that expression of RTA 
could lead to a decrease in Nup98 protein levels in 293T cells in the absence of 
all other KSHV lytic factors. 
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Figure 3.4 Nup98 protein levels decrease in 293T cells after transfection with KSHV RTA protein. a) 
A representative western blot of Nup98 levels in 293T cells 24 h post transfection with RTA expression 
plasmid and untransfected cells. RTA levels also shown along with GAPDH as a loading control. b) 
Densitometry of the Nup98 band intensity from western blot analysis normalised to GAPDH for experiments 
where RTA was transfected into 293T cells with protein extracted 24 h post transfection. n=3, 95% 
confidence intervals shown, T-test p-value shown between indicated conditions. c) qPCR analysis of Nup98 
mRNA levels normalised to GAPDH mRNA in untransfected and RTA transfected 293T. n=3, confidence 
intervals shown, T-test p-value shown between indicated conditions. 
 
Having demonstrated that transfection of RTA led to a decrease in Nup98 protein 
levels but did not reduce Nup98 mRNA levels to the same extent the next step 
was to identify whether the downregulation was via the ubiquitin-proteasome 
pathway. Therefore, a series of experiments were performed with MG132, a 
peptide aldehyde that binds to the chymotrypsin-like active site of the b subunit 
of the proteasome inhibiting protein degradation (Rock et al., 1994), to determine 
whether Nup98 degradation upon transfection of RTA could be prevented.  
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Initially, 293T cells were transfected with an untagged RTA expression construct 
and incubated for 24 h before cells were treated with DMSO or 20 µM MG132. 6 
h after treatment with MG132 or DMSO cells were harvested and lysed for 
western blot analysis. Western blots were performed to confirm RTA expression 
and to compare Nup98 protein levels in each treatment (Figure 3.5a). A 
significant downregulation of Nup98 was observed in RTA-transfected 293T cells 
compared with untransfected cells treated with DMSO however, this significant 
decrease is not detectable between untransfected and RTA-transfected cells that 
were treated with 20 µM MG132 (Figure 3.5b). Similar experiments were 
performed on reactivated TREx cells, with TREx cells treated with doxycycline to 
induce KSHV lytic replication and 2 h post doxycycline treatment DMSO or 20 
µM MG132 was added. 6 h after DMSO or MG132 treatment cells were harvested 
and lysed. This allowed for the comparison of Nup98 levels at 8 h post induction 
of lytic replication, the timepoint where the downregulation of Nup98 is observed 
in lytically replicating cells. Western blot analysis of these samples showed that 
doxycycline treated cells were able to induce mycRTA expression and that Nup98 
levels decreased in reactivated cells treated with DMSO, however in MG132 
treated cells Nup98 levels did not decrease between 0 h and 8 h (Figure 3.5c). 
Densitometry analysis of Nup98 relative band intensity normalised to GAPDH 
showed a significant decrease in Nup98 in DMSO treated TREx cells at 8 h post 
doxycycline treatment when compared to Nup98 at 0 h (Figure 3.5d). This 
decrease was not observed in reactivated MG132 treated TREx between 8 h and 
0 h, with an apparent increase in Nup98 at 8 h compared to 0 h although this was 
not significant (Figure 3.5d). These observations showed that the RTA-induced 
decrease of Nup98 in 293T was sensitive to inhibition of the proteasome and that 
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the Nup98 decrease observed in TREx cells at 8 h post reactivation with 
doxycycline was also dependent on the proteasome. Overall, these data 
suggested that RTA was responsible for decreasing Nup98 protein levels via the 
ubiquitin-proteasome pathway. 
 
Figure 3.5 Nup98 degradation is prevented on treatment with proteasome inhibitor MG132. a) A 
representative western blot of Nup98, RTA and GAPDH (loading control) from 293T cells that were either 
untransfected or transfected with RTA for 24 h before treatment with either DMSO or 20 µM MG132 for 6 h 
before protein was collected. b) Densitometry analysis of Nup98 band relative intensity normalised to 
GAPDH from western blots of protein extracted from 293T cells (untransfected or RTA transfected 24 h post 
transfection) treated for 6 h with either DMSO or 20 µM MG132. n=3, 95% confidence intervals shown, T-
test p-value shown between indicated conditions. c) A representative western blot of Nup98, mycRTA and 
GAPDH (loading control) from TREx cells treated with doxycycline and 2 h subsequently treated with DMSO 
or 20 µM MG132 before protein extracted 8 h post doxycycline treatment. d) Densitometry analysis of Nup98 
band relative intensity normalised to GAPDH from western blots of protein extracted from TREx cells treated 
with doxycycline and 2 h later either DMSO or 20 µM MG132 with protein extracted at 8 h post doxycycline 
treatment. n=3, 95% confidence intervals shown, T-test p-value shown between indicated conditions.  
 
a) c) 
 
 
i) 
 
 
b) d) 
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Next, attempts were made to use co-immunoprecipitation techniques to pull down 
Nup98 protein and determine whether RTA binding could be detected. This 
involved inducing lytic replication in TREx cells and performing Nup98 
immunoprecipitations on protein lysates at different time points post induction of 
lytic infection. RTA was not identified when immunoprecipitation samples were 
analysed via western blotting (Figure 3.6). However, this did not exclude the 
hypothesis that RTA is targeting Nup98 for degradation via its E3 ubiquitin ligase 
as interactions between E3 ligases and their substrates can be highly transient 
and therefore not always identifiable via co-immunoprecipitation experiments 
(Pierce et al., 2009). 
 
Figure 3.6 RTA could not be shown to co-immunoprecipitate with Nup98 in TREx. 
Immunoprecipitations using anti-Nup98 antibodies were performed at different time points post the induction 
of lytic replication in TREx cells with doxycycline. Endogenous RTA was probed at each time point and no 
co-immunoprecipitation was observed. n=2. 
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3.5 Nucleoplasmic Nup98 binding partner DHX9 does not play a role 
during early KSHV lytic replication 
Thus far experiments had indicated that Nup98 protein was downregulated early 
during KSHV lytic infection via enhanced degradation through the proteasome-
ubiquitin pathway. This decrease did not appear to occur at the NPC and 
therefore was speculated to be specific to the nucleoplasmic Nup98 fraction. The 
next steps of this work involved determining why KSHV targeted Nup98 and the 
mechanism behind its hypothesised restrictive role of viral replication. The 
function of Nup98 within the nucleoplasm is not fully understood but has been 
suggested to involve transcription regulation via its interaction with a range of 
nucleoplasmic binding partners (Light et al., 2013; Panda et al., 2014; Capitanio 
et al., 2017). One of its main binding partners is DExH-helicase 9 or DHX9 (also 
referred to as RNA Helicase A) (Capitanio et al., 2017).  It was therefore 
speculated that the targeting of nucleoplasmic Nup98 by KSHV could be related 
to DHX9 due to its interactions with CREB-binding protein (CBP) and RNA 
Polymerase 2 (Nakajima et al., 1997). This is a critical pathway for KSHV during 
early lytic infection because RTA, the viral transactivator, also recruits CBP to 
stimulate transcription of early viral genes (Gwack et al., 2001). It was 
hypothesised therefore that the nucleoplasmic Nup98-DHX9 interaction maybe 
disrupted by RTA early during lytic infection to allow DHX9 to be recruited as part 
of the CBP complex with RTA to KSHV early lytic gene promoters. 
To investigate this hypothesis, shRNAs against DHX9 were transduced with 
Lentivirus into BCBL-1 cells to deplete DHX9. It was hypothesised that upon the 
reactivation of lytic replication in DHX9-depleted cells RTA expression would 
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have a less efficient induction of lytic replication due to the potential role of DHX9. 
BCBL-1 cells were chosen for these experiments rather than TREx cells to 
eliminate the potential for doxycycline induced mycRTA expression to mask the 
proposed effect of DHX9 at early lytic promoters. Many of these early lytic 
promoters rely on RTA to stimulate expression through ORF50 response 
elements, therefore the doxycycline inducible mycRTA system was inappropriate 
for these experiments. DHX9 protein levels were successfully depleted using 
targeted shRNAs and subsequent analysis of BCBL-1 cells induced into lytic 
replication with 12-O-tetradecanoylphorbol-13-acetate (TPA) and sodium 
butyrate showed a modest decrease in RTA levels at 48 h in DHX9-depleted cells 
compared to scrambled treated cells (Figure 3.7a). However, there were minimal 
observable differences in ORF57 expression levels at both 24 h and 48 h time 
points post induction of the lytic replication. qPCR analysis of ORF57 and ORF50 
RNA levels further confirmed there was no significant difference in expression 
levels at 24 h post induction of lytic replication (Figure 3.7b). At 48 h there was 
an increase in ORF50 levels observed in DHX9-depleted cells but this was not 
significant when compared to scrambled treated cells, ORF57 levels were 
observed to be significantly different however the difference was only a slight 
increase (0.56 fold in scrambled treated cells, 0.75 fold in DHX9-depleted cells, 
Figure 3.7b). This data suggests no significant role of DHX9 specifically in KSHV 
lytic infection although it is possible that redundancy within the dead-box helicase 
family means the effects of DHX9-depletion were obscured.  
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Figure 3.7 The depletion of Nup98 nucleoplasmic binding partner DHX9 did not impact KSHV lytic 
replication. a) A representative western blot of viral immediate-early proteins (ORF57 and RTA) in BCBL-
1 cells expressing either scrambled or 1209 shRNA against DHX9, lytic replication induced with TPA and 
sodium butyrate. GAPDH shown as a loading control. b) qPCR analysis of KSHV immediate-early transcripts 
in BCBL-1 cells expressing either scrambled or 1209 shRNA targeting DHX9 at time points post induction 
of lytic replication with TPA and sodium butyrate. n=3. 95% confidence intervals shown, T-test p-value shown 
between indicated conditions. 
 
b) 
a) 
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3.6 Nucleoplasmic Nup98 acts to prevent transcription of KSHV lytic 
ORFs at ORF50-promoters 
The observations thus far led to the speculation that KSHV was targeting the 
nucleoplasmic fraction of Nup98 due to no observable changes of Nup98 
localisation. To test whether nucleoplasmic Nup98 had a restrictive effect on early 
KSHV lytic processes, 293T cells were transfected with a series of plasmid 
combinations to test the effect of overexpressing GFP-Nup98, a donation from 
collaborators from the Wozniak Laboratory, on a viral ORF50-promoter-luciferase 
construct. Overexpression of Nup98 has been shown to saturate the 
nucleoplasmic fraction which could highlight the more transient impacts of Nup98 
on KSHV (Griffis et al., 2002). Cells were transfected in triplicate and incubated 
for 24 h before lysis and luciferase substrate addition. Luminescence readings 
were then obtained using an automated plate reader and results analysed. 
Interestingly, overexpression of GFP-Nup98 along with an FLAG-RTA 
overexpression construct led to a significant decrease in the luminescence 
produced from ORF50-promoter luciferase construct compared to luminescence 
in FLAG-RTA and GFP transfected cells (Figure 3.8a). An empty FLAG vector 
was used to control for RTA overexpression showing the baseline level of 
luminescence from the ORF50-promoter luciferase construct (Figure 3.8a). This 
suggested that when cells were oversaturated with GFP-Nup98, RTA was unable 
to induce transcription at the ORF50 promoter. To test the kinetics of GFP-Nup98 
repression of RTA-induced transcription at the ORF50 promoter, the above 
luciferase experiments were extended using sequentially increased doses of 
GFP-Nup98 and GFP. Results showed that the negative transcriptional effect of 
GFP-Nup98 was dose-dependent with luminescence from ORF50-driven 
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luciferase decreasing as the amount of GFP-Nup98 transfected increased 
(Figure 3.8b). This suggests that nucleoplasmic Nup98 negatively regulates RTA-
induced transcription at the ORF50 promoter and furthermore, suggests that this 
negative effect is implicitly linked to the level of Nup98 present within the cell. 
Therefore, the targeting of Nup98 protein levels by KSHV early during lytic 
replication is essential to ensure transcriptional activation of immediate-early 
KSHV genes. 
 
Figure 3.8. Overexpressing Nup98 alongside RTA and an ORF50 luciferase construct in 293T cells 
significantly reduces luminesence. a) Luminesence analysis of ORF50 luciferase construct when treated 
with FLAG-RTA and GFP, FLAG-RTA and GFP-Nup98 or an empty FLAG-vector and GFP-Nup98 in 293T 
cells. Luminescence standardized to Renilla control. n=4, 95% confidence intervals shown, T-test p-value 
shown between indicated conditions. b) Dose dependent experiment transfecting ORF50 luciferase 
promoter, FLAG-RTA and GFP or GFP-Nup98 at various concentrations. Luminescence standardized to 
Renilla control. n=3, 95% confidence intervals shown, T-test p-value shown between indicated conditions. 
 
3.7 Chromatin Immunoprecipitation of Nup98 
To identify whether the downregulation of expression at the RTA promoter was 
mediated by binding of Nup98 at the ORF50 promoter, chromatin 
immunoprecipitations were attempted. Initial work to optimise the protocol was 
a) b) 
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performed on unreactivated TREx cells to confirm that Nup98 
immunoprecipitation could be accomplished. Anti-RNA polymerase II antibody 
was utilised as a positive control, as it had been previously used for ChIP 
experiments in the Whitehouse Laboratory, anti-rabbit IgG was utilised as a 
negative control. Cells were harvested using the Pierce Chromatin Prep Module 
to obtain formaldehyde fixed chromatin. Chromatin was then digested into 
fragments for ChIP using micrococcal nuclease. Successful fragmentation was 
visualised on an agarose gel and samples were carried forward for 
immunoprecipitation (Figure 3.9a). The EZ-ChIP kit from Millipore was utilised for 
the immunoprecipitation alongside a rabbit anti-Nup98 antibody previously used 
for Nup98 ChIP (Light et al., 2013). Immunoprecipitations were performed 
overnight, and DNA was obtained for both sample inputs and 
immunoprecipitations via a DNA spin clean column from the EZ-ChIP kit. qPCR 
was then performed to quantify the % of input obtained from the 
immunoprecipitations for the DNA at the MYC promoter, a site Nup98 has 
previously been shown to bind (Capitanio et al., 2017). Disappointingly, there was 
very poor fold enrichment of the MYC promoter from the anti-Nup98 
immunoprecipitation when compared to the IgG control. Further to this, when 
compared to anti-RNA polymerase II where 23.6 fold enrichment was observed 
it was apparent that immunoprecipitation with anti-Nup98 had been unsuccessful 
(Figure 3.9b). This result was consistent across two experiments and led to the 
prioritisation of alternative experiments to look for the interaction between Nup98 
and the KSHV genome.  
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Figure 3.9 Chromatin Immunoprecipitation in TREx cells using Nup98 was unsuccessful. a) DNA gel 
showing the efficiency of micrococcal nuclease shearing of genomic DNA for ChIP. 100kbp ladder used, 
between each treatment lane volumes have been doubled for better resolution. b) Comparison of the fold 
enrichment between IgG, anti-RNA polymerase II and anti-Nup98 antibodies for ChIP of MYC promoter. 
n=2. 
 
3.8 Overexpression of GFP-Nup98 in TREx does not prevent the 
progression of KSHV lytic infection when induced with sodium 
butyrate 
Utilising the GFP-Nup98 expression described above, a Lentiviral transfer vector 
was developed to allow for the generation of stably expressing GFP-Nup98 cell 
lines. Lentiviral transduction was performed with this transfer vector and an empty 
GFP vector on TREx cells and puromycin at 2 µg/mL was used select stably 
expressing cells (Balistreri et al., 2016). Untransduced cells were used as a 
control to confirm puromycin induced cell death and after 12 days of selection no 
control cells were alive. At this stage a hypothesis had been developed that 
speculated nucleoplasmic Nup98 was targeted early during KSHV lytic infection 
in order to prevent Nup98 negatively regulating ORF50 responsive KSHV genes. 
a) b) 
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This negative regulation was speculated to revolve around the ability of 
nucleoplasmic Nup98 to bind at promoters and recruit histone remodelling 
complexes (Liang et al., 2013; Franks et al., 2017). Therefore, it was 
hypothesised that the inclusion of overexpressed GFP-Nup98 may act to prevent 
expression at ORF50 responsive viral genes on the induction of KSHV lytic 
replication. 
Due to the proposed action of RTA downregulating Nup98 protein levels induction 
of TREx cells via doxycycline to induce lytic replication with mycRTA was not 
possible. This is due to the potential for doxycycline-induced mycRTA expression 
to counter-act the action of GFP-Nup98 due to previously demonstrated RTA-
induced Nup98 degradation and mycRTA ability to activate endogenous RTA 
expression via the ORF50 promoter. This high level of cross talk could potentially 
mask any real protective effects offered by GFP-Nup98. Therefore, TREx cells 
were induced to KSHV lytic replication via treatment with sodium butyrate, a well-
established alternative (Lu et al., 2003). Cells were induced with sodium butyrate 
and left for 24 h before they were harvested and lysed for RNA isolation and 
protein isolation. Western blot analysis was performed and showed poor 
expression of GFP and GFP-Nup98, in fact, levels were so low that blotting for 
GFP resulted in a blank blot (Figure 3.10a). GFP-Nup98 could only be detected 
in lytically replicating cells when probing for Nup98 but the signal was minimal 
suggesting poor transduction efficiency or a loss of the GFP expression cassette. 
Western blots for endogenous RTA and ORF57 protein showed higher levels of 
RTA in GFP-Nup98 cells in both NaBut treated and untreated cells however 
ORF57 levels appeared slightly reduced in treated GFP-Nup98 cells compared 
to GFP cells (Figure 3.10b). Nevertheless, the low detection of GFP-Nup98 
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means these differences may results largely from variations in reactivation 
efficency than any effect of GFP-Nup98. qPCR was also performed RNA levels 
for viral immediate-early transcripts ORF50 and ORF57 with no significant 
difference in ORF57 transcript levels (Figure 3.10a) However, there was a slight 
but significant increase in ORF50 levels observed (1 fold in GFP lytic cells, 1.16 
fold in GFP-Nup98 lytic cells, Figure 3.10), but again this difference cannot be 
attributed to any effect of GFP-Nup98 given its low level of expression. 
 
Figure 3.10 Overexpression of GFP-Nup98 in TREx cells could not be detected by western blot and 
no significant changes to KSHV early lytic infection mRNA or protein was observed. a) A 
representative western blot of KSHV immediate-early lytic genes (endogenous RTA and ORF57) after stably 
expressing GFP and GFP-Nup98 cells were treated with sodium butyrate (NaBut), GFP shown to probe 
GFP constructs, GAPDH is a loading control. b) qPCR analysis of immediate-early KSHV lytic genes ORF57 
and ORF50 after stably expressing GFP and GFP-Nup98 cells were treated with sodium butyrate. n=3, 95% 
confidence intervals shown, T-test p-value shown between indicated conditions. 
 
a) 
b) 
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Concomitant with these experiments, immunofluorescence was performed on 
GFP and GFP-Nup98 expressing cells induced to KSHV lytic replication with 
sodium butyrate. Given the indication from western blot analysis that GFP/GFP-
Nup98 expression had been lost or transduction efficiency low it was hoped that 
confocal immunofluorescence would allow for the identification of a phenotype 
within the small number of GFP-Nup98 expressing cells. GFP and GFP-Nup98 
TREx cells were seeded onto poly-l-lysine coated coverslips and incubated for 
24 h before sodium butyrate was added to stimulate reactivation of KSHV lytic 
replication. Cells were fixed 24 h post sodium butyrate treatment and stained for 
anti-RTA, to confirm successful induction of KSHV lytic replication, before 
washing and staining with secondary antibodies conjugated to Alexa FluorTM 
before finally being mounted onto coverslips with DAPI. Coverslips were then 
visualised on a Ziess LSM 880 confocal microscope and both GFP and GFP-
Nup98 cells were observed although at a very low rate as suggested by western 
blotting (Figure 3.11). 
Nevertheless, GFP-Nup98 was seen to localise at the NPC and in the 
nucleoplasm as expected. Interestingly, the nucleoplasmic signal of GFP-Nup98 
occurred as both a diffuse stain and also as discrete, intense foci (Figure 3.11). 
These were not previously observed when staining for endogenous Nup98 in 
TREx cells (Figure 3.3a) and appear to be a common artefact of Nup98 
overexpression refered to as GLFG-bodies (Griffis et al., 2002). Nevertheless, 
the induction of KSHV lytic replication does not appear ablated in GFP-Nup98 
overexpressing cells with a strong RTA stain present alongside good GFP-Nup98 
staining (Figure 3.11). There was observed a level of colocalization between 
GFP-Nup98 particularly with several GLFG-foci although this was not 
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consistently seen with some GLFG-bodies occurring in the nucleolar regions of 
the nucleus which have minimal RTA signal. These data suggested that even 
amoungst the low level of successfully overexpressing GFP-Nup98 TREx cells 
that increased cellular saturation of Nup98 at both the NPC and in the 
nucleoplasm did not affect the induction of KSHV lytic replication when cells are 
treated with sodium butyrate. 
 
Figure 3.11 Immunofluorescence analysis of stably expressing GFP and GFP-Nup98 TREx cells 
shows no difference RTA levels or localisation in reactivated cells. Cells were treated with sodium 
butyrate to induce KSHV lytic replication and fixed 24 h post induction of KSHV lytic replication. Cells were 
then permeabilized, blocked with BSA and stained with anti-RTA before mounting with DAPI and 
visualisation on a Zeiss LSM 880 upright confocal microscope. 
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3.9 Discussion 
In this chapter the nucleoporin Nup98 protein has been shown to be specifically 
targeted early during KSHV lytic infection (Figure 3.1). The decrease in Nup98 
can be achieved through the overexpression of RTA and Nup98 degradation can 
be ablated by inhibiting the ubiquitin-proteasome pathway (Figure 3.4 and Figure 
3.5). However, attempts to visualise a relocalisation or decrease of Nup98 by 
confocal microscopy were inconclusive, with levels at the NPC remaining 
unchanged (Figure 3.2) This led to the hypothesis that KSHV was targeting the 
nucleoplasmic fraction of Nup98 in order to subvert a transcriptional role of Nup98 
rather than a nucleocytoplasmic role. Further experimentation showed that 
overexpressing Nup98 led to reduced transcription at viral promoters specifically 
the ORF50-promoter (Figure 3.8). This observation has serious implications for 
early KSHV lytic infection; with several immediate-early KSHV genes requiring 
the ORF50 gene product, RTA for their transcription (Song et al., 2001; Lukac et 
al., 2001b; Deng et al., 2002; Chang et al., 2002). It was hypothesised this 
restrictive action of Nup98 could be a serious impediment during the latent-lytic 
switch to the low initial concentrations of RTA. 
The next steps of this work aimed to validate this hypothesis by confirming 
binding of Nup98 to the KSHV genome using ChIP and utilising a GFP-Nup98 
overexpression construct in TREx cells to test its effect on KSHV lytic replication. 
Previous work had shown ChIP of Nup98 was possible and Nup98 binding had 
previously characterised at a variety of cellular genomic sites (Liang et al., 2013). 
Nevertheless, attempts at ChIP in TREx cells with this particular Nup98 antibody 
were unsuccessful although remain a key experiment for future work, in order to 
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confirm whether Nup98 directly binds to the ORF50 promoter (Figure 3.9). To 
investigate whether overexpressing Nup98 could have a preventative effect on 
the induction of KSHV lytic replication, a GFP-Nup98 overexpression construct 
was produced as a lentiviral transfer plasmid to allow for the establishment of 
stably expressing GFP-Nup98 TREx cells. Experiments were performed 
reactivating cells to KSHV lytic replication using sodium butyrate rather than the 
doxycycline inducible mycRTA system to prevent overexpressed mycRTA 
masking an effect. However, low levels of GFP and GFP-Nup98 expression were 
achieved after puromycin selection either due to low transduction efficiency or 
loss of the expression cassette (Figure 3.10). In the small set of GFP/GFP-Nup98 
positive cells the overexpression of GFP-Nup98 did not lead to reduce RTA 
expression (Figure 3.11). This could relate to the role of sodium butyrate as a 
histone deacetylase inhibitor that induces global changes to the epigenetic 
landscape (Davie, 2003). It has previously been shown that nucleoplasmic Nup98 
is able to alter chromatin structures and affect transcription (Liang et al., 2013; 
Light et al., 2013; Franks et al., 2017). Therefore, the action of sodium butyrate 
treatment could disrupt a hypothetical Nup98-induced chromatin remodelling 
event, masking any potential protective effect. Therefore, it is crucial that for 
future work efforts are made to test alternative methods of reactivation of KSHV 
lytic replication, including heat shock or hypoxia to test for a protective effect of 
Nup98. 
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4 CHMP7 is targeted by KSHV via a Nup98-
dependent mechanism to enhance virion egress 
4.1 Introduction 
In the previous chapter, it was demonstrated that KSHV downregulates a specific 
nucleoporin, Nup98, early during KSHV lytic replication. Nup98 is a dynamic 
nucleoporin that exists both at the nuclear pore and within the nucleoplasm 
playing multiple roles within the cell. At the NPC, Nup98 is orientated towards the 
nucleoplasm facilitating a range of RNA export pathways via complex formation 
with host proteins NXF1 and Rae1 (Powers et al., 1997; Blevins et al., 2003). 
Nup98 has also been shown to be interferon inducible and regulate antiviral gene 
expression (Enninga et al., 2002; Panda et al., 2014). KSHV has been shown to 
target factors that prevent the interferon response during early lytic infection (Ma 
et al., 2015; Ma et al., 2017). Initial experiments therefore looked to investigate 
whether KSHV downregulated Nup98 as part of a preventative strategy against 
an antiviral response. This chapter expands upon the unexpected results of those 
experiments which led to an entirely new line of enquiry regarding the role of 
Nup98 at the NPC during KSHV lytic infection and the requirement of Nup98 to 
ensure successful virion egress.  
KSHV virion egress is a complex, multistep process as new virions transition from 
the nucleus to release from the cell (Mettenleiter et al., 2009). The general model 
for herpesvirus particle assembly is: newly synthesised viral DNA is packaged 
into the capsid in the nucleus; the capsid leaves the nucleus by primary 
envelopment at the inner nuclear membrane, the primary envelope then fuses 
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with the outer nuclear membrane releasing capsids into the cytoplasm; final 
maturation of the capsid occurs in the cytoplasm where the capsids acquire a 
tegument layer before the secondary envelopment step via budding at the trans 
Golgi network (TGN); at this stage the virus acquires its glycoproteins and exits 
the TGN within a cellular vesicle; this capsid-containing-vesicle is transported to 
the cell surface where the vesicle fuses with the plasma membrane releasing a 
mature, enveloped virion (Reviewed in (Mettenleiter, 2002; Mettenleiter et al., 
2009)). However, much of this work has been performed primarily using 
alphaherpesviruses and there is much still to be elucidated regarding how the 
gammaherpesviruses interact with cellular components to ensure successful 
packaging and eventual egress. 
Herein, it is shown that whole-cell Nup98 depletion does not alter early KSHV 
lytic replication however Nup98-depleted TREx cells exhibit reduced infectious 
virion egress. This phenotype is attributed to Nup98-depletion disrupting the 
action of KSHV lytic ORF10, a viral protein that interacts at the NPC with Rae1, 
a Nup98 binding partner, to inhibit RNA export a certain cellular mRNA. One 
cellular mRNA targeted in this manner is that of ESCRT-III component charged 
multivesicular body protein 7 (CHMP7). Through experiments overexpressing 
CHMP7 it was demonstrated that a similar failed virus egress phenotype could 
be observed leading to the hypothesis that KSHV targets CHMP7 mRNA during 
lytic infection to prevent its role in membrane repair. Crucially, this work highlights 
an interesting juxtaposition to the previous chapter where it was shown Nup98 is 
reduced during KSHV lytic infection with evidence suggesting this was targeted 
to nucleoplasmic Nup98. This chapter highlights how KSHV may require Nup98 
at the NPC during lytic infection for the action of viral ORF10. 
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4.2 siRNA treatment successfully depleted Nup98 in TREx cells 
In the Chapter 3, Nup98 levels were shown to be downregulated early after the 
induction of KSHV lytic infection (Figure 3.1). Nup98 has previously been shown 
to be targeted by other viruses to inhibit bulk mRNA export and furthermore, 
Nup98 expression can be induced by interferon to alleviate a virally-induced 
export block (Enninga et al., 2002). Therefore, it was hypothesised that KSHV 
was downregulating Nup98 early during KSHV lytic infection to prevent a Nup98-
mediated antiviral pathway. To test this, siRNAs against Nup98 were 
nucleofected into TREx cells and after 48 h RNA and protein was collected. qPCR 
analysis showed a significant ~70 % reduction in Nup98 mRNA levels (Figure 
4.1a). Western blot and densitometry analysis also showed a significant reduction 
Nup98 protein levels (Figure 4.1b and Figure 4.1c). 
 
Figure 4.1 Nup98 can be significantly depleted by siRNAs in TREx cells. a) qPCR analysis of Nup98 
mRNA levels in TREx cells nucleofected with scrambled (scr) and Nup98 siRNAs 48 h post nucleofection. 
n=3. 95 % confidence intervals shown, T-test p-value shown between indicated conditions. b) A 
a) b) 
c) 
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representative western blot of Nup98 protein levels 48 h post nucleofection with scrambled and Nup98 
siRNA treated TREx cells, loading control GAPDH. c) Quantified densitometry of Nup98 band intensity 
normalised to GAPDH for siRNA treated TREx cells. n=3, 95 % confidence intervals shown, T-test p-value 
shown between indicated conditions. 
4.3 Normal bulk mRNA export is maintained during Nup98 siRNA 
treatment 
With the establishment of a functional Nup98-depletion system in TREx cells, it 
was important to initially identify whether depletion of Nup98 led to alterations in 
mRNA export. Fluorescence in-situ hybridization (FISH) was used to identify 
whether the siRNA depletion of Nup98 arrested bulk mRNA export in TREx cells. 
TREx cells were nucleofected with scrambled or Nup98 siRNA and incubated for 
48 h before treatment with doxycycline to induce KSHV lytic replication. 24 h after 
doxycycline treatment cells were fixed and cells permeabilised and stained with 
fluorescently labelled oligo(dT) probe to detect polyadenylated (polyA) RNA. 
These cells were visualised using an LSM 880 confocal microscopy and showed 
that in unreactivated TREx cells depletion of Nup98 did not lead to significant 
differences in bulk mRNA localisation (Figure 4.2a). This was further confirmed 
using pixel profiling of the confocal images which showed that in unreactivated 
TREx the strongest fluorescent oligo-dT signal was seen outside the nucleus or 
in specific low DAPI intensity foci within the nucleus (Figure 4.2b). Nup98 
depletion did not affect changes in bulk mRNA localisation caused by KSHV lytic 
replication (Figure 4.2a). In scrambled treated reactivated cells fluorescent oligo-
dT overlaps more with areas of DAPI signal, with less signal in the cytoplasm but 
high intensity foci still apparent in the nucleus (Figure 4.2b). These changes on 
reactivation are also observed in Nup98-depleted TREx cells with predominant 
oligo-dT signal overlapping with the DAPI signal along with high intensity foci in 
the nucleus. Overall, this work suggests that Nup98-depletion does not alter 
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normal bulk mRNA nucleocytoplasmic transport in TREx cells and does not 
prevent mRNA retention observed on TREx reactivation. 
 
Figure 4.2 SiRNA depletion of Nup98 does not impact bulk mRNA export in unreactivated TREx or 
prevent the retention of PolyA RNA during KSHV lytic replication. a) Confocal microscope images of 
FISH analysis between scrambled (scr) and Nup98 siRNA treated cells, 48 h post nucleofection cells were 
treated with doxycycline to induce KSHV lytic replication. Cells were then fixed 24 h post doxycycline 
treatment. Cells were permeabilized and stained with fluorescently tagged oligo-dT. b) Confocal pixel 
profiling of a single cell from each image (shown by red arrow in Merge) showing DAPI intensity (blue) and 
Poly A signal intensity. 
 
4.4 Nup98-depletion did not impede normal KSHV lytic gene 
expression 
Next, Nup98-depleted TREx cells were reactivated to investigate whether the 
depletion of Nup98 would aid the progress of viral lytic replication. qPCR analysis 
showed that the depletion of Nup98 did not significantly impact ORF50 
a) b) 
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expression suggesting that induction via the doxycycline inducible system was 
not affected (Figure 4.3a). Moreover, analysis of ORF57, an RTA-responsive 
immediate-early gene, showed that ORF57 transcription was similarly not 
significantly impacted by Nup98-depletion (Figure 4.3a). Western blot analysis of 
ORF57 protein levels showed a similar phenotype with ORF57 levels unaffected 
by Nup98 depletion with no significant difference in ORF57 relative band 
intensities detected (Figure 4.3b and Figure 4.3). This suggested that the 
absence of Nup98 did not affect the kinetics of lytic replication progression, nor 
did it lead to increased levels of spontaneous reactivation in latent cells. These 
results suggested that depletion of Nup98 did not effect KSHV lytic induction via 
the doxycycline-mycRTA system and did improve the level of immediate-early 
gene expression. 
 
Figure 4.3 SiRNA depletion of Nup98 does not impact the expression of IE KSHV genes during lytic 
infection in TREx cells. a) qPCR analysis of KSHV immediate-early transcripts ORF50 and ORF57 in TREx 
cells nucleofected with siRNAs and 48 h treated with doxycycline to induce KSHV lytic replication. RNA 
a) 
b) 
c) 
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extracted at 24 h post doxycycline treatment. n=3, 95 % confidence intervals shown, T-test p-value shown 
between indicated conditions. b) A representative western blot analysis ORF57 levels in TREx cells 
nucleofected with scrambled (scr) and Nup98 siRNAs for 48 h before doxycycline treatment to induce KSHV 
lytic replication. Lysates taken at 24 h post doxycycline treatment, Nup98 shown to confirm siRNA depletion, 
mycRTA to confirm doxycycline induction, GAPDH present as loading control. c) Quantified densitometry of 
ORF57 band intensity normalised to GAPDH at 24 h post doxycycline treatment in TREx cells nucleofected 
with scr and Nup98 siRNA 48 h prior to doxycycline treatment. n=4, 95 % confidence intervals shown, T-test 
p-value shown between indicated conditions. 
 
In the previous chapter it was shown that Nup98 decreased early during KSHV 
lytic infection, but confocal analysis showed no change in localisation or Nup98 
levels (Figure 3.4). Therefore, a series of experiments were performed on TREx 
cells treated with scrambled or Nup98 siRNA and seeded onto poly-l-lysine 
coverslips. 48 h after nucleofection with siRNAs cells were treated with 
doxycycline to induce KSHV lytic infection and fixed at either 0 h, 8 h, 24 h post 
doxycycline treatment. TREx cells were then permabilized, blocked with BSA and 
stained with anti-RTA and anti-Nup98 before washing and secondary antibody 
treatment. Cells were then mounted with DAPI and visualised using an LSM 880 
confocal microscopy (Ziess). In Nup98-depleted cells, Nup98 levels appear 
significantly reduced at all time points post doxycycline treatment at both the NPC 
and the nucleoplasm (Figure 4.4). Nup98-depletion however does not appear to 
have a negative effect on RTA expression levels with replication compartments 
occurring in both scrambled and Nup98 siRNA treated cells by 24 h (Figure 4.4). 
Overall, these results suggest Nup98 depletion with siRNAs achieves a 
significant reduction in whole-cell Nup98 levels and confirms observations from 
the previous chapter that Nup98 levels at the NPC do not appear to change within 
8 h of the induction of lytic infection with doxycycline. 
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Figure 4.4 Nup98 siRNA treatment significantly decreased Nup98 at the NPC and in the nucleoplasm. 
TREx cells were nucleofected with either scrambled or Nup98 siRNA and seeded onto poly-l-lysine 
coverslips, 48 h post nucleofection cells were treated with doxycycline to induce KSHV lytic replication. Cells 
were then fixed at either 0 h, 8 h or 24 h post doxycycline treatment and stained with anti-RTA and anti-
Nup98. Coverslips were mounted with DAPI and visualised using an LSM 880 confocal microscope. 
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4.5 Nup98-depletion reduced viral infectivity but did not impact KSHV 
DNA replication 
To examine whether Nup98 depletion affected late stages of viral lytic replication, 
viral DNA load and infectious virion production were assessed. In order to test 
viral load TREx cells were nucleofected with either scrambled or Nup98 siRNA 
and incubated for 48 h before cells were treated with doxycycline to induce KSHV 
lytic replication. Cells were incubated for 72 h after doxycycline treatment before 
DNA was extracted. qPCR was then performed to determine viral DNA load which 
showed that the depletion of Nup98 actually increased viral DNA load levels but 
not significantly when compared to scrambled cells (Figure 4.5a). To determine 
the effect of Nup98-depletion on viral infectivity, TREx cells were treated as 
described above and 72 h post doxycycline treatment supernatant was collected 
from TREx cells and added at a 1:1 ratio with DMEM and incubated for 24 h with 
naïve 293T cells. RNA was then extracted from these 293T cells and qPCR 
performed to determine levels of ORF57. A significant reduction in ORF57 levels 
was observed in 293T cells treated with supernatant from Nup98-depleted TREx 
cells (Figure 4.5b). Furthermore, western blot analysis of viral capsid protein 
ORF65 showed an increase within Nup98-depleted cells at 72 h post doxycycline 
treatment to induce KSHV lytic replication (Figure 4.5c). Due to difficulties 
consistently detecting ORF65 by western blot this experiment was only 
performed once. Overall, depletion of Nup98 did not appear to impact viral DNA 
production, which corroborates the findings in Figure 4.3 that showed no impact 
on the induction of lytic replication or IE gene expression. However, Nup98-
depletion did significantly reduce the rate of infectivity of virions produced from 
Nup98-depleted cells. This finding, along with the suggestive observation of 
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increased levels of the viral capsid protein ORF65 in Nup98-depleted TREx cells, 
led to the hypothesis that Nup98-depletion negatively impacted virion egress at 
an unspecified stage.  
 
a) 
b) 
c) 
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Figure 4.5 SiRNA depletion of Nup98 does not impact KSHV genome replication but reduces viral 
reinfectivity and leads to an accumulation of viral late protein ORF65. a) qPCR analysis of viral DNA 
levels in scrambled (scr) and Nup98 siRNA treated TREx cells reactivated for 72 h. n=3, 95 % confidence 
intervals shown, T-test p-value shown between indicated conditions. b) Viral progeny levels measured as 
ORF57 expression in infected naïve 293T cells 24 h post addition of supernatant from scrambled (scr) and 
Nup98 siRNA treated TREx cells 72 h post induction of lytic replication. n=3, 95 % confidence intervals 
shown, T-test p-value shown between indicated conditions. c) Western blot analysis of ORF65 protein levels 
in siRNA treated TREx reactivated for 72 h. GAPDH shown as a loading control. n=1. 
 
4.6 Nup98-depletion led to an accumulation of viral capsids at the 
plasma membrane suggesting impaired virion egress 
To determine how Nup98-depletion led to reduced KSHV infectivity confocal 
immunofluorescence was performed on TREx cells treated with either scrambled 
or Nup98 siRNA. These experiments looked to confirm the observation by 
western blot that levels of viral capsid protein ORF65 were increased at 72 h in 
Nup98-depleted TREx cells. TREx cells were nucleofected with either scrambled 
or Nup98 siRNAs and after 48 h treated with doxycycline to induce KSHV lytic 
replication. 72 h post doxycycline treatment cells were fixed, permeabilized and 
stained with antibodies against the viral capsid protein ORF65. Nup98 depletion 
was confirmed prior to this experiment via western blotting at 48 h post 
nucleofection. In Nup98-depleted cells an accumulation of ORF65 was observed 
at the plasma membrane forming a halo like phenotype when compared to 
comparable cells treated with the scrambled siRNA (Figure 4.6a). Inspection of 
Nup98-depleted cells at a higher zoom clearly shows a build-up of ORF65 at a 
periphery outside the DAPI stain rather than a more dispersed appearance 
outside the DAPI stain in scrambled treated TREx cells (Figure 4.6c). This 
suggested that Nup98 depletion was affecting virion egress at the plasma 
membrane. Utilising the tile scan functionality of the confocal microscope multiple 
1.5 mm2 tiles of images were taken and the observed phenotype was quantified 
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and calculated as a percentage of total ORF65 positive cells (Figure 4.6c). This 
analysis showed a significant increase in the occurrence of the halo phenotype 
in Nup98-depleted cells compared to scrambled siRNA treated cells. This 
supported the hypothesis that Nup98-depletion impaired virion egress, 
presumably via a mechanism affecting the final step of egress at the plasma 
membrane. 
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Figure 4.6 Depletion of Nup98 leads to ORF65 accumulation at the cell membrane in a halo pattern 
when visualised by confocal immunofluorescence microscopy. a) A panel of multiple confocal 
immunofluorescence microscopy images of siRNA treated TREx cells reactivated for 72 h (Scr or Nup98 
siRNA), stained with DAPI and viral capsid protein ORF65. b) A single cell comparison of ORF65 localisation 
in siRNA treated TREx cells reactivated for 72 h (Scr or Nup98). 5x zoom window inset, white arrow indicates 
‘halo’ phenotype. c) Quantification of halo phenotype (ORF65 stain as a semi-continuous ring outside the 
DAPI stain) in both Scr and Nup98 siRNA treated cells reactivated for 72 h. n=5, 95 % confidence intervals 
shown, 95 % confidence intervals shown, T-test p-value shown between indicated conditions. 
  
b) 
c) 
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4.7 Nup98-depletion led to maintained expression of KSHV-targeted 
cellular protein CHMP7 
Previous results raised the interesting question of how a nucleoporin could inhibit 
virion egress from the plasma membrane. It was hypothesised this effect may be 
related to the role of Nup98 at the nuclear pore in mRNA export and how KSHV 
subverts nucleocytoplasmic transport during lytic replication. A recent study had 
highlighted how the KSHV ORF10 protein interacts with Nup98-binding partner 
Rae1 to scan the 3’UTRs of a subset of cellular mRNAs preventing them from 
being exported during KSHV lytic infection (Gong et al., 2016). Crucially, this 
study showed that mutating ORF10 led to a decrease in viral titre but did not 
impact viral DNA load, a similar phenotype to the one observed in the Nup98-
depletion experiments described previously. Therefore, it was hypothesised that 
Nup98-depletion disrupted the action of ORF10 during lytic replication and 
allowing previously retained mRNAs to be transported and translated.  
The previous study identified 686 genes that showed a significant 50 % increase 
in nuclear/cytoplasmic ratio which included CHMP7, a member of the endosomal 
sorting complexes required for transport (ESCRT) complex (Gong et al., 2016, 
Table S3). When corroborating this data with an existing whole cell SILAC data 
set (Schuman et al., unpublished data) components of the ESCRT-III complex 
including CHMP7 were substantially downregulated by 24 h after the induction of 
KSHV lytic infection (Figure 4.7a). The downregulation of CHMP7 was 
subsequently confirmed with western blot analysis and densitometry showing that 
CHMP7 protein levels significantly decreased (~80 %) between 8 h and 24 h post 
induction of lytic replication (Figure 4.7b and Figure 4.7c). Overall, this work 
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characterised the observation from previously published work that KSHV targets 
CHMP7 and the ESCRT-III complex during lytic infection. 
 
 
Figure 4.7 CHMP7 is specifically downregulated during KSHV lytic infection in TREx cells. a) SILAC 
ratios of protein levels at 24h/0h for three ESCRT-III complex proteins. Data from a whole-cell SILAC screen 
performed on TREx cells reactivated at 0 h, 8 h, 24 h with doxycycline (Schuman et al., unpublished data). 
n=1. b) A representative western blot of CHMP7 levels in TREx cells treated with doxycycline to induce 
KSHV lytic replication at 0 h, 8 h, 24 h post doxycycline treatment. c) Quantified densitometry of CHMP7 
band intensity normalised to GAPDH at either 0 h, 8 h, 24 h post doxycycline treatment in TREx cells 
nucleofected with scrambled (scr) and Nup98 siRNA 48 h prior to doxycycline treatment. n=3, 95 % 
confidence intervals shown, T-test p-value shown between indicated conditions. 
 
To further test the hypothesis that Nup98-depletion disrupted KSHV induced 
CHMP7 mRNA retention subcellular fractionation was performed on scrambled 
and Nup98 siRNA treated TREx cells. RNA was isolated from the whole cell and 
cytoplasmic fractions and CHMP7 mRNA levels compared between latent and 
lytically replicating cells (Figure 4.8a). Results demonstrated that whole cell 
CHMP7 mRNA levels decreased 24 h after the induction of KSHV lytic replication 
by doxycycline (~50  %) and in scrambled treated cells the cytoplasmic fraction 
of CHMP7 mRNA significantly decreased (Figure 4.8a). However, in Nup98-
a) 
b) 
c) 
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depleted TREx cells the proportion of CHMP7 mRNA in the cytoplasm was not 
significantly different to CHMP7 levels in unreactivated Nup98-depleted TREx 
cells (Figure 4.8a). Furthermore, western blot analysis of CHMP7 protein levels 
showed that in scrambled siRNA treated cells, CHMP7 protein levels decreased 
at 24 h  post induction of KSHV lytic replication, in contrast a smaller scale 
reduction was observed in Nup98-depleted cells (Figure 4.8b). These 
observations were confirmed by densitometry analysis of western blots which 
showed a significant difference in CHMP7 normalised relative band intensity 
between reactivated and unreactivated scrambled treated cells but no significant 
change between Nup98 siRNA treated cells (Figure 4.8c). It is important to note 
that a complete rescue of CHMP7 levels should not be expected even if Nup98-
depletion prevents nuclear sequestration of CHMP7 mRNA. This is because 
during KSHV lytic infection the virus initiates host cell shut off through the action 
of the ORF37 protein which accelerates global mRNA turnover (Glaunsinger and 
Ganem, 2004). Overall, these results further confirm the observations that 
CHMP7 mRNA is sequestered in the nucleus during KSHV lytic infection and 
show that this sequestration is dependent on the presence of Nup98. 
Furthermore, the depletion of Nup98 from the NPC prevents CHMP7 mRNA 
sequestration in the nucleus leading to maintained CHMP7 protein levels during 
KSHV lytic infection.  
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Figure 4.8 Cytoplasmic CHMP7 mRNA reduction during KSHV lytic infection is ablated by Nup98-
depletion. a) qPCR analysis of CHMP7 mRNA levels in whole-cell (WCL) and cytoplasmic (C) 
compartments in scrambled (scr) or Nup98 siRNA treated cells in either a latent (0 h) or lytic state (24 h post 
doxycycline treatment). n=3, 95 % confidence intervals shown, T-test p-value shown between indicated 
conditions. b) A representative western blot analysis of CHMP7 levels in either scrambled (scr) or Nup98 
siRNA treated cells and treated with doxycycline to induce KSHV lytic replication. Nup98 shown to confirm 
knock down, mycRTA to confirm induction via doxycycline, GAPDH present as a loading control c) Quantified 
densitometry of CHMP7 band intensity normalised to GAPDH for scrambled (scr) or Nup98 siRNA treated 
a) 
b) 
c) 
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TREx cells at either 0 h (-), 24 h (+) post doxycycline treatment. n=3, 95 % confidence intervals shown, T-
test p-value shown between indicated conditions. 
4.8 Overexpression of ESCRT-III components has no impact on KSHV 
lytic gene expression or replication compartment formation 
Having established that upon Nup98-depletion KSHV-mediated targeting of 
CHMP7 was disrupted, work began to confirm that CHMP7 had a protective role 
within the cell by preventing virion egress. To test this a number of ESCRT-III 
complex protein overexpression transfer vectors were transduced into TREx cells 
using a second-generation Lentiviral system. These included CHMP7, IST1 and 
VPS4A in order determine whether the observation was specifically related to the 
role of CHMP7 or the ESCRT-III complex more broadly (Horii et al., 2006; 
Guizetti, Schermelleh, Mäntler, et al., 2011; Mierzwa et al., 2017). All 
overexpressed proteins were V5-tagged allowing for simple detection via western 
blot and confocal microscopy, an empty Lentiviral transfer vector was used as a 
transduction control (referred to as mock). Transduced cells were selected with 
puromycin alongside untransduced control TREx cells for 12 days to ensure all 
untransduced cells died before transduced cells were transferred to larger flasks 
for expansion. 
Initially, it was important to establish the transduction efficiency of the ESCRT-III 
overexpression proteins. Therefore, confocal microscopy was performed to 
determine the percentage transduction efficiency 28 days post transduction. 
Multiple tile scans were performed and quantified using ImageJ to determine the 
percentage of V5 positive cells. These experiments showed a low level of V5 
expression within transduced cells (20 %) suggesting that there was either loss 
of the expression cassette or poor transduction efficiency (Figure 4.9).  
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Figure 4.9 Lentiviral transduction of ESCRT-III components in TREx cells produced a low 
transduction level. a) Representative confocal tile scans of TREx cells transduced with Lentiviral 
overexpression constructs including an empty puromycin vector (Mock), CHMP7, IST1, VPS4 transfer 
vectors. b) Quantification of confocal tile scans showing the percentage transduction efficiency (number of 
V5 positive cells divided by total cells per image). n=3, 95 % confidence intervals shown. 
 
a) 
b) 
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Due to time constraints the decision was taken to pursue experiments with these 
transduced cells. Furthermore, given the complexity of the ESCRT-III complex it 
was decided to conduct subsequent experiments comparing IST1 and CHMP7 
overexpression alongside a mock transduced control. IST1 was chosen because 
of similarities in its role recruiting the ESCRT-III complex during multivesicular 
body trafficking and CHMP7 role recruiting ESCRT-III at the endoplasmic 
reticulum (Olmos et al., 2016; Frankel et al., 2017). Whilst VPS4A, an AAA-
ATPase, is involved in the disassembly of the ESCRT-III complex (Merrill and 
Hanson, 2010; Takahashi et al., 2018).  Having determined there was a level of 
expression of proteins of  it was now important to determine that the doxycycline-
inducible system of initiating KSHV lytic replication was not disrupted by the 
Lentiviral transduction. Transduced TREx cells were treated with doxycycline to 
induce KSHV lytic replication and protein extracted at 24 h post treatment. 
Western blot analysis was performed on cell lysates and probes for levels of the 
V5 tagged ESCRT-III complex proteins, mycRTA and ORF57 (Figure 4.10a). 
Probing with anti-V5 antibody yielded bands at the expected approximate sizes 
of IST1 at 39 kDa and CHMP7 at 51 kDa. It also confirmed the low level of 
expression of both of these proteins with no IST1 detectable in unreactivated cells 
although it was detectable in reactivated cells. CHMP7 was detectable in both 
unreactivated and reactivated cells but at a low intensity (Figure 4.10b). Crucially, 
there was no observable impact on the induction of KSHV lytic replication in these 
transduced cells in the western blot with ORF57 expression following on from 
mycRTA expression. However, differences in ESCRT-III overexpressing cells 
could be masked by the low expression rate therefore confocal microscopy was 
also performed to ensure that overexpression did not prevent the formation of 
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KSHV replication compartments in the nucleus, a critical step in successful KSHV 
lytic replication (Figure 4.10b). Both CHMP7 and IST1 staining occurred in the 
cytoplasm as expected along with the correct formation of viral replication 
compartments confirmed via RTA staining within discrete nuclear foci at 24 h post 
induction of KSHV lytic replication (Figure 4.10b). These results confirmed that in 
transduced cells that successfully expressed ESCRT-III complex proteins the 
induction and progression of KSHV lytic replication was not disrupted.   
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Figure 4.10 Overexpressing CHMP7 and IST1  of the ESCRT-III complex in TREx does not affect the 
induction of KSHV lytic replication and the formation of replication compartments. a) Western blot 
analysis of overexpressed ESCRT-III components with V5 tag alongside mycRTA and ORF57 to show 
induction of KSHV lytic infection at different time points post doxycycline treatment. b) Confocal 
immunofluorescence of KSHV replication compartments in stably expressing CHMP7 or IST1 or mock 
transduced cells 24 h post the induction of KSHV lytic replication. 
a) 
b) 
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4.9 Overexpression of CHMP7 leads to a decrease in infectious virion 
release 
After demonstrating that the overexpression of ESCRT-III components did not 
impact on KSHV lytic replication in TREx cells attempts were made to test 
whether the overexpression of CHMP7 reduced viral infectivity. This was derived 
from the observation that CHMP7 levels were maintained in Nup98-depleted cells 
where reduced viral infectivity was also observed. Mock transduced, CHMP7 and 
IST1 overexpressing cells were reactivated for 72 h and DNA was extracted 
before quantification of viral DNA levels by qPCR. qPCR showed increases in 
viral DNA in both ESCRT-III overexpressing cell lines compared to mock 
transduced cells however neither of these increases can be considered 
significant (Figure 4.11a). The release of infectious virions from these cell lines 
was also tested, with cells treated with doxycycline to induce KSHV lytic 
replication and incubated for 72 h before supernatant taken and mixed 1:1 with 
DMEM and incubated for 24 h on naïve 293T cells. 293T cells were then lysed 
and RNA extracted to determine KSHV ORF57 mRNA levels. Interestingly, there 
was a significant ~65 % decrease in the production of ORF57 mRNA in naïve 
293T cells treated with supernatant from CHMP7 overexpressing cells compared 
to mock transduced cells, implying that either fewer infectious virions had been 
released or virions released were less able to infect 293T cells (Figure 4.11b). 
Furthermore, this decrease in infectious virion production appeared specific to 
CHMP7 and was not observed in IST1-overexpressing cells (Figure 4.11b). 
Overall, these data suggest that increased levels of CHMP7 during KSHV lytic 
replication impair virion infectivity. Whether this related to release of virion or the 
production of defective virions was unclear. Interestingly, this observation 
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mirrored the observation made in Nup98-depleted cells suggesting CHMP7 was 
the factor responsible in Nup98-depleted cells for reduced viral infectivity. 
 
Figure 4.11 Overexpressing CHMP7 reduces the production of infectious virions of KSHV but does 
not decrease viral DNA production. a) Relative levels of viral DNA in mock transduced, IST1, CHMP7 
overexpressing cells compared in latent cells and cells 72 h post the induction of lytic replication. n=3, 95 % 
confidence intervals shown, T-test p-value shown between indicated conditions. b) Levels of ORF57 
expression in naïve 293T cells reinfected with the supernatant of mock transduced, IST1, CHMP7 
overexpressing cells that were either latent or had been induced to lytic replication for 72 h. n=3, 95 % 
confidence intervals shown, T-test p-value shown between indicated conditions. 
 
As previously mentioned, confocal microscopy of Nup98-depleted cells showed 
the ORF65 capsid protein formed a halo outside of the DAPI stain at the plasma 
membrane. Identical confocal immunofluorescence experiments were performed 
a) 
b) 
163 
 
on CHMP7- and IST1-overexpressing cells and the ORF65 halo phenotype was 
observed in TREx cells that had been transduced with the CHMP7-
overexpression construct (Figure 4.12a). Crucially, these experiments were 
lacking confirmation that the cells visualised are overexpressing CHMP7-V5 due 
to cross-species reactivity problems with the ORF65 antibody and the anti-V5 tag 
antibody. Attempts were made to visualise V5 with antibodies from different 
animal species however none were able to successfully. In order to determine 
whether the ORF65 halo phenotype was more frequent in cells transduced with 
the CHMP7 overexpression construct tile scans were performed on multiple 
coverslips to produce a series of 1.5 mm2 images that were analysed to quantify 
the proportion of ORF65 halo cells, as a proportion of all ORF65 positive cells. 
This quantification showed a significantly greater proportion of ORF65 positive 
cells had the halo phenotype in cells transduced with the CHMP7-overexpression 
construct when compared to mock transduced cells (Figure 4.12b). Whilst it was 
disappointing that overexpression of ESCRT-III components could not be 
confirmed in ORF65 positive cells the global analyses of tile scans suggested 
that the transduction of CHMP7 specifically lead to increased ORF65 halos even 
though overexpression was occurred in a minority of cells. 
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Figure 4.12 Overexpression of CHMP7 leads to an increase in the halo phenotype of ORF65 at the 
cell membrane during KSHV lytic infection. a) A panel of multiple confocal immunofluorescence images 
of ORF65 in 72 h reactivated TREx cells either mock transduced, or overexpressing CHMP7 or IST1. V5 is 
missing due to cross species reactivity between the anti-ORF65 and anti-V5 antibodies b) The percentage 
of ORF65 halo phenotypes observed as a percentage of total ORF65 positive cells from 3 x 1.5 mm2 tile 
scans for reactivated (72 h) mock transduced cells, or overexpressing IST1 or CHMP7. n=5, 95 % 
confidence intervals shown, T-test p-value shown between indicated conditions. 
 
4.10 Overexpression of CHMP7 led to increased membrane bubbling 
and maintenance of membrane integrity  
Having tentatively demonstrated that the overexpression of CHMP7 led to 
reduced virion infectivity and a potential reduction in viral egress at the plasma 
membrane the next step was to test a mechanism by which CHMP7 prevented 
viral egress. This was crucial in understanding how Nup98-depletion also led to 
reduced virion infectivity and would highlight, the importance of Nup98 at the NPC 
during KSHV lytic replication. Given the variety of functions of the ESCRT-III 
complex within the cell initial attempts to characterise the action of CHMP7 in 
preventing viral egress focused on the action of ESCRT-III at the plasma 
membrane given the phenotype of the ORF65 halo. CHMP7 and other ESCRT-
III factors have been shown to regulate plasma membrane integrity during 
necroptosis, a regulated form of cell death. During necroptosis, ESCRT-III 
b) 
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components bind at sites of damage to the plasma membrane and excise 
damaged sections as membrane bubbles (Gong et al., 2017). Therefore, it was 
hypothesised CHMP7 was targeted by KSHV during the lytic infection to prevent 
this membrane repair pathway which disrupted viral egress. To test whether cells 
transduced with a CHMP7 overexpression construct had a greater degree of 
membrane bubbling at late stages of KSHV lytic replication the perimeter/area 
ratio of TREx cells transduced with CHMP7, IST1 overexpression constructs or 
mock transduced was measured. This followed the assumption that cells able to 
produce membrane bubbles would have a greater perimeter/area ratio given the 
additional cell membrane perimeter produced by the bubble. In order to quantify 
the plasma membrane, cells were stained with phalloidin conjugated to 
rhodamine, which stained F-actin at the cell membrane. In order to stain just the 
plasma membrane cells were unpermeabilized during this experiment meaning it 
was not possible to co-stain for V5 to determine which cells were overexpressing 
ESCRT-III components. Confocal microscopy was then performed to produce tile 
scans of coverslips for perimeter analysis by ImageJ. Normally, it was observed 
that phalloidin stained the plasma membrane sufficiently well in all cell lines at 72 
h post doxycycline treatment to induce KSHV lytic replication (Figure 4.13a). 
Subjectively, it was apparent that in cells transduced with CHMP7 overexpression 
construct there was a greater proportion of cells with small bubbles contiguous 
with or proximal to the normal cell membrane when compared to mock 
transduced or cells transduced with IST1 overexpression construct (Figure 
4.13b).  However, given the inability to visualise whether these cells were 
overexpressing ESCRT-III components it is impossible to draw strong 
conclusions from this cell-to-cell analysis. Therefore, to determine whether this 
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trend was observable across a wider sample of cells confocal tile scans were 
performed to quantify the perimeter/area ratio of hundreds of cells from each 
condition. This data was analysed through ImageJ and plotted as a box and 
whisker plot (Figure 4.13c). Overall the variety of cell shapes and sizes are 
broadly similar between all three cell lines as seen by the similarity in distribution 
of the interquartile ranges (Figure 4.13c). However, in cells transduced with the 
CHMP7 overexpression construct the median perimeter/area ratio is significantly 
increased when compared to mock transduced and IST1-overexpressing cells. 
This suggests that whilst overexpressing ESCRT-III components does not 
change the distribution of cell sizes (as seen with the similarity in interquartile 
ranges) it does lead to an increase in the typical cell perimeter/area ratio in 
CHMP7-overexpressing cells. Whilst it was not possible to show CHMP7 
overexpression in cells with membrane bubbling these data do suggest there was 
a positive effect on global cell perimeter/area values within cells that were 
transduced with a CHMP7 overexpression construct. 
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Figure 4.13 Overexpressing CHMP7 leads to bubbles forming at the plasma membrane during KSHV 
lytic infection. a) Confocal immunofluorescence of transduced cells (mock, IST1, CHMP7) reactivated for 
72 h stained with DAPI and phalloidin. b) Phalloidin-only images magnified 5x with white arrows highlighting 
potential membrane bubbles. c) Box and whisker plot of perimeter/area ratio of cells from each transduced 
cell line (mock, IST1, CHMP7). Black dots are outliers outside of 1.5*IQR, notches around median line 
a) 
b) 
c) 
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indicate 95% confidence intervals of the median shown as notches. n=2, with >100 cells counted for each 
condition in each tile scan, T-test p-value shown between indicated conditions. 
 
4.11 Discussion 
Previous work has highlighted how specific herpesviruses have targeted 
components of the nuclear pore complex to aid their replication (Wild et al., 2009; 
Chang et al., 2015). However, little is known about how KSHV interacts with 
nucleoporins during its lytic replication cycle. Whole cell proteomic work 
previously performed in the Whitehouse laboratory had identified that between 
latency and the first 8 hours of lytic replication, Nup98 was specifically 
downregulated when compared to other nucleoporins although levels at the NPC 
appeared unchanged (Figure 3.3). Initially, it was hypothesised that this may be 
due to the virus targeting an antiviral role of Nup98, as previous studies had 
shown it could restrict viral infection and reverse virally induced mRNA export 
arrest (Enninga et al., 2002; Panda et al., 2014). However, upon Nup98-depletion 
from the whole-cell it became apparent that the significant Nup98 reduction was 
detrimental to viral lytic replication, specifically to virion infectivity (Figure 4.4). 
Further analysis suggested this was due to an accumulation of virions at the 
plasma membrane suggesting a failure in viral egress (Figure 4.6). 
In order to determine how Nup98-depletion could lead to reduce virion infectivity 
and inhibit viral egress, work focused on previous studies that have shown KSHV 
utilises the Nup98-binding partner and export adapter protein Rae1 during KSHV 
lytic infection to retain certain cellular transcripts in the nucleus (Pritchard et al., 
1999). This occurs through the action of the viral protein ORF10 that interacts 
with Rae1 to scan the 3’ UTR of transcripts as they prepare to be exported at the 
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nuclear pore (Gong et al., 2016). Nup98 and Rae1 interact at the NPC to help 
facilitate mRNA export therefore it is not surprising that depletion of Nup98 could 
disrupt the action of ORF10 protein (Blevins et al., 2003; Ren et al., 2010). 
Therefore, it was hypothesised that whilst KSHV decreased Nup98 protein levels 
early during lytic replication it did not decrease them sufficiently at the NPC to 
disrupt the Rae1-Nup98 interaction that was observed in siRNA depleted cells. 
Comparing datasets from previous published work on ORF10 and the existing 
proteomic work of the Whitehouse laboratory led to a potential link in the ESCRT-
III pathway, specifically CHMP7 (Sophie Schuman, unpublished data) (Gong et 
al., 2016). CHMP7 is a component of the ESCRT-III complex that is responsible 
for membrane manipulation within the cell, including the formation of 
multivesicular bodies (MVB), cellular abscission, and viral budding (Alonso Y 
Adell and Teis, 2011; Morita et al., 2011; Vita and Broadie, 2017). Existing data 
suggested that CHMP7 was specifically targeted by KSHV during lytic infection 
by ORF10 sequestering CHMP7 mRNA in the nucleus. Using subcellular 
fractionation, it was demonstrated that this sequestration of CHMP7 mRNA could 
be disrupted by siRNA depletion of Nup98, and that this led to maintained CHMP7 
protein levels during lytic infection (Figure 4.8). To test whether CHMP7 was 
responsible for decreasing viral infectivity TREx cells were transduced with a 
Lentiviral overexpression construct for CHMP7 along with IST1 (another ESCRT-
III component) and a mock transduced control. Cells transduced with a CHMP7 
overexpression construct exhibited significantly reduced viral infectivity when 
compared to the other cell lines (Figure 4.11). Furthermore, there was also an 
observable increase in the proportion of cells exhibiting an accumulation of viral 
capsid protein at the plasma membrane, although it was not possible to confirm 
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this occurrence was specifically linked to CHMP7 overexpressing cells (Figure 
4.12).  
Finally, attempts were made to determine the mechanism by which CHMP7 
expression was able to reduce viral infectivity. This focused on whether CHMP7 
overexpression was able to promote an ESCRT-III plasma membrane repair 
pathway (Gong et al., 2017). During this process the ESCRT-III complex controls 
plasma membrane integrity by producing bubbles from the plasma membrane 
helping sustain cell survival. A greater frequency of membrane bubbles were 
observed in lytically replicating cells transduced with a CHMP7 overexpression 
construct and a significantly greater median perimeter/area ratio were observed 
in these cells compared to mock transduced cells and cells expressing other 
ESCRT-III proteins (Figure 4.13). However, at a cell-to-cell level it was not 
possible to establish whether cells with membrane bubbles were overexpressing 
CHMP7. Therefore, it is difficult to draw meaningful conclusions on whether this 
is the mechanism of reduced KSHV virion infectivity. More work is required to 
determine how exactly CHMP7 could act to inhibit late stage viral processes. 
Given that evidence from other studies that some ESCRT-III components are 
required for successful herpesvirus replication the observation that CHMP7 is 
specifically downregulated and negatively affects virion infectivity warrants further 
exploration  (Crump et al., 2007; Pawliczek and Crump, 2009). 
Overall, the observations in this chapter open interesting questions regarding 
how KSHV targets Nup98 during its lytic infection. Observations outlined above 
demonstrate that a significant depletion in Nup98 across the whole cell is 
detrimental to KSHV lytic replication. Therefore, it could be hypothesised, given 
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no observations of a decrease in Nup98 levels at the NPC during lytic infection 
that the downregulation of Nup98 at 8 h during lytic infection is specifically 
targeting the nucleoplasmic fraction. 
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5 Using proximity dependent biotin identification 
to probe for nuclear pore remodelling during 
KSHV lytic infection 
5.1 Introduction 
The traditional understanding of the NPC held that the nucleoporin composition 
of the pore was uniform across cell types and environments. However, recent 
work has established that NPC specialization can occur in different cell types and 
cellular circumstances (Ori et al., 2013). The specialization of nuclear pores also 
opens an interesting question regarding virus-nuclear pore interactions, 
specifically do viral remodelling events specialise nuclear pores to aid viral 
replication? 
Previous work on viral remodelling of the nuclear pore has demonstrated how 
viruses target single or subsets of nucleoporins to aid with viral replication. For 
example, Picornaviridae have been shown to target FG-nucleoporins for 
proteolytic cleavage, whilst HSV-1 has been shown to inhibit host 
nucleocytoplasmic transport and induce nuclear pore dilation (Gustin and 
Sarnow, 2001; Wild et al., 2009; Malik et al., 2012). Interestingly, during HIV-1 
infection the NPC undergoes a range of extensive compositional changes without 
affecting overall nuclear envelope integrity. Many of these changes appear critical 
to HIV-1 replication suggesting that the virus remodels and specialises NPCs to 
enhance HIV-1 replication (Monette et al., 2011b). 
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To determine whether KSHV lytic replication induced a stoichiometric remodelling 
at the nuclear pore a novel technique called proximity dependent biotin 
identification (BioID) was utilised. BioID is a technique developed by Roux et al. 
(2012) that adapts a similar technique Dam-ID, for analysing proximal protein-
protein interactions. The principal is to fuse a promiscuous biotin ligase to a 
protein of interest, express this fusion protein in vivo where it will biotinylate 
proximal proteins after biotin is introduced to the media. These biotinylated 
proteins can then be isolated using streptavidin beads and identified by mass 
spectrometry. This technique had previously been used to analyse interactions 
at the nuclear pore and therefore offered an immediate starting point for 
understanding remodelling events during KSHV lytic infection (Kim et al., 2014).  
In this chapter, BioID was applied to TREx cells that were reactivated to the lytic 
replication cycle to identify protein changes at the NPC. Initial work aimed to 
optimise the experimental system in both 293T and TREx cells. This was initially 
performed with GFP-nucleoporin and BioID-nucleoporin plasmids provided by the 
Roux laboratory. Attempts were made to establish TREx cell lines that stably 
expressed these plasmids after transfection, however this led to persistent 
mislocalisation of the target protein. Work then continued using transient 
transfections, which achieved good target localisation and was optimised to 
achieve the best biotinylation efficiency. LC-MS/MS analysis showed these 
transient transfections were able to specifically target a nuclear subset of proteins 
compared to the free ligase. Finally, work attempted to combine this system with 
tandem mass tagging-based quantitative proteomics which allowed for relative 
quantitation of protein levels between KSHV latent and lytic replication phases. 
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These data were then analysed using bioinformatic tools and clustering analysis 
to identify potential changes at the nuclear pore. 
5.2 Optimisation of BioID-nucleoporin expression and subcellular 
targeting 
The premise of the experiment was to use BioID to specifically biotinylate 
nucleoporins via a biotin ligase fusion protein with nucleoporin members of the 
Y-complex (Nup160, Nup85, Nup133, Nup53) (Kim et al., 2014). This would 
ensure the labelling of the majority of the NPC due to the stability and positioning 
of the Y-complex within the inner rings of the NPC. Biotin labelled nucleoporins 
could then be isolated after SDS lysis of transfected cells via biotin affinity capture 
with streptavidin (Figure 5.1a). The first steps of developing the BioID system to 
analyse KSHV-mediated NPC remodelling were performed using analogous 
GFP-nucleoporin plasmids. This allowed for faster analysis via confocal 
microscopy to confirm successful subcellular targeting of overexpressed 
nucleoporins. 
GFP-nucleoporin plasmids were transfected into 293T cells and visualised via 
confocal immunofluorescence to confirm that nucleoporin overexpression 
resulted in subcellular targeting. However, these experiments showed consistent 
mistargeting of the GFP-nucleoporin constructs in 293T cells (Figure 5.1b). Using 
Lamin B1 to costain for the nuclear envelope highlighted the level of mistargeting 
with the GFP signal predominantly in the cytoplasm rather than at the nuclear 
envelope. In the case of Nup85-GFP, there is observable staining at the nuclear 
envelope however a strong dense stain is also present in the cytoplasm. It is 
thought that this localisation is precursor NPCs within the specialised 
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endoplasmic reticulum region of the annulate laemalle which are oversaturated 
by the overexpression of Nup85-GFP. 
 
Figure 5.1 Transfection of GFP-nucleoporin constructs in 293T cells led to mistargeting of 
nucleoporins away from the nuclear envelope. a) Representation of the principal of proximity dependent 
biotinylation. b) Confocal immunofluorescence of GFP-nucleoporin transfected into 293T cells. Lamin B1 
was used as a nuclear envelope stain. 
 
a) 
b) 
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Due to the availability of TREx cells it was decided to move away from 
optimisation of these constructs in 293T-based cell lines and focus on developing 
correct targeting in TREx. Using Amaxa nucleofector® technology, TREx cells 
were nucleofected with GFP-nucleoporin constructs which showed successful 
localization at the nuclear envelope (Figure 5.2b). Attempts were then made to 
select these cells to create a stably-expressing cell line. Cells were treated with 
G418 due to the neomycin resistance marker within the plasmid backbone. A kill 
curve for G418 in TREx cells was determining by performing a serial dilution of 
G418 and determining cell viability 24 h after the addition of G418. This showed 
~100 % cell death at a concentration of 0.4 mg/ml G418 and so was the 
concentration taken forward to for selection (Figure 5.2a). However, after four 
weeks of selection the overexpressed nucleoporin became mistargeted with 
diffuse staining within the cytoplasm and no specific signal at the nuclear pore 
(Figure 5.2b). Therefore, it was decided to proceed using transient nucleofections 
as the biotin affinity identification protocol contained sufficient steps to specifically 
isolate biotinylated proteins. 
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Figure 5.2 Selection of GFP-nucleoporins in TREx after nucleofection led to loss of targeting after 4 
weeks. a) A G418 kill curve for TREx cells. Different dilutions of G418 were mixed with fresh media and 
incubated with TREx cells for 24 h before an MTS assay was performed to determine cell viability. n=5, 95 
% confidence intervals shown. b) Confocal immunofluorescence of GFP-nucleoporins nucleofected into 
TREx cells 1 week after transfection and 4 weeks after selection with G418. 
 
Subsequently, transient nucleofection was performed using BioID-nucleoporin 
plasmids, along with the free ligase (BioID) and the non-biotinylating mutant 
(R118G) (Figure 5.3a). Transfections were performed, and cells given at least 24 
h recovery time before media was supplemented with biotin. 
Immunofluorescence and confocal microscopy were used to determine the 
targeting of biotinylation (Figure 5.3a). This showed good targeting at the nuclear 
pore complex in BioID-Nup53, still with occasional staining of the annulate 
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laemalle. BioID, or the free ligase, showed staining throughout the cell, with a 
stronger signal within the nucleus but still diffuse and not specific to the nuclear 
envelope. R118G showed no signal when probed with Alexa-Fluor conjugated 
streptavidin indicating that biotinylation detected was specific to the BioID ligase. 
One key concern surrounding transient nucleofections was the proportion of 
successful transfection. Therefore, ImageJ was used to quantify confocal tile 
scans of coverslips to determine from a large field image the proportion of 
biotinylation. This was performed as a time course post nucleofection to 
determine the best time to conduct the biotin affinity pull down. Unfortunately, the 
level of biotinylation detected was very low (<10 %) and gradually decreased over 
time (Figure 5.3b). 3 days post nucleofection appeared to most consistently give 
the highest level of biotinylation for BioID-nup53 and thus it was decided that for 
experiments this time point would be used. Similar analysis was also performed 
to determine whether the induction of lytic replication in TREx using doxycycline 
had any impact on biotinylation efficiency (Figure 5.3c). These cells were induced 
48 h post nucleofection and simultaneously induced with doxycycline and biotin 
added to the media. Whilst there was an observable decrease in biotinylation 
efficiency in both BioID and BioID-nup53 after induction it was not of a large 
enough magnitude to suggest that using this technique to identify nuclear pore 
components would be unfeasible. 
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Figure 5.3 Transient nucleofection of BioID-nucleoporins showed efficient biotinylation targeting 
even after the induction of lytic replication. a) Confocal immunofluorescence of transiently nucleofected 
TREx after the introduction of biotin to media. Nup98 shown as a control to confirm biotinylation at the 
nuclear pore. b) ImageJ quantitation of % biotinylation over several days post nucleofection for free ligase 
(BioID) and nucleoporin-bound ligase (BioID-nup53). n=3, 95 % confidence intervals shown. c) ImageJ 
quantitation of % biotinylation between induced and uninduced TREx cells when transfected with free ligase 
(BioID) and nucleoporin-bound ligase (BioID-nup53). n=3, 95 % confidence intervals shown. 
  
a) 
b) 
c) 
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5.3 Pilot LC-MS/MS analysis of BioID-nucleoporin pull downs 
After initial difficulties the BioID system was demonstrated to work within the 
TREx cell line and biotinylation was maintained after the induction of lytic 
replication. The next steps of this project involved biotin affinity capture of 
biotinylated proteins and analysis via mass spectrometry comparing latent and 
lytic replicating cells. 
Following the biotin affinity capture protocol previously used by the Roux 
laboratory to investigate structural interactions in the NPC Y-complex (Kim et al., 
2014), initial work used LC-MS/MS to identify proteins biotinylated by either the 
free ligase or BioID-nup53 (Figure 5.4). This approach produced two datasets 
that were analysed through an automated work flow to produce a list of enriched 
hits and unique hits (Figure 5.4a). Enrichment was defined by comparing the 
number of peptide fragments of one protein observed in the BioID condition and 
BioID-nup53. If 2x as many peptides were observed between those conditions 
the protein was considered enriched in its respective condition. These enriched 
hits were combined with unique hits that only occurred in one condition to create 
a complete hit list from each BioID experiment. These new curated data sets were 
then further annotated to convert accession codes to gene names using the freely 
available UniProt tool. These gene names can then be analysed via the free 
network and cluster analysis tool STRING-db. STRING-db is a web application 
that predicts protein-protein interactions based on a number of factors including 
published experimental data, pathway database information,  text mining, gene 
cooccurrence, similar gene evolutionary neighbourhoods, relatedness by gene 
fusion events (Szklarczyk et al., 2017). STRING network analysis performed here 
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excluded connections based on text mining data. Pathway analysis of the curated 
data tables showed that proteins identified from the free ligase BioID fall into a 
variety of gene ontology groups including a number of cytoplasmic proteins along 
with components of the nucleus (nuclear part) (Figure 5.4b). Moreover, the 
network illustrates the predominantly cytoplasmic nodes (red) with fewer nuclear 
part nodes (blue), there are also few edges between nodes indicating fewer 
connections (Figure 5.4d). However, when this was compared to pathway 
analysis for BioID-nup53 a large number of cytoplasmic nodes (red) are still 
detected however there are more defined clusters of nuclear part nodes (blue) 
with a greater number of edges between these nuclear part nodes (Figure 5.4e). 
Furthermore, the false discovery rate calculation for BioID-nup53 pathway 
analysis is much lower than for BioID, suggesting that STRING-db analysis has 
a greater confidence that the proteins within the BioID-nup53 curated data set 
are specifically from these pathways and cellular compartments. Manual analysis 
of the curated data sets also showed that BioID-nup53 successfully pulled out a 
number of nucleoporins compared to BioID including Nup62, an expected Nup53 
interaction partner, and Nup98, which has been previously identified using BioID-
Nup53 (Figure 5.4c) (Kim et al., 2014). It is however, disappointing that the 
specific bait protein was not itself identified. However, the success of identifying 
specific subcellular networks of functionally related proteins at and around the 
NPC led us to proceed with the tandem mass tagging experiment. 
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Figure 5.4 LC-MS/MS analysis of biotin affinity immunoprecipitation of BioID and BioID-
nup53. a) Percentage comparison of protein hits between BioID and BioID-nup53. Data is 
expressed as enriched (number of proteins analysed is >2x the opposite condition) or only (where 
protein is only present in that sample. b) Gene Ontology analysis of the cellular component protein 
hits from BioID are related to. c) Gene Ontology analysis of the cellular component protein hits from 
BioID-nup53 are related to. d) Nucleoporin hits identified in BioID-Nup53 hits. e) STRING network 
map of enriched BioID hits. Nodes coloured red indicated cytoplasmic in gene ontology, nodes in 
blue indicate nuclear gene ontology. Edge colour indicates a connection between nodes based on  
of gene fusion evidence (red), gene neighborhood evidence (green), gene cooccurrence evidence 
(blue), experimental evidence (purple), database evidence (light blue), coexpression evidence 
(black). f) STRING network map of enriched BioID-nup53 hits. Nodes coloured red indicated 
cytoplasmic in gene ontology, nodes in blue indicate nuclear gene ontology. Edge colour indicates 
a connection between nodes based on  of gene fusion evidence (red), gene neighborhood evidence 
(green), gene cooccurrence evidence (blue), experimental evidence (purple), database evidence 
(light blue), coexpression evidence (black). 
 
 
f) 
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5.4 Tandem Mass Tagging LC-MS/MS coupled to BioID 
To understand specific stochiometric changes at the NPC during KSHV lytic 
infection, transient BioID was combined with the quantitative proteomic technique 
tandem mass tagging prior to LC-MS/MS analysis.  
Tandem mass tagging (TMT) is an emerging technique within mass spectrometry 
for the analysis of relative protein abundance. The concept of TMT is to 
incorporate a isobaric peptide tag composed of a sensitization (reporter) group, 
a mass normalization group and a peptide reactive functional region (Thompson 
et al., 2003). The peptide reactive region attaches the tag to proteins within the 
sample whilst the mass normalization group acts to ensure that the tag is isobaric 
after tagging, thus ensuring that proteins tagged from different samples are the 
same mass and run identically on HPLC. The sensitization or reporter group acts 
as the internal mass standard and is unique for each sample that is tagged. It is 
removed from the overall TMT molecule by collision induced dissociation during 
LC-MS/MS and forms a distinct isotope peak within the MS readout. 
Alongside the nucleoporin fusion proteins, the free ligase and ligase mutant 
R118G were used to provide an internal control to ensure proper targeting and a 
control for background binding to the streptavidin beads during biotin affinity 
capture. Samples were labelled with TMT reagents prior to LC-MS/MS to allow 
for relative abundance measurements (Figure 5.5a). To ensure suitable 
biotinylation coverage of the NPC these experiments utilised three nucleoporin 
biotin ligase fusion proteins: Nup53, a nucleoporin that sits centrally within the 
NPC as part of the Nup93-Nup53 complex helping anchor central plug 
nucleoporins to the nuclear membrane (Hawryluk-Gara et al., 2005; Mansfeld et 
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al., 2006); Nup133 and Nup85 are components of the Y-complex, a modular 
subdomain of the NPC that is critical to nuclear pore assembly and gives rise to 
central doughnut shaped structure of the NPC (Walther et al., 2003; Harel et al., 
2003). These three nucleoporin fusion proteins would provide coverage of both 
the central plug region and cytoplasmic and nucleoplasmic facing regions as 
previously demonstrated by the Roux laboratory (Kim et al., 2014). 
To analyse the quantitative proteomic data, which was provided as a spreadsheet 
readout from SEQUEST software set at a 1% False Discovery Rate (FDR), the 
tables were converted to columns of comma separated values (.csv) and 
processed through a series of R scripts to clean the data producing lists of 
proteins that were true hits (i.e. proteins with a greater than 1.5 protein ratio of 
protein in the experimental condition compared to the corresponding condition 
ligase mutant R118G). These lists were produced for each nucleoporin fusion 
protein in the unreactivated and reactivated condition. These were then analysed 
via STRING-db to identify via Gene Ontology the pathway associated with these 
proteins and confirm correct biotinylation targeting compared to the free ligase.  
Initial network analysis was disappointing (Figure 5.5b). With two key 
experimental conditions Nup53 and Nup133 not producing significant protein-
protein interaction maps based on STRING-db. This was due to a low number of 
hits being identified and minimal pathway similarity between these proteins. This 
is potentially a consequence of the transient nucleofection system limiting the 
initial pool of biotinylated protein alongside the stringent biotin affinity protocol. 
However, Nup85 did successfully produce a list of hits that produced a significant 
protein-protein interactions network map. Furthermore, Gene Ontology pathway 
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analysis showed strong identification of nuclear proteins in both unreactivated 
and reactivated compared to the free ligase (Figure 5.5c). 
Having performed network clustering analysis and confirming for each condition 
enriched nuclear targeting versus the free ligase, these lists were then combined 
to include peptides that matched one of two criteria: the peptide was present in 
both unreactivated and reactivated samples; or the peptide was only found in one 
condition and its relative abundance underwent a significant increase or decrease 
(for example viral peptides which were significantly increased in abundance 
during reactivation but not at all present in the unreactivated sample). 
 
a) 
b) 
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Figure 5.5 Overview of Tandem mass tagging of BioID-nucleoporins samples. a) Schematic of process 
of tandem mass tagging with samples initially prepared, then labelled with different TMT tags (highlighted 
by colour), then samples are combined before LC-MS/MS analysis. b) STRING overview of node clustering 
for each experimental condition. c) Gene Ontology analysis of likely Cellular Component that peptide hits 
(enriched compared to R118G) are associated with for all experimental conditions. 
 
With the combined list of true peptide hits identified from the Nup85 data it was 
possible to perform further network analysis to identify clusters of functionally 
c) 
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related peptides and analyse any changes in their relative abundance during lytic 
replication. This initial network cluster analysis was again performed using 
STRING-db and showed a good protein-protein interaction p-value (Figure 5.6a), 
suggesting more interactions than would be typically expected. Gene Ontology 
pathway analysis then identified a number of pathways which were enriched for 
a variety of peptides which allowed for further analysis of relative abundance 
changes of these clusters of functionally related peptides (Figure 5.6b). However, 
this clustering showed that of proteins identified the majority did not cluster into 
any highly specific pathways (only the nucleoplasm and cytosol compartments) 
except a small group involved in the ribonucleoprotein complex. Due to the 
relative position of Nup85 at the NPC it is plausible for BioID to label proteins that 
are in the nucleoplasm or the cytosol. When comparing the relative abundance 
of these identified peptides between latency and lytic replication it was observed 
that ribonucleoprotein complex proteins identified by BioID were increased by 
approximately 2.5-fold (Figure 5.6c). However, for nucleoplasmic peptides a 
much wider range of relative abundance ratios can be seen although the general 
trend still suggests 2.5-fold increase in relative abundance at the NPC during lytic 
replication. STRING-db network analysis highlights the areas of functional 
clustering particularly around proteosomal proteins (PSME1, PSMB1, PSMC4), 
ribosomal biogenesis-related proteins (RPS21, TBL3, PWP2, RRS1) and 
regulators of nuclear transcription (UFL1, TCEB2, TCEA1) (Figure 5.6d). 
However, the experiment failed to identify any nucleoporins other than TPR and 
failed to pull down the bait protein as would be expected.  
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Figure 5.6 TMT of BioID-Nup85 shows that at 24 h post lytic replication specific ribosomal 
biogenesis pathways are maintained. a) The STRING-db network overview of combined Nup85 
peptide hits. b) Gene Ontology analysis of likely Cellular Component that peptide hits (enriched 
compared to R118G) are associated with for BioID-Nup85. c) Boxplot of reactivated/unreactivated 
protein ratios for two Cellular component subsets identified from STRING-db. d) STRING-db 
network of combined Nup85 peptide hits. Nodes coloured red indicated cytoplasmic in gene 
ontology, nodes in blue indicate nuclear gene ontology. Edge colour indicates a connection 
between nodes based on  of gene fusion evidence (red), gene neighborhood evidence (green), 
gene cooccurrence evidence (blue), experimental evidence (purple), database evidence (light 
blue), coexpression evidence (black). 
 
  
d) 
194 
 
5.5 Discussion 
In this chapter the novel technique of proximity dependent biotinylation (BioID) 
was combined with tandem mass tagging (TMT) in an attempt to identify relative 
stochiometric changes at the nuclear pore during KSHV lytic replication. This 
work followed on from previous work using BioID to probe the structure of the 
nuclear pore, specifically showing new interaction data regarding components of 
the Y-complex (Kim et al., 2014). This approach was constrained by the difficult-
to-transfect cell lines utilised in this study and difficulties establishing stable cell 
lines (Figure 5.2). Therefore, after work optimising this system through transient 
nucleofection a series of experiments were performed using three BioID-
nucleoporins in tandem with TMT labelling and mass spectrometry to identify 
changes at the NPC during KSHV lytic infection (Figure 5.3). Through mass 
spectrometric analysis a series of large, relational datasets were produced. 
These were analysed via R scripts to identify true hits when compared to a beads-
only control and then analysed to identify proteins enriched at the NPC in either 
latency or lytic replicating cells and proteins present at the NPC during both 
lifecycle stages. This produced a final list of peptide hits for hierarchical cluster 
analysis of functions and analysis of relative abundance changes (Figure 5.5). 
This identified a variety of proteins of interest however time constraints prevented 
extensive validation in a wet-laboratory setting.  
However, only one of the three BioID-nucleoporins, Nup85, successfully pulled 
down enough peptides to perform network analysis (Figure 5.6). Further analysis 
of this one successful experiment identified three main groups of labelled 
proteins: cytosolic, nucleoplasmic and ribonucleoprotein complex. The highly 
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generic nature of these groups suggests no highly specific functional pathways 
were identified. This is disappointing given it would be expected to identify 
peptides related to the nuclear pore complex within this experiment. However, 
the identification of nucleoplasmic and cytosolic proteins is plausible given the 
approximate position of Nup85 on the NPC (Kelley et al., 2015). Analysis of the 
relative abundance changes of these peptides between latent and lytic cells 
showed that across all three groups the levels of these peptides at the NPC 
increased by approximately 2.5-fold between latent cells to lytic cells. It is 
important to note that this could be related to the fact that the dataset from lytic 
replicating Nup85 expressing cells identified the most peptides when compared 
to beads-only (Figure 5.5b). However, this increase could relate to the virus 
manipulating export pathways to preferentially boost nucleocytoplasmic transport 
systems required by the virus. Herpes simplex 1 virus has been shown to inhibit 
nucleocytoplasmic transport pathways via interaction with nucleoporins (Malik et 
al., 2012). Research on the impact of KSHV lytic replication on protein export at 
the NPC is limited but studies with CRM1 inhibitor leptomycin B have shown that 
viral proteins such as ORF45 require CRM1 to shuttle between the nucleus and 
the cytoplasm (Li and Zhu, 2009). This would suggest that the CRM1 export 
pathway is not specifically disabled by the virus during lytic infection, 
nevertheless future work investigating the impact of KSHV lytic replication on 
alternate forms of protein import and export would help clarify the increases seen 
here. 
Finally, it is also worth noting the identification of ribonucleoprotein complex 
proteins from this data. The impact of KSHV on ribosomes during lytic infection 
is not well characterised but the above data shows a relative increase in 
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ribosomal proteins at the NPC during lytic infection. This suggests that ribosomal 
proteins are not significantly affected by the virus-induced process of host cell 
shut off (Glaunsinger and Ganem, 2004). Furthermore, several components of 
the ribonucleoprotein complex were identified at higher levels during lytic 
replication suggesting either aspects of the ribosome were upregulated during 
lytic infection or that components of the ribosome came together more rapidly 
after pre-ribosomal export at the nuclear pore complex during lytic replication. 
  
197 
 
 
 
 
 
 
 
 
Chapter 6 
~ 
Discussion 
 
  
198 
 
6 Discussion 
The nuclear pore complex (NPC) is a sophisticated barrier that separates the 
nucleus and the cytoplasm. The protective role of the NPC is challenged by a 
variety of factors, none more diverse and unrelenting as viruses. Many different 
families of viruses have co-evolved to target the NPC, leading to a variety of 
strategies for overcoming the selective barrier.  
Little is known about how KSHV targets the NPC therefore this thesis set out to 
explore how KSHV manipulates the NPC during its lytic infection. It looked to 
validate observations from previous whole cell quantitative proteomic data 
obtained by the Whitehouse Laboratory that indicated changes at the NPC during 
KSHV lytic infection. It also aimed to implement proximity dependent biotin 
identification (BioID) at the NPC during KSHV lytic replication, in combination with 
tandem mass tagging (TMT), to develop a semi-quantitative profile of how the 
NPC is altered over the course of KSHV lytic infection. 
Chapters 3 and 4 explored the specific targeting of nucleoporin Nup98 by KSHV 
early during lytic infection. This began with the observation that 8 h after the 
induction of KSHV lytic replication whole-cell Nup98 protein levels decreased by 
approximately half in the proteomic data (Figure 3.1a). This was confirmed by 
Western blot analysis and pointed to rapid targeting of this nucleoporin by the 
virus (Figure 3.1b). A number of other viruses have been shown to specifically 
target Nup98 during their lifecycles: Influenza A has been shown to downregulate 
Nup98 expression and sequester other components of RNA export machinery to 
inhibit export of host mRNAs; Vesicular stomatitis virus (VSV) interacts with 
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Rae1-Nup98 complexes to disrupt nucleocytoplasmic transport (von Kobbe C et 
al., 2000; Satterly et al., 2007; Chen et al., 2010; Rajani et al., 2012). 
Furthermore, Nup98 has also been shown to be interferon inducible, specifically 
in the case of the VSV export block, IFN-γ treatment or ectopic expression of 
Nup98 reverses virus-mediated disruption (Enninga et al., 2002). However, 
KSHV has been shown to suppress IFN signalling during lytic replication through 
the action of caspases (Tabtieng et al., 2018). Notwithstanding, Nup98 has also 
been shown to regulate antiviral genes in Drosophila as part of its off-pore role 
within the nucleoplasm (Panda et al., 2015). Therefore, it was hypothesised that 
KSHV targeted nucleoplasmic Nup98 due to its role modulating transcription of 
antiviral genes. This was supported by observations that the localisation and 
levels of Nup98 at the NPC did not appear to change during lytic replication 
(Figure 3.3). This can be compared with a more obvious depletion phenotype 
seen when TREx cells are treated with Nup98 siRNAs, in these cells a clear 
decrease in Nup98 levels can be observed at the NPC (Figure 4.4). Therefore, it 
was hypothesised that KSHV was specifically targeting the nucleoplasmic 
fraction of Nup98 in TREx cells during lytic replication. 
The viral transactivator protein RTA arose as the most likely determinant of 
Nup98 targeting during early lytic infection. RTA expression occurs rapidly on the 
switch from KSHV latency to lytic replication, making it highly likely there is 
sufficient levels of RTA at 8 h post reactivation to negatively impact endogenous 
Nup98 protein levels (Lukac et al., 1998; Nakamura et al., 2003). This was 
confirmed by transfecting an RTA overexpression construct into 293T cells which 
led to a significant decrease in Nup98 levels 24 h post transfection (Figure 3.4). 
RTA is a multifunctional transcriptional activator and repressor protein. It is able 
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to activate genes through a variety of mechanisms either through direct binding 
to specific DNA sequences called RTA response elements (RREs) or through 
interactions with other transcription factors such as RBP-Jk, AP1 and C/EBP 
(Liang et al., 2002; Wang et al., 2003; Liang and Ganem, 2004; Wang et al., 
2004). RTA is also able to suppress transcription through targeting proteins for 
proteasomal degradation such as Hey1, IRF7 and KSHV-RTA binding protein (K-
RBP) through its E3 ubiquitin ligase activity (Yu et al., 2005; Yang et al., 2008; 
Gould et al., 2009). Therefore, RTA could potentially be downregulating Nup98 
through a variety of mechanisms. However, qPCR analysis of both reactivated 
TREx and transfected 293T showed Nup98 mRNA did not decrease sufficiently 
to cause a decrease in Nup98 protein levels (Figure 3.1d and Figure 3.4c). This 
suggested RTA was targeting Nup98 protein levels through its E3 ubiquitin ligase 
domain. RTA has previously been shown to target transcriptional repressor Hey1 
for degradation via its E3 ubiquitin ligase domain in order to prevent Hey1 
repressing transcription at the ORF50 promoter (Gould et al., 2009). ICP0, an 
immediate-early HSV-1 lytic protein, also possesses a RING-finger ubiquitin 
ligase activity that acts to disrupt ND10 bodies in the nucleus that participate in 
host cell antiviral responses (Maul et al., 2000; Boutell et al., 2002; Gu and 
Roizman, 2003).  Utilising the proteasome inhibitor MG132, Nup98 degradation 
was shown to be dependent on proteasome activity both when overexpressing 
transfected RTA in 293T cells and during lytic replication in KSHV-infected B cells 
(Figure 3.5). Further efforts were made to co-immunoprecipitate RTA bound to 
Nup98 to support the hypothesis that RTA directly interacts with Nup98 to induce 
its degradation. These experiments were not successful but do not exclude the 
possibility that RTA is inducing the degradation of Nup98 (Figure 3.6). The 
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interaction between E3 ligases and their targets is highly dynamic through very 
weak, transient interactions making the determination of E3 ligase substrates 
technically difficult (Pierce et al., 2009).  
Having established that the decrease in Nup98 was dependent on RTA and the 
activity of the proteasome the crucial question now turned to why KSHV was 
targeting Nup98. As described above, Nup98 is interferon inducible and 
responsible for regulating antiviral genes. This suggested Nup98 might play a 
restrictive role on the virus which was explored in two experiments: the first by 
comparing immediate-early gene expression in Nup98-depleted TREx cells; the 
second by looking at the effect of overexpressing Nup98 and RTA in 293T cells 
along with a luciferase gene controlled by the ORF50 promoter. In Nup98-
depleted TREx cells, the absence of Nup98 had no impact on the expression of 
immediate-early gene ORF57 at both the mRNA and protein level (Figure 4.3). It 
was hypothesised that the absence of Nup98 might lead to either greater levels 
of spontaneous reactivation or increased ORF57 expression in the absence of 
Nup98 as a viral restriction factor. Neither was observed although this could be 
due to the doxycycline inducible mycRTA system for inducing lytic replication in 
TREx cells leading to overexpressed mycRTA that obscured an effect in Nup98-
depleted cells. However, the second experiment showed that overexpressing 
Nup98 and RTA led to decreased luciferase luminescence from the ORF50-
promoter in a dose-dependent manner suggesting Nup98 had a restrictive effect 
on the ORF50 promoter (Figure 3.8). ORF50 encodes for the viral transactivator 
RTA highlighting the importance to the virus of disrupting this restrictive role of 
Nup98 for successful viral lytic replication. The exact mechanism of how Nup98 
would repress expression at the ORF50 promoter is unclear, however, 
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nucleoplasmic Nup98 binds to promoters of developmental and cell cycle genes 
and when depleted from these sites gene expression is concomitantly 
downregulated (Kalverda et al., 2010; Capelson et al., 2010). Furthermore, the 
overexpression of Nup98 enhances the transcription of Nup98-bound genes, 
pointing to a key transcriptional role of Nup98 in the nucleoplasm (Kalverda et al., 
2010). Nup98 also plays a causative but poorly understood role in human 
leukaemia, with chromosomal translocations in acute myeloid leukaemia 
resulting in chimeric proteins containing the Nup98 FG-domain and homeobox 
transcription factors (Lam and Aplan, 2001). Both these domains are required for 
the transforming ability of these chimeric proteins which appear to potently active 
Hox genes (L H Kasper et al., 1999; Kroon, 2001; Argiropoulos and Humphries, 
2007). The Nup98 component of these chimeras recruits histone acetylases and 
deacetylases via its FG-repeat domain (L H Kasper et al., 1999; Bai et al., 2006; 
Wang et al., 2007). This multitude of mechanisms through which Nup98 exerts 
control over transcription makes identifying how Nup98 restricts ORF50 
transcription difficult to pinpoint although it is likely acting through a repressive 
binding partner. Attempts were made to transduce a Lentiviral GFP-Nup98 
overexpression construct into TREx cells in order to test whether this restricted 
the progress of KSHV lytic infection (Figure 3.10). However, poor levels of GFP-
Nup98 were detected suggesting either a low transduction efficiency or loss of 
the expression cassette. Attempts were made to use confocal microscopy to 
identify whether GFP-Nup98 positive cells exhibited an alternate phenotype to 
GFP-Nup98 negative cells on induction of lytic replication, however no phenotype 
was observed (Figure 3.11). These experiments were performed by reactivating 
cells with sodium butyrate, an alternative to induction via the doxycycline-
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inducible mycRTA system, due to concerns this overexpressed mycRTA would 
induce the degradation of Nup98 sufficiently to override any effect of GFP-Nup98. 
However, previously described Nup98 binding partners that could be responsible 
for repressing ORF50 expression including histone deacetylases that could also 
be inactivated by sodium butyrate treatment (Davie, 2003). Overall, the poor level 
of GFP-Nup98 expression and potentially confounding reactivation treatments of 
sodium butyrate and mycRTA make drawing conclusions from these experiments 
difficult.  
Whilst the above describes a potential role of nucleoplasmic Nup98 in acting a 
viral restriction factor further experiments depleting Nup98 from TREx cells 
showed a significant loss of Nup98 was detrimental to viral replication. Whilst 
Nup98-depletion had no impact on the expression of immediate-early KSHV lytic 
genes it did lead to reduce infectivity of virions produced at 72 h after the induction 
of lytic replication (Figure 4.5b). Whilst Nup98-depletion did not reduce viral DNA 
levels produced at this late stage it did lead to an apparent accumulation of viral 
capsid proteins at the cell periphery (Figure 4.6). KSHV virions assemble within 
the nucleus and have a multi-step egress mechanism that includes budding 
through the nuclear membrane (Mettenleiter et al., 2009). This posed an 
interesting question of how a nucleoporin was able to inhibit the final stage of 
egress at the plasma membrane. Serendipitously, work in 2016 highlighted the 
role of KSHV ORF10, a delayed early lytic protein, that selectively sequesters 
certain cellular mRNAs in the nucleus during lytic infection through interacting 
with RNA export adaptor Rae1 (Gong et al., 2016). One cellular transcript that 
was specifically retained encoded the cellular protein CHMP7, a member of the 
ESCRT-III family (Horii et al., 2006). ESCRT-III or endosomal sorting complexes 
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required for transport is a cellular protein complex involved in a variety of 
membrane remodelling processes within cells including the sorting of 
multivesicular bodies (MVB), membrane abscission during necroptosis, 
cytokinesis and formation of the nuclear pore complex (Guizetti, Schermelleh, 
Jana, et al., 2011; Webster et al., 2014; Gong et al., 2017). The nuclear retention 
of CHMP7 mRNA was confirmed by qRT-PCR of subcellular fractions and 
analysis of existing whole cell quantitative proteomic data showed a 100-fold 
reduction in CHMP7 protein levels at 24 h after the induction of KSHV lytic 
replication (Figure 4.7a and Figure 4.8a). This retention during lytic replication 
was shown to be ablated by Nup98 depletion by siRNA treatment and 
furthermore, led to increased levels of CHMP7 protein in Nup98-depleted TREx 
cells (Figure 4.8a). Overexpression of CHMP7 also produced a reduction in virion 
infectivity and led to an observable increase in viral capsid accumulation at the 
cell periphery (Figure 4.11b and Figure 4.12b). However, the transduction 
efficiency of these overexpression constructs was low (~20 %) and CHMP7 
overexpression could not be confirmed in cells with viral capsid accumulation due 
to antibody cross-reactivity. Whilst the ESCRT-III complex acts in a variety of 
roles within the cell attempts to determine how CHMP7 was able to induce viral 
capsid accumulation at the cell periphery focused on the role of ESCRT-III in 
plasma membrane repair. Necroptosis is a caspase-independent form of cell 
death that relies on receptor-interacting serine/threonine kinase 1 (RIPK1) as its 
primary regulator. RIPK1 mediates necroptosis in the absence of caspase 8 
activity leading to the autophosphorylation activation of the RIPK1 binding 
partner, RIPK3, to form the necrosome. This includes mixed-lineage kinase 
domain-like protein (MLKL) which is recruited by RIPK3 and phosphorylated. 
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MLKL then, by a poorly understood mechanism, localises to and destabilises the 
plasma membrane (Reviewed in (Weinlich et al., 2017)). It has been shown that 
ESCRT-III plays a role downstream of MLKL in shedding damaged sections of 
the plasma membrane. This helps maintain plasma membrane integrity so that 
dying cells are able to secrete cytokines and other signalling molecules into their 
microenvironment (Gong et al., 2017). It has been proposed that KSHV may 
indirectly induce necroptosis within infected cells through reduced caspase-8 
activity (Feoktistova et al., 2012). Therefore, CHMP7 could be sequestered by 
KSHV ORF10 to prevent it recruiting ESCRT-III to the plasma membrane during 
late lytic replication so as not to disrupt normal viral egress. However, this specific 
ESCRT-III mechanism may not be the key disrupting factor for viral infectivity. 
Some components of the ESCRT-III complex have been shown to be critical for 
successful herpesvirus egress (Crump et al., 2007; Pawliczek and Crump, 2009). 
Furthermore, the nuclear budding step of herpesviruses also appears to require 
ESCRT-III components (Lee et al., 2012; Arii et al., 2018). Therefore, the finding 
that KSHV specifically downregulates an ESCRT-III protein is intriguing and could 
relate to a more specialised role of CHMP7 such as in plasma membrane repair 
described above or in nuclear envelope reformation (Olmos et al., 2016). Overall, 
Nup98 depletion appears to disrupt KSHV lytic sequestering of a viral restriction 
factor CHMP7 mRNA. However, during KSHV lytic replication the targeted 
depletion of Nup98 does not achieve as significant a reduction in Nup98 as 
achieved by siRNA treatment. This suggests that KSHV specifically targets the 
non-pore bound fraction of Nup98 to aid with early lytic replication but does not 
deplete Nup98 at the NPC.  
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Overall, Nup98 targeting by KSHV appears to be dynamic and responsive to the 
alternate subcellular fractions of Nup98 within the cell (Figure 6.1). KSHV 
appears to require Nup98 presence at a certain level at the NPC during lytic 
replication in order to ensure the function of KSHV ORF10 protein and its 
interaction with Rae1. If Nup98 levels are depleted sufficiently, the ORF10-Rae1 
interaction fails to sequester cellular mRNAs in the nucleus allowing for their 
continued transcription at a level greater than when Nup98 is present at the NPC. 
This allows for CHMP7 expression to be maintained and remain functional later 
during KSHV lytic replication, which may then play a role disrupting viral egress. 
Nevertheless, KSHV actively targets the a non-pore fraction of Nup98 through 
the E3 ligase activity of immediate-early protein RTA. This appears to prevent the 
inhibitory effect of Nup98 on transcription at the ORF50 promoter and may involve 
Nup98 recruiting a nucleoplasmic binding partner that represses transcription. 
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Figure 6.1 Schematic of the proposed role of Nup98 during KSHV infection. During latency Nup98 is 
present at the nuclear pore assisting Rae1 with mRNA export and in the nucleoplasm bound to the KSHV 
ORF50 promoter where it recruits repressor proteins to inhibit ORF50 transcription. On the lytic switch (red 
arrows) Nup98 is targeted in both pools by the virus, at the nuclear pore Nup98 is required by KSHV to 
anchor Rae1 to the NPC in order for KSHV ORF10 protein to sequester specific cellular mRNAs in the 
nucleus. In the nucleoplasm, RTA targets Nup98 for degradation helping remove repressor proteins allowing 
for RTA to trigger a feedback loop of ORF50 expression. 
 
Future work should look to build on these observations through three key 
questions: does Nup98 bind at the ORF50 promoter, can Nup98 be 
overexpressed in the nucleoplasm and prevent the latent-lytic switch of KSHV, 
and finally do histone modifications at the ORF50 promoter depend on Nup98. 
The first question can be answered by continuing to use chromatin 
immunoprecipitation (ChIP) experiments in unreactivated and reactivated TREx 
cells. Initial work using a previously published Nup98 ChIP antibody were 
unsuccessful but future work should look to utilising the well-published 2H10 rat 
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monoclonal that was used for other Nup98 experiments in this thesis. 
Identification of Nup98 binding at the ORF50 promoter during KSHV latency is 
the first crucial step in confirming the potential negative regulatory role of Nup98 
on the virus. The second question, using Nup98 overexpression constructs to 
repress the induction of KSHV lytic replication is more complex. As shown in 
previous chapters, there was no observed effect on KSHV lytic replication in 
TREx overexpressing GFP-Nup98 when induced to lytic replication with sodium 
butyrate. The difficulty of successfully inducing lytic replication without 
overexpressing the viral transactivator protein RTA or inducing global histone 
remodelling via HDACi means experiments to test for the protective effect of 
Nup98 should utilise alternate reactivation mechanisms. Previous work shows 
that KSHV lytic replication can be induced by increasing oxidative stress, hypoxia 
and treatment with virus-like vesicles (Davis et al., 2001; Horii et al., 2006; Li et 
al., 2011). Future experiments should attempt to induce KSHV lytic replication 
through these alternate stimuli in GFP-Nup98 overexpressing cells to 
characterise its potential protective effect. Finally, the question of confirming 
Nup98-dependent histone modifications at the ORF50 promoter will require work 
using ChIP for specific histone markers, with previous studies showing that during 
latency ORF50 exhibits H3K4me3 and H3K27me3 modifications (Günther and 
Grundhoff, 2010; Toth et al., 2013). 
In chapter 5, the novel interactomic technique BioID was combined with TMT to 
create a quantitative profile of changes at the NPC during KSHV lytic infection. 
This built on previously established usage of BioID-nucleoporin fusion proteins 
that were shown to provide good coverage of the NPC (Kim et al., 2014). After 
difficulties establishing a good transfection efficiency and subcellular targeting of 
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these constructs it was decided to perform the experiments using transient 
transfections of TREx cells (Figure 5.3). BioID-nucleoporins were transfected into 
cells that were either maintained in the latent state or induced to lytic replication. 
The results of these experiments were by and large disappointing with minimal 
purification of other components of the NPC (Figure 5.4). This can be attributed 
to the low transfection efficiency which in conjunction with a stringent purification 
procedure made it difficult to harvest a high concentration of proteins. 
Nevertheless, the combination of BioID and TMT provide a small level of insight 
in changes around the nuclear envelope microenvironment during KSHV lytic 
infection. During lytic infection there was an observed increase in the level of 
proteins associated with the ribonucleoprotein complex, including preribosomal 
components, in the vicinity of the nuclear envelope. This potentially points to 
increased transport of ribosomal components during KSHV lytic infection which 
could relate to the concept of virally induced specialised ribosomes, which has 
been proposed to occur during KSHV lytic infection (Bussey et al., 2018).  
Future efforts to utilise BioID to characterise changes at the NPC during viral 
infection should focus on developing stably expressing inducible BioID-
nucleoporins. Through communication with the Roux laboratory it was highlighted 
that their stably expressing HEK293T cell lines were selected for low BioID-
nucleoporin expression levels (Personal communication). This was due to 
common mistargeting of the BioID-nucleoporins into the cytoplasm, typically in 
the annulate laemella region. Transient transfections into latently infected B cells, 
exhibited good nuclear envelope staining with no mistargeting however attempts 
to select for stably expressing cells produced strong mistargeting effects. To 
alleviate these problems future attempts could look to use inducible expression 
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systems to regulate BioID-nucleoporin expression to ensure the prevention of 
major mistargeting effects (Firat-Karalar et al., 2014). Furthermore, recent 
advances in developing a lentiviral BioID toolkit mean that overcoming the 
problem of transfection efficiency in the traditionally difficult to transfect B cell line 
may also be possible (Samavarchi-Tehrani et al., 2018). Finally, the use of a 
smaller, more efficient biotin ligase, BioID2, should also be considered. This 
smaller ligase requires less biotin supplementation but achieves enhanced 
labelling activity (Kim et al., 2016). 
Overall, the work within this thesis expands our understanding of KSHV 
interactions with key cellular processes during lytic infection. This work provides 
enticing observations into how KSHV specifically remodels the NPC to aid its 
replication and highlights the importance of one specific nucleoporin, Nup98. The 
importance of targeting Nup98 early during KSHV lytic infection may provide a 
new avenue for developing therapeutics that prevent the transition to lytic 
infection which is a key stage in the development of KSHV-related malignancy. 
Furthermore, this work has highlighted how the dualistic nature of Nup98 is 
exploited by the virus, both by targeting its nucleoplasmic role and by requiring 
Nup98 at the NPC. Finally, this thesis lays out an initial attempt at using 
interactomic techniques to produce a more comprehensive map of viral 
interactions and induced changes at the nuclear pore complex and provides a 
guide on how to develop this approach further. 
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